Motif 437 (n=282)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A0A0B4J203 | None | S808 | ochoa | receptor protein-tyrosine kinase (EC 2.7.10.1) | None |
A0AV02 | SLC12A8 | S665 | ochoa | Solute carrier family 12 member 8 (Cation-chloride cotransporter 9) | Cation/chloride cotransporter that may play a role in the control of keratinocyte proliferation. {ECO:0000269|PubMed:11863360}. |
A6H8Y1 | BDP1 | S1784 | ochoa | Transcription factor TFIIIB component B'' homolog (Transcription factor IIIB 150) (TFIIIB150) (Transcription factor-like nuclear regulator) | General activator of RNA polymerase III transcription. Requires for transcription from all three types of polymerase III promoters. Requires for transcription of genes with internal promoter elements and with promoter elements upstream of the initiation site. {ECO:0000269|PubMed:11040218}. |
A6NKG5 | RTL1 | S1030 | ochoa | Retrotransposon-like protein 1 (Mammalian retrotransposon derived protein 1) (Paternally expressed gene 11 protein) (Retrotransposon-derived protein PEG11) | Plays an essential role in capillaries endothelial cells for the maintenance of feto-maternal interface and for development of the placenta. {ECO:0000250}. |
C9J069 | AJM1 | S512 | ochoa | Apical junction component 1 homolog | May be involved in the control of adherens junction integrity. {ECO:0000250|UniProtKB:A0A1C3NSL9}. |
H0YJW9 | None | S64 | ochoa | Uncharacterized protein | None |
O14924 | RGS12 | S879 | ochoa | Regulator of G-protein signaling 12 (RGS12) | Regulates G protein-coupled receptor signaling cascades. Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form. {ECO:0000250|UniProtKB:O08774}.; FUNCTION: [Isoform 5]: Behaves as a cell cycle-dependent transcriptional repressor, promoting inhibition of S-phase DNA synthesis. {ECO:0000269|PubMed:12024043}. |
O15085 | ARHGEF11 | S592 | ochoa | Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF) | May play a role in the regulation of RhoA GTPase by guanine nucleotide-binding alpha-12 (GNA12) and alpha-13 (GNA13). Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPase and may act as GTPase-activating protein (GAP) for GNA12 and GNA13. Involved in neurotrophin-induced neurite outgrowth. {ECO:0000269|PubMed:21670212}. |
O15403 | SLC16A6 | S240 | ochoa | Monocarboxylate transporter 7 (MCT 7) (Monocarboxylate transporter 6) (MCT 6) (Solute carrier family 16 member 6) | Monocarboxylate transporter selective for taurine. May associate with BSG/CD147 or EMB/GP70 ancillary proteins to mediate facilitative efflux or influx of taurine across the plasma membrane. The transport is pH- and sodium-independent. Rather low-affinity, is likely effective for taurine transport in tissues where taurine is present at high concentrations. {ECO:0000250|UniProtKB:Q7TMR7}. |
O15417 | TNRC18 | S2375 | ochoa | Trinucleotide repeat-containing gene 18 protein (Long CAG trinucleotide repeat-containing gene 79 protein) | None |
O43149 | ZZEF1 | S1540 | ochoa | Zinc finger ZZ-type and EF-hand domain-containing protein 1 | Histone H3 reader which may act as a transcriptional coactivator for KLF6 and KLF9 transcription factors. {ECO:0000269|PubMed:33227311}. |
O43493 | TGOLN2 | S224 | ochoa | Trans-Golgi network integral membrane protein 2 (Trans-Golgi network glycoprotein 46) (TGN38 homolog) (hTGN46) (Trans-Golgi network glycoprotein 48) (hTGN48) (Trans-Golgi network glycoprotein 51) (hTGN51) (Trans-Golgi network protein 2) | May be involved in regulating membrane traffic to and from trans-Golgi network. |
O43683 | BUB1 | S250 | psp | Mitotic checkpoint serine/threonine-protein kinase BUB1 (hBUB1) (EC 2.7.11.1) (BUB1A) | Serine/threonine-protein kinase that performs 2 crucial functions during mitosis: it is essential for spindle-assembly checkpoint signaling and for correct chromosome alignment. Has a key role in the assembly of checkpoint proteins at the kinetochore, being required for the subsequent localization of CENPF, BUB1B, CENPE and MAD2L1. Required for the kinetochore localization of PLK1. Required for centromeric enrichment of AUKRB in prometaphase. Plays an important role in defining SGO1 localization and thereby affects sister chromatid cohesion. Promotes the centromeric localization of TOP2A (PubMed:35044816). Acts as a substrate for anaphase-promoting complex or cyclosome (APC/C) in complex with its activator CDH1 (APC/C-Cdh1). Necessary for ensuring proper chromosome segregation and binding to BUB3 is essential for this function. Can regulate chromosome segregation in a kinetochore-independent manner. Can phosphorylate BUB3. The BUB1-BUB3 complex plays a role in the inhibition of APC/C when spindle-assembly checkpoint is activated and inhibits the ubiquitin ligase activity of APC/C by phosphorylating its activator CDC20. This complex can also phosphorylate MAD1L1. Kinase activity is essential for inhibition of APC/CCDC20 and for chromosome alignment but does not play a major role in the spindle-assembly checkpoint activity. Mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. {ECO:0000269|PubMed:10198256, ECO:0000269|PubMed:15020684, ECO:0000269|PubMed:15525512, ECO:0000269|PubMed:15723797, ECO:0000269|PubMed:16760428, ECO:0000269|PubMed:17158872, ECO:0000269|PubMed:19487456, ECO:0000269|PubMed:20739936, ECO:0000269|PubMed:35044816}. |
O43822 | CFAP410 | S166 | ochoa | Cilia- and flagella-associated protein 410 (C21orf-HUMF09G8.5) (Leucine-rich repeat-containing protein 76) (YF5/A2) | Plays a role in cilia formation and/or maintenance (By similarity). Plays a role in the regulation of cell morphology and cytoskeletal organization (PubMed:21834987). Involved in DNA damage repair (PubMed:26290490). {ECO:0000250|UniProtKB:Q8C6G1, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:26290490}. |
O60238 | BNIP3L | S120 | ochoa | BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) | Induces apoptosis. Interacts with viral and cellular anti-apoptosis proteins. Can overcome the suppressors BCL-2 and BCL-XL, although high levels of BCL-XL expression will inhibit apoptosis. Inhibits apoptosis induced by BNIP3. Involved in mitochondrial quality control via its interaction with SPATA18/MIEAP: in response to mitochondrial damage, participates in mitochondrial protein catabolic process (also named MALM) leading to the degradation of damaged proteins inside mitochondria. The physical interaction of SPATA18/MIEAP, BNIP3 and BNIP3L/NIX at the mitochondrial outer membrane regulates the opening of a pore in the mitochondrial double membrane in order to mediate the translocation of lysosomal proteins from the cytoplasm to the mitochondrial matrix. May function as a tumor suppressor. {ECO:0000269|PubMed:10381623, ECO:0000269|PubMed:21264228}. |
O60333 | KIF1B | S1057 | ochoa | Kinesin-like protein KIF1B (Klp) (EC 5.6.1.3) | Has a plus-end-directed microtubule motor activity and functions as a motor for transport of vesicles and organelles along microtubules. {ECO:0000269|PubMed:16225668}.; FUNCTION: [Isoform 2]: Has a plus-end-directed microtubule motor activity and functions as a motor for anterograde synaptic vesicle transport along axonal microtubules from the cell body to the presynapse in neuronal cells (By similarity). Functions as a downstream effector in a developmental apoptotic pathway that is activated when nerve growth factor (NGF) becomes limiting for neuronal progenitor cells (PubMed:18334619). {ECO:0000250|UniProtKB:Q60575, ECO:0000269|PubMed:18334619}.; FUNCTION: [Isoform 3]: Has a plus-end-directed microtubule motor activity and functions as a motor for anterograde transport of mitochondria. {ECO:0000269|PubMed:16225668}. |
O75044 | SRGAP2 | S799 | ochoa | SLIT-ROBO Rho GTPase-activating protein 2 (srGAP2) (Formin-binding protein 2) (Rho GTPase-activating protein 34) | Postsynaptic RAC1 GTPase activating protein (GAP) that plays a key role in neuronal morphogenesis and migration mainly during development of the cerebral cortex (PubMed:20810653, PubMed:27373832, PubMed:28333212). Regulates excitatory and inhibitory synapse maturation and density in cortical pyramidal neurons (PubMed:22559944, PubMed:27373832). SRGAP2/SRGAP2A limits excitatory and inhibitory synapse density through its RAC1-specific GTPase activating activity, while it promotes maturation of both excitatory and inhibitory synapses through its ability to bind to the postsynaptic scaffolding protein HOMER1 at excitatory synapses, and the postsynaptic protein GPHN at inhibitory synapses (By similarity). Mechanistically, acts by binding and deforming membranes, thereby regulating actin dynamics to regulate cell migration and differentiation (PubMed:27373832). Promotes cell repulsion and contact inhibition of locomotion: localizes to protrusions with curved edges and controls the duration of RAC1 activity in contact protrusions (By similarity). In non-neuronal cells, may also play a role in cell migration by regulating the formation of lamellipodia and filopodia (PubMed:20810653, PubMed:21148482). {ECO:0000250|UniProtKB:Q91Z67, ECO:0000269|PubMed:20810653, ECO:0000269|PubMed:21148482, ECO:0000269|PubMed:22559944, ECO:0000269|PubMed:27373832, ECO:0000269|PubMed:28333212}. |
O75334 | PPFIA2 | S263 | ochoa | Liprin-alpha-2 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-2) (PTPRF-interacting protein alpha-2) | Alters PTPRF cellular localization and induces PTPRF clustering. May regulate the disassembly of focal adhesions. May localize receptor-like tyrosine phosphatases type 2A at specific sites on the plasma membrane, possibly regulating their interaction with the extracellular environment and their association with substrates. In neuronal cells, is a scaffolding protein in the dendritic spines which acts as immobile postsynaptic post able to recruit KIF1A-driven dense core vesicles to dendritic spines (PubMed:30021165). {ECO:0000269|PubMed:30021165, ECO:0000269|PubMed:9624153}. |
O75385 | ULK1 | S719 | ochoa | Serine/threonine-protein kinase ULK1 (EC 2.7.11.1) (Autophagy-related protein 1 homolog) (ATG1) (hATG1) (Unc-51-like kinase 1) | Serine/threonine-protein kinase involved in autophagy in response to starvation (PubMed:18936157, PubMed:21460634, PubMed:21795849, PubMed:23524951, PubMed:25040165, PubMed:29487085, PubMed:31123703). Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes (PubMed:18936157, PubMed:21460634, PubMed:21795849, PubMed:25040165). Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR (PubMed:21795849). Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity (PubMed:21460634). May phosphorylate ATG13/KIAA0652 and RPTOR; however such data need additional evidences (PubMed:18936157). Plays a role early in neuronal differentiation and is required for granule cell axon formation (PubMed:11146101). Also phosphorylates SESN2 and SQSTM1 to regulate autophagy (PubMed:25040165, PubMed:37306101). Phosphorylates FLCN, promoting autophagy (PubMed:25126726). Phosphorylates AMBRA1 in response to autophagy induction, releasing AMBRA1 from the cytoskeletal docking site to induce autophagosome nucleation (PubMed:20921139). Phosphorylates ATG4B, leading to inhibit autophagy by decreasing both proteolytic activation and delipidation activities of ATG4B (PubMed:28821708). {ECO:0000269|PubMed:11146101, ECO:0000269|PubMed:18936157, ECO:0000269|PubMed:20921139, ECO:0000269|PubMed:21460634, ECO:0000269|PubMed:21795849, ECO:0000269|PubMed:23524951, ECO:0000269|PubMed:25040165, ECO:0000269|PubMed:25126726, ECO:0000269|PubMed:28821708, ECO:0000269|PubMed:29487085, ECO:0000269|PubMed:31123703, ECO:0000269|PubMed:37306101}. |
O75533 | SF3B1 | S488 | ochoa | Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155) | Component of the 17S U2 SnRNP complex of the spliceosome, a large ribonucleoprotein complex that removes introns from transcribed pre-mRNAs (PubMed:12234937, PubMed:27720643, PubMed:32494006, PubMed:34822310). The 17S U2 SnRNP complex (1) directly participates in early spliceosome assembly and (2) mediates recognition of the intron branch site during pre-mRNA splicing by promoting the selection of the pre-mRNA branch-site adenosine, the nucleophile for the first step of splicing (PubMed:32494006, PubMed:34822310). Within the 17S U2 SnRNP complex, SF3B1 is part of the SF3B subcomplex, which is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence in pre-mRNA (PubMed:12234937). Sequence independent binding of SF3A and SF3B subcomplexes upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA (PubMed:12234937). May also be involved in the assembly of the 'E' complex (PubMed:10882114). Also acts as a component of the minor spliceosome, which is involved in the splicing of U12-type introns in pre-mRNAs (PubMed:15146077, PubMed:33509932). Together with other U2 snRNP complex components may also play a role in the selective processing of microRNAs (miRNAs) from the long primary miRNA transcript, pri-miR-17-92 (By similarity). {ECO:0000250|UniProtKB:Q99NB9, ECO:0000269|PubMed:10882114, ECO:0000269|PubMed:12234937, ECO:0000269|PubMed:15146077, ECO:0000269|PubMed:27720643, ECO:0000269|PubMed:32494006, ECO:0000269|PubMed:33509932, ECO:0000269|PubMed:34822310}. |
O75554 | WBP4 | S280 | ochoa | WW domain-binding protein 4 (WBP-4) (Formin-binding protein 21) (WW domain-containing-binding protein 4) | Involved in pre-mRNA splicing as a component of the spliceosome (PubMed:19592703, PubMed:28781166, PubMed:9724750). May play a role in cross-intron bridging of U1 and U2 snRNPs in the mammalian A complex (PubMed:9724750). {ECO:0000269|PubMed:19592703, ECO:0000269|PubMed:28781166, ECO:0000269|PubMed:9724750}. |
O94762 | RECQL5 | S491 | ochoa | ATP-dependent DNA helicase Q5 (EC 5.6.2.4) (DNA 3'-5' helicase RecQ5) (DNA helicase, RecQ-like type 5) (RecQ5) (RecQ protein-like 5) | DNA helicase that plays an important role in DNA replication, transcription and repair (PubMed:20643585, PubMed:22973052, PubMed:28100692). Probably unwinds DNA in a 3'-5' direction (Probable) (PubMed:28100692). Binds to the RNA polymerase II subunit POLR2A during transcription elongation and suppresses transcription-associated genomic instability (PubMed:20231364). Also associates with POLR1A and enforces the stability of ribosomal DNA arrays (PubMed:27502483). Plays an important role in mitotic chromosome separation after cross-over events and cell cycle progress (PubMed:22013166). Mechanistically, removes RAD51 filaments protecting stalled replication forks at common fragile sites and stimulates MUS81-EME1 endonuclease leading to mitotic DNA synthesis (PubMed:28575661). Required for efficient DNA repair, including repair of inter-strand cross-links (PubMed:23715498). Stimulates DNA decatenation mediated by TOP2A. Prevents sister chromatid exchange and homologous recombination. A core helicase fragment (residues 11-609) binds preferentially to splayed duplex, looped and ssDNA (PubMed:28100692). {ECO:0000269|PubMed:20231364, ECO:0000269|PubMed:20348101, ECO:0000269|PubMed:20643585, ECO:0000269|PubMed:22013166, ECO:0000269|PubMed:22973052, ECO:0000269|PubMed:23715498, ECO:0000269|PubMed:23748380, ECO:0000269|PubMed:27502483, ECO:0000269|PubMed:28100692, ECO:0000269|PubMed:28575661, ECO:0000305|PubMed:28100692}. |
O94804 | STK10 | S374 | ochoa | Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase) | Serine/threonine-protein kinase involved in regulation of lymphocyte migration. Phosphorylates MSN, and possibly PLK1. Involved in regulation of lymphocyte migration by mediating phosphorylation of ERM proteins such as MSN. Acts as a negative regulator of MAP3K1/MEKK1. May also act as a cell cycle regulator by acting as a polo kinase kinase: mediates phosphorylation of PLK1 in vitro; however such data require additional evidences in vivo. {ECO:0000269|PubMed:11903060, ECO:0000269|PubMed:12639966, ECO:0000269|PubMed:19255442}. |
O94888 | UBXN7 | S288 | ochoa | UBX domain-containing protein 7 | Ubiquitin-binding adapter that links a subset of NEDD8-associated cullin ring ligases (CRLs) to the segregase VCP/p97, to regulate turnover of their ubiquitination substrates. {ECO:0000269|PubMed:22537386}. |
O95251 | KAT7 | S102 | ochoa | Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2) | Catalytic subunit of histone acetyltransferase HBO1 complexes, which specifically mediate acetylation of histone H3 at 'Lys-14' (H3K14ac), thereby regulating various processes, such as gene transcription, protein ubiquitination, immune regulation, stem cell pluripotent and self-renewal maintenance and embryonic development (PubMed:16387653, PubMed:21753189, PubMed:24065767, PubMed:26620551, PubMed:31767635, PubMed:31827282). Some complexes also catalyze acetylation of histone H4 at 'Lys-5', 'Lys-8' and 'Lys-12' (H4K5ac, H4K8ac and H4K12ac, respectively), regulating DNA replication initiation, regulating DNA replication initiation (PubMed:10438470, PubMed:19187766, PubMed:20129055, PubMed:24065767). Specificity of the HBO1 complexes is determined by the scaffold subunit: complexes containing BRPF scaffold (BRPF1, BRD1/BRPF2 or BRPF3) direct KAT7/HBO1 specificity towards H3K14ac, while complexes containing JADE (JADE1, JADE2 and JADE3) scaffold direct KAT7/HBO1 specificity towards histone H4 (PubMed:19187766, PubMed:20129055, PubMed:24065767, PubMed:26620551). H3K14ac promotes transcriptional elongation by facilitating the processivity of RNA polymerase II (PubMed:31827282). Acts as a key regulator of hematopoiesis by forming a complex with BRD1/BRPF2, directing KAT7/HBO1 specificity towards H3K14ac and promoting erythroid differentiation (PubMed:21753189). H3K14ac is also required for T-cell development (By similarity). KAT7/HBO1-mediated acetylation facilitates two consecutive steps, licensing and activation, in DNA replication initiation: H3K14ac facilitates the activation of replication origins, and histone H4 acetylation (H4K5ac, H4K8ac and H4K12ac) facilitates chromatin loading of MCM complexes, promoting DNA replication licensing (PubMed:10438470, PubMed:11278932, PubMed:18832067, PubMed:19187766, PubMed:20129055, PubMed:21856198, PubMed:24065767, PubMed:26620551). Acts as a positive regulator of centromeric CENPA assembly: recruited to centromeres and mediates histone acetylation, thereby preventing centromere inactivation mediated by SUV39H1, possibly by increasing histone turnover/exchange (PubMed:27270040). Involved in nucleotide excision repair: phosphorylation by ATR in response to ultraviolet irradiation promotes its localization to DNA damage sites, where it mediates histone acetylation to facilitate recruitment of XPC at the damaged DNA sites (PubMed:28719581). Acts as an inhibitor of NF-kappa-B independently of its histone acetyltransferase activity (PubMed:16997280). {ECO:0000250|UniProtKB:Q5SVQ0, ECO:0000269|PubMed:10438470, ECO:0000269|PubMed:11278932, ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:16997280, ECO:0000269|PubMed:18832067, ECO:0000269|PubMed:19187766, ECO:0000269|PubMed:20129055, ECO:0000269|PubMed:21753189, ECO:0000269|PubMed:21856198, ECO:0000269|PubMed:24065767, ECO:0000269|PubMed:26620551, ECO:0000269|PubMed:27270040, ECO:0000269|PubMed:28719581, ECO:0000269|PubMed:31767635, ECO:0000269|PubMed:31827282}.; FUNCTION: Plays a central role in the maintenance of leukemia stem cells in acute myeloid leukemia (AML) (PubMed:31827282). Acts by mediating acetylation of histone H3 at 'Lys-14' (H3K14ac), thereby facilitating the processivity of RNA polymerase II to maintain the high expression of key genes, such as HOXA9 and HOXA10 that help to sustain the functional properties of leukemia stem cells (PubMed:31827282). {ECO:0000269|PubMed:31827282}. |
P01042 | KNG1 | S332 | ochoa | Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor] | Kininogens are inhibitors of thiol proteases. HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII; HMW-kininogen inhibits the thrombin- and plasmin-induced aggregation of thrombocytes. LMW-kininogen inhibits the aggregation of thrombocytes. LMW-kininogen is in contrast to HMW-kininogen not involved in blood clotting.; FUNCTION: [Bradykinin]: The active peptide bradykinin is a potent vasodilatator that is released from HMW-kininogen shows a variety of physiological effects: (A) influence in smooth muscle contraction, (B) induction of hypotension, (C) natriuresis and diuresis, (D) decrease in blood glucose level, (E) it is a mediator of inflammation and causes (E1) increase in vascular permeability, (E2) stimulation of nociceptors (4E3) release of other mediators of inflammation (e.g. prostaglandins), (F) it has a cardioprotective effect (directly via bradykinin action, indirectly via endothelium-derived relaxing factor action). {ECO:0000305|PubMed:4322742, ECO:0000305|PubMed:6055465}. |
P04004 | VTN | S406 | ochoa | Vitronectin (VN) (S-protein) (Serum-spreading factor) (V75) [Cleaved into: Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B] | Vitronectin is a cell adhesion and spreading factor found in serum and tissues. Vitronectin interact with glycosaminoglycans and proteoglycans. Is recognized by certain members of the integrin family and serves as a cell-to-substrate adhesion molecule. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway.; FUNCTION: Somatomedin-B is a growth hormone-dependent serum factor with protease-inhibiting activity. |
P08238 | HSP90AB1 | S468 | ochoa | Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84) (Heat shock protein family C member 3) | Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle linked to its ATPase activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function (PubMed:16478993, PubMed:19696785). Engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself. Recruitment of ATP and co-chaperone followed by client protein forms a functional chaperone. After the completion of the chaperoning process, properly folded client protein and co-chaperone leave HSP90 in an ADP-bound partially open conformation and finally, ADP is released from HSP90 which acquires an open conformation for the next cycle (PubMed:26991466, PubMed:27295069). Apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. HSP90 and its co-chaperones modulate transcription at least at three different levels. They first alter the steady-state levels of certain transcription factors in response to various physiological cues. Second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or DNA methyl transferases, and thereby respond to the change in the environment. Third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression (PubMed:25973397). Antagonizes STUB1-mediated inhibition of TGF-beta signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and degradation (PubMed:24613385). Promotes cell differentiation by chaperoning BIRC2 and thereby protecting from auto-ubiquitination and degradation by the proteasomal machinery (PubMed:18239673). Main chaperone involved in the phosphorylation/activation of the STAT1 by chaperoning both JAK2 and PRKCE under heat shock and in turn, activates its own transcription (PubMed:20353823). Involved in the translocation into ERGIC (endoplasmic reticulum-Golgi intermediate compartment) of leaderless cargos (lacking the secretion signal sequence) such as the interleukin 1/IL-1; the translocation process is mediated by the cargo receptor TMED10 (PubMed:32272059). {ECO:0000269|PubMed:16478993, ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:19696785, ECO:0000269|PubMed:20353823, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:32272059, ECO:0000303|PubMed:25973397, ECO:0000303|PubMed:26991466, ECO:0000303|PubMed:27295069}.; FUNCTION: (Microbial infection) Binding to N.meningitidis NadA stimulates monocytes (PubMed:21949862). Seems to interfere with N.meningitidis NadA-mediated invasion of human cells (Probable). {ECO:0000269|PubMed:21949862, ECO:0000305|PubMed:22066472}. |
P0C7T5 | ATXN1L | S292 | ochoa | Ataxin-1-like (Brother of ataxin-1) (Brother of ATXN1) | Chromatin-binding factor that repress Notch signaling in the absence of Notch intracellular domain by acting as a CBF1 corepressor. Binds to the HEY promoter and might assist, along with NCOR2, RBPJ-mediated repression (PubMed:21475249). Can suppress ATXN1 cytotoxicity in spinocerebellar ataxia type 1 (SCA1). In concert with CIC and ATXN1, involved in brain development (By similarity). {ECO:0000250|UniProtKB:P0C7T6, ECO:0000269|PubMed:21475249}. |
P11137 | MAP2 | S1133 | ochoa | Microtubule-associated protein 2 (MAP-2) | The exact function of MAP2 is unknown but MAPs may stabilize the microtubules against depolymerization. They also seem to have a stiffening effect on microtubules. |
P11171 | EPB41 | S95 | ochoa | Protein 4.1 (P4.1) (4.1R) (Band 4.1) (EPB4.1) (Erythrocyte membrane protein band 4.1) | Protein 4.1 is a major structural element of the erythrocyte membrane skeleton. It plays a key role in regulating membrane physical properties of mechanical stability and deformability by stabilizing spectrin-actin interaction. Recruits DLG1 to membranes. Required for dynein-dynactin complex and NUMA1 recruitment at the mitotic cell cortex during anaphase (PubMed:23870127). {ECO:0000269|PubMed:23870127}. |
P11362 | FGFR1 | S789 | ochoa|psp | Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331) | Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation. {ECO:0000250|UniProtKB:P16092, ECO:0000269|PubMed:10830168, ECO:0000269|PubMed:11353842, ECO:0000269|PubMed:12181353, ECO:0000269|PubMed:1379697, ECO:0000269|PubMed:1379698, ECO:0000269|PubMed:15117958, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17623664, ECO:0000269|PubMed:18480409, ECO:0000269|PubMed:19224897, ECO:0000269|PubMed:19261810, ECO:0000269|PubMed:19665973, ECO:0000269|PubMed:20133753, ECO:0000269|PubMed:20139426, ECO:0000269|PubMed:21765395, ECO:0000269|PubMed:8622701, ECO:0000269|PubMed:8663044}. |
P13010 | XRCC5 | S580 | ochoa|psp | X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)) | Single-stranded DNA-dependent ATP-dependent helicase that plays a key role in DNA non-homologous end joining (NHEJ) by recruiting DNA-PK to DNA (PubMed:11493912, PubMed:12145306, PubMed:7957065, PubMed:8621488). Required for double-strand break repair and V(D)J recombination (PubMed:11493912, PubMed:12145306, PubMed:7957065, PubMed:8621488). Also has a role in chromosome translocation (PubMed:11493912, PubMed:12145306, PubMed:7957065, PubMed:8621488). The DNA helicase II complex binds preferentially to fork-like ends of double-stranded DNA in a cell cycle-dependent manner (PubMed:11493912, PubMed:12145306, PubMed:7957065, PubMed:8621488). It works in the 3'-5' direction (PubMed:11493912, PubMed:12145306, PubMed:7957065, PubMed:8621488). During NHEJ, the XRCC5-XRRC6 dimer performs the recognition step: it recognizes and binds to the broken ends of the DNA and protects them from further resection (PubMed:11493912, PubMed:12145306, PubMed:7957065, PubMed:8621488). Binding to DNA may be mediated by XRCC6 (PubMed:11493912, PubMed:12145306, PubMed:7957065, PubMed:8621488). The XRCC5-XRRC6 dimer acts as a regulatory subunit of the DNA-dependent protein kinase complex DNA-PK by increasing the affinity of the catalytic subunit PRKDC to DNA by 100-fold (PubMed:11493912, PubMed:12145306, PubMed:20383123, PubMed:7957065, PubMed:8621488). The XRCC5-XRRC6 dimer is probably involved in stabilizing broken DNA ends and bringing them together (PubMed:12145306, PubMed:20383123, PubMed:7957065, PubMed:8621488). The assembly of the DNA-PK complex to DNA ends is required for the NHEJ ligation step (PubMed:12145306, PubMed:20383123, PubMed:7957065, PubMed:8621488). The XRCC5-XRRC6 dimer probably also acts as a 5'-deoxyribose-5-phosphate lyase (5'-dRP lyase), by catalyzing the beta-elimination of the 5' deoxyribose-5-phosphate at an abasic site near double-strand breaks (PubMed:20383123). XRCC5 probably acts as the catalytic subunit of 5'-dRP activity, and allows to 'clean' the termini of abasic sites, a class of nucleotide damage commonly associated with strand breaks, before such broken ends can be joined (PubMed:20383123). The XRCC5-XRRC6 dimer together with APEX1 acts as a negative regulator of transcription (PubMed:8621488). In association with NAA15, the XRCC5-XRRC6 dimer binds to the osteocalcin promoter and activates osteocalcin expression (PubMed:12145306). As part of the DNA-PK complex, involved in the early steps of ribosome assembly by promoting the processing of precursor rRNA into mature 18S rRNA in the small-subunit processome (PubMed:32103174). Binding to U3 small nucleolar RNA, recruits PRKDC and XRCC5/Ku86 to the small-subunit processome (PubMed:32103174). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728). {ECO:0000269|PubMed:11493912, ECO:0000269|PubMed:12145306, ECO:0000269|PubMed:20383123, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:32103174, ECO:0000269|PubMed:7957065, ECO:0000269|PubMed:8621488}. |
P13804 | ETFA | S192 | ochoa | Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF) | Heterodimeric electron transfer flavoprotein that accepts electrons from several mitochondrial dehydrogenases, including acyl-CoA dehydrogenases, glutaryl-CoA and sarcosine dehydrogenase (PubMed:10356313, PubMed:15159392, PubMed:15975918, PubMed:27499296, PubMed:9334218). It transfers the electrons to the main mitochondrial respiratory chain via ETF-ubiquinone oxidoreductase (ETF dehydrogenase) (PubMed:9334218). Required for normal mitochondrial fatty acid oxidation and normal amino acid metabolism (PubMed:12815589, PubMed:1430199, PubMed:1882842). {ECO:0000269|PubMed:10356313, ECO:0000269|PubMed:12815589, ECO:0000269|PubMed:1430199, ECO:0000269|PubMed:15159392, ECO:0000269|PubMed:15975918, ECO:0000269|PubMed:27499296, ECO:0000269|PubMed:9334218, ECO:0000303|PubMed:17941859, ECO:0000305|PubMed:1882842}. |
P16070 | CD44 | S182 | ochoa | CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44) | Cell-surface receptor that plays a role in cell-cell interactions, cell adhesion and migration, helping them to sense and respond to changes in the tissue microenvironment (PubMed:16541107, PubMed:19703720, PubMed:22726066). Participates thereby in a wide variety of cellular functions including the activation, recirculation and homing of T-lymphocytes, hematopoiesis, inflammation and response to bacterial infection (PubMed:7528188). Engages, through its ectodomain, extracellular matrix components such as hyaluronan/HA, collagen, growth factors, cytokines or proteases and serves as a platform for signal transduction by assembling, via its cytoplasmic domain, protein complexes containing receptor kinases and membrane proteases (PubMed:18757307, PubMed:23589287). Such effectors include PKN2, the RhoGTPases RAC1 and RHOA, Rho-kinases and phospholipase C that coordinate signaling pathways promoting calcium mobilization and actin-mediated cytoskeleton reorganization essential for cell migration and adhesion (PubMed:15123640). {ECO:0000269|PubMed:15123640, ECO:0000269|PubMed:16541107, ECO:0000269|PubMed:18757307, ECO:0000269|PubMed:19703720, ECO:0000269|PubMed:22726066, ECO:0000269|PubMed:23589287, ECO:0000269|PubMed:7528188}. |
P16234 | PDGFRA | S1048 | ochoa | Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a) | Tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis. Depending on the context, promotes or inhibits cell proliferation and cell migration. Plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells. Required for normal skeleton development and cephalic closure during embryonic development. Required for normal development of the mucosa lining the gastrointestinal tract, and for recruitment of mesenchymal cells and normal development of intestinal villi. Plays a role in cell migration and chemotaxis in wound healing. Plays a role in platelet activation, secretion of agonists from platelet granules, and in thrombin-induced platelet aggregation. Binding of its cognate ligands - homodimeric PDGFA, homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFC -leads to the activation of several signaling cascades; the response depends on the nature of the bound ligand and is modulated by the formation of heterodimers between PDGFRA and PDGFRB. Phosphorylates PIK3R1, PLCG1, and PTPN11. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the activation of protein kinase C. Phosphorylates PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and thereby mediates activation of the AKT1 signaling pathway. Mediates activation of HRAS and of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3 and STAT5A and/or STAT5B. Receptor signaling is down-regulated by protein phosphatases that dephosphorylate the receptor and its down-stream effectors, and by rapid internalization of the activated receptor. {ECO:0000269|PubMed:10734113, ECO:0000269|PubMed:10947961, ECO:0000269|PubMed:11297552, ECO:0000269|PubMed:12522257, ECO:0000269|PubMed:1646396, ECO:0000269|PubMed:17087943, ECO:0000269|PubMed:1709159, ECO:0000269|PubMed:17141222, ECO:0000269|PubMed:20972453, ECO:0000269|PubMed:21224473, ECO:0000269|PubMed:21596750, ECO:0000269|PubMed:2554309, ECO:0000269|PubMed:8188664, ECO:0000269|PubMed:8760137, ECO:0000269|PubMed:8943348}. |
P16949 | STMN1 | S31 | ochoa | Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17) | Involved in the regulation of the microtubule (MT) filament system by destabilizing microtubules. Prevents assembly and promotes disassembly of microtubules. Phosphorylation at Ser-16 may be required for axon formation during neurogenesis. Involved in the control of the learned and innate fear (By similarity). {ECO:0000250}. |
P17181 | IFNAR1 | Y538 | psp | Interferon alpha/beta receptor 1 (IFN-R-1) (IFN-alpha/beta receptor 1) (Cytokine receptor class-II member 1) (Cytokine receptor family 2 member 1) (CRF2-1) (Type I interferon receptor 1) | Together with IFNAR2, forms the heterodimeric receptor for type I interferons (including interferons alpha, beta, epsilon, omega and kappa) (PubMed:10049744, PubMed:14532120, PubMed:15337770, PubMed:2153461, PubMed:21854986, PubMed:24075985, PubMed:31270247, PubMed:33252644, PubMed:35442418, PubMed:7813427). Type I interferon binding activates the JAK-STAT signaling cascade, resulting in transcriptional activation or repression of interferon-regulated genes that encode the effectors of the interferon response (PubMed:10049744, PubMed:21854986, PubMed:7665574). Mechanistically, type I interferon-binding brings the IFNAR1 and IFNAR2 subunits into close proximity with one another, driving their associated Janus kinases (JAKs) (TYK2 bound to IFNAR1 and JAK1 bound to IFNAR2) to cross-phosphorylate one another (PubMed:21854986, PubMed:32972995, PubMed:7665574, PubMed:7813427). The activated kinases phosphorylate specific tyrosine residues on the intracellular domains of IFNAR1 and IFNAR2, forming docking sites for the STAT transcription factors (PubMed:21854986, PubMed:32972995, PubMed:7526154, PubMed:7665574, PubMed:7813427). STAT proteins are then phosphorylated by the JAKs, promoting their translocation into the nucleus to regulate expression of interferon-regulated genes (PubMed:19561067, PubMed:21854986, PubMed:32972995, PubMed:7665574, PubMed:7813427, PubMed:9121453). Can also act independently of IFNAR2: form an active IFNB1 receptor by itself and activate a signaling cascade that does not involve activation of the JAK-STAT pathway (By similarity). {ECO:0000250|UniProtKB:P33896, ECO:0000269|PubMed:10049744, ECO:0000269|PubMed:14532120, ECO:0000269|PubMed:15337770, ECO:0000269|PubMed:19561067, ECO:0000269|PubMed:2153461, ECO:0000269|PubMed:21854986, ECO:0000269|PubMed:24075985, ECO:0000269|PubMed:31270247, ECO:0000269|PubMed:32972995, ECO:0000269|PubMed:33252644, ECO:0000269|PubMed:35442418, ECO:0000269|PubMed:7526154, ECO:0000269|PubMed:7665574, ECO:0000269|PubMed:7813427, ECO:0000269|PubMed:9121453}. |
P17936 | IGFBP3 | S204 | ochoa | Insulin-like growth factor-binding protein 3 (IBP-3) (IGF-binding protein 3) (IGFBP-3) | Multifunctional protein that plays a critical role in regulating the availability of IGFs such as IGF1 and IGF2 to their receptors and thereby regulates IGF-mediated cellular processes including proliferation, differentiation, and apoptosis in a cell-type specific manner (PubMed:10874028, PubMed:19556345). Also exhibits IGF-independent antiproliferative and apoptotic effects mediated by its receptor TMEM219/IGFBP-3R (PubMed:20353938). Inhibits the positive effect of humanin on insulin sensitivity (PubMed:19623253). Promotes testicular germ cell apoptosis (PubMed:19952275). Acts via LRP-1/alpha2M receptor, also known as TGF-beta type V receptor, to mediate cell growth inhibition independent of IGF1 (PubMed:9252371). Mechanistically, induces serine-specific dephosphorylation of IRS1 or IRS2 upon ligation to its receptor, leading to the inhibitory cascade (PubMed:15371331). In the nucleus, interacts with transcription factors such as retinoid X receptor-alpha/RXRA to regulate transcriptional signaling and apoptosis (PubMed:10874028). {ECO:0000269|PubMed:10874028, ECO:0000269|PubMed:15371331, ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19556345, ECO:0000269|PubMed:19623253, ECO:0000269|PubMed:19952275, ECO:0000269|PubMed:20353938}. |
P18583 | SON | S1783 | ochoa | Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3) | RNA-binding protein that acts as a mRNA splicing cofactor by promoting efficient splicing of transcripts that possess weak splice sites. Specifically promotes splicing of many cell-cycle and DNA-repair transcripts that possess weak splice sites, such as TUBG1, KATNB1, TUBGCP2, AURKB, PCNT, AKT1, RAD23A, and FANCG. Probably acts by facilitating the interaction between Serine/arginine-rich proteins such as SRSF2 and the RNA polymerase II. Also binds to DNA; binds to the consensus DNA sequence: 5'-GA[GT]AN[CG][AG]CC-3'. May indirectly repress hepatitis B virus (HBV) core promoter activity and transcription of HBV genes and production of HBV virions. Essential for correct RNA splicing of multiple genes critical for brain development, neuronal migration and metabolism, including TUBG1, FLNA, PNKP, WDR62, PSMD3, PCK2, PFKL, IDH2, and ACY1 (PubMed:27545680). {ECO:0000269|PubMed:20581448, ECO:0000269|PubMed:21504830, ECO:0000269|PubMed:27545680}. |
P18887 | XRCC1 | S421 | ochoa | DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1) | Scaffold protein involved in DNA single-strand break repair by mediating the assembly of DNA break repair protein complexes (PubMed:11163244, PubMed:28002403). Negatively regulates ADP-ribosyltransferase activity of PARP1 during base-excision repair in order to prevent excessive PARP1 activity (PubMed:28002403, PubMed:34102106, PubMed:34811483). Recognizes and binds poly-ADP-ribose chains: specifically binds auto-poly-ADP-ribosylated PARP1, limiting its activity (PubMed:14500814, PubMed:34102106, PubMed:34811483). {ECO:0000269|PubMed:11163244, ECO:0000269|PubMed:14500814, ECO:0000269|PubMed:28002403, ECO:0000269|PubMed:34102106, ECO:0000269|PubMed:34811483}. |
P20810 | CAST | S663 | ochoa | Calpastatin (Calpain inhibitor) (Sperm BS-17 component) | Specific inhibition of calpain (calcium-dependent cysteine protease). Plays a key role in postmortem tenderization of meat and have been proposed to be involved in muscle protein degradation in living tissue. |
P22059 | OSBP | S389 | ochoa | Oxysterol-binding protein 1 | Lipid transporter involved in lipid countertransport between the Golgi complex and membranes of the endoplasmic reticulum: specifically exchanges sterol with phosphatidylinositol 4-phosphate (PI4P), delivering sterol to the Golgi in exchange for PI4P, which is degraded by the SAC1/SACM1L phosphatase in the endoplasmic reticulum (PubMed:24209621). Binds cholesterol and a range of oxysterols including 25-hydroxycholesterol (PubMed:15746430, PubMed:17428193). Cholesterol binding promotes the formation of a complex with PP2A and a tyrosine phosphatase which dephosphorylates ERK1/2, whereas 25-hydroxycholesterol causes its disassembly (PubMed:15746430). Regulates cholesterol efflux by decreasing ABCA1 stability (PubMed:18450749). {ECO:0000269|PubMed:15746430, ECO:0000269|PubMed:17428193, ECO:0000269|PubMed:18450749, ECO:0000269|PubMed:24209621}. |
P23497 | SP100 | S410 | ochoa | Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa) | Together with PML, this tumor suppressor is a major constituent of the PML bodies, a subnuclear organelle involved in a large number of physiological processes including cell growth, differentiation and apoptosis. Functions as a transcriptional coactivator of ETS1 and ETS2 according to PubMed:11909962. Under certain conditions, it may also act as a corepressor of ETS1 preventing its binding to DNA according to PubMed:15247905. Through the regulation of ETS1 it may play a role in angiogenesis, controlling endothelial cell motility and invasion. Through interaction with the MRN complex it may be involved in the regulation of telomeres lengthening. May also regulate TP53-mediated transcription and through CASP8AP2, regulate FAS-mediated apoptosis. Also plays a role in infection by viruses, including human cytomegalovirus and Epstein-Barr virus, through mechanisms that may involve chromatin and/or transcriptional regulation. {ECO:0000269|PubMed:11909962, ECO:0000269|PubMed:14647468, ECO:0000269|PubMed:15247905, ECO:0000269|PubMed:15592518, ECO:0000269|PubMed:15767676, ECO:0000269|PubMed:16177824, ECO:0000269|PubMed:17245429, ECO:0000269|PubMed:21274506, ECO:0000269|PubMed:21880768}. |
P23497 | SP100 | S459 | ochoa | Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa) | Together with PML, this tumor suppressor is a major constituent of the PML bodies, a subnuclear organelle involved in a large number of physiological processes including cell growth, differentiation and apoptosis. Functions as a transcriptional coactivator of ETS1 and ETS2 according to PubMed:11909962. Under certain conditions, it may also act as a corepressor of ETS1 preventing its binding to DNA according to PubMed:15247905. Through the regulation of ETS1 it may play a role in angiogenesis, controlling endothelial cell motility and invasion. Through interaction with the MRN complex it may be involved in the regulation of telomeres lengthening. May also regulate TP53-mediated transcription and through CASP8AP2, regulate FAS-mediated apoptosis. Also plays a role in infection by viruses, including human cytomegalovirus and Epstein-Barr virus, through mechanisms that may involve chromatin and/or transcriptional regulation. {ECO:0000269|PubMed:11909962, ECO:0000269|PubMed:14647468, ECO:0000269|PubMed:15247905, ECO:0000269|PubMed:15592518, ECO:0000269|PubMed:15767676, ECO:0000269|PubMed:16177824, ECO:0000269|PubMed:17245429, ECO:0000269|PubMed:21274506, ECO:0000269|PubMed:21880768}. |
P25054 | APC | S908 | ochoa | Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5) | Tumor suppressor. Promotes rapid degradation of CTNNB1 and participates in Wnt signaling as a negative regulator. APC activity is correlated with its phosphorylation state. Activates the GEF activity of SPATA13 and ARHGEF4. Plays a role in hepatocyte growth factor (HGF)-induced cell migration. Required for MMP9 up-regulation via the JNK signaling pathway in colorectal tumor cells. Associates with both microtubules and actin filaments, components of the cytoskeleton (PubMed:17293347). Plays a role in mediating the organization of F-actin into ordered bundles (PubMed:17293347). Functions downstream of Rho GTPases and DIAPH1 to selectively stabilize microtubules (By similarity). Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. It is required for the localization of MACF1 to the cell membrane and this localization of MACF1 is critical for its function in microtubule stabilization. {ECO:0000250|UniProtKB:Q61315, ECO:0000269|PubMed:10947987, ECO:0000269|PubMed:17293347, ECO:0000269|PubMed:17599059, ECO:0000269|PubMed:19151759, ECO:0000269|PubMed:19893577, ECO:0000269|PubMed:20937854}. |
P25054 | APC | S1510 | psp | Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5) | Tumor suppressor. Promotes rapid degradation of CTNNB1 and participates in Wnt signaling as a negative regulator. APC activity is correlated with its phosphorylation state. Activates the GEF activity of SPATA13 and ARHGEF4. Plays a role in hepatocyte growth factor (HGF)-induced cell migration. Required for MMP9 up-regulation via the JNK signaling pathway in colorectal tumor cells. Associates with both microtubules and actin filaments, components of the cytoskeleton (PubMed:17293347). Plays a role in mediating the organization of F-actin into ordered bundles (PubMed:17293347). Functions downstream of Rho GTPases and DIAPH1 to selectively stabilize microtubules (By similarity). Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. It is required for the localization of MACF1 to the cell membrane and this localization of MACF1 is critical for its function in microtubule stabilization. {ECO:0000250|UniProtKB:Q61315, ECO:0000269|PubMed:10947987, ECO:0000269|PubMed:17293347, ECO:0000269|PubMed:17599059, ECO:0000269|PubMed:19151759, ECO:0000269|PubMed:19893577, ECO:0000269|PubMed:20937854}. |
P27816 | MAP4 | S71 | ochoa | Microtubule-associated protein 4 (MAP-4) | Non-neuronal microtubule-associated protein. Promotes microtubule assembly. {ECO:0000269|PubMed:10791892, ECO:0000269|PubMed:34782749}. |
P30414 | NKTR | S1203 | ochoa | NK-tumor recognition protein (NK-TR protein) (Natural-killer cells cyclophilin-related protein) (Peptidyl-prolyl cis-trans isomerase NKTR) (PPIase) (EC 5.2.1.8) (Rotamase) | PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding (PubMed:20676357). Component of a putative tumor-recognition complex involved in the function of NK cells (PubMed:8421688). {ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:8421688}. |
P31749 | AKT1 | S129 | ochoa|psp | RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) | AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}. |
P31751 | AKT2 | S131 | ochoa|psp | RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC protein kinase beta) (RAC-PK-beta) | Serine/threonine kinase closely related to AKT1 and AKT3. All 3 enzymes, AKT1, AKT2 and AKT3, are collectively known as AKT kinase. AKT regulates many processes including metabolism, proliferation, cell survival, growth and angiogenesis, through the phosphorylation of a range of downstream substrates. Over 100 substrates have been reported so far, although for most of them, the precise AKT kinase catalyzing the reaction was not specified. AKT regulates glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1). AKT mediates the antiapoptotic effects of IGF1. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development (PubMed:21432781, PubMed:21620960). In response to lysophosphatidic acid stimulation, inhibits the ciliogenesis cascade. In this context, phosphorylates WDR44, hence stabilizing its interaction with Rab11 and preventing the formation of the ciliogenic Rab11-FIP3-RAB3IP complex. Also phosphorylates RAB3IP/Rabin8, thus may affect RAB3IP guanine nucleotide exchange factor (GEF) activity toward Rab8, which is important for cilia growth (PubMed:31204173). Phosphorylates PKP1, facilitating its interaction with YWHAG and translocation to the nucleus, ultimately resulting in a reduction in keratinocyte intercellular adhesion (By similarity). Phosphorylation of PKP1 increases PKP1 protein stability, translocation to the cytoplasm away from desmosome plaques and PKP1-driven cap-dependent translation (PubMed:23444369). {ECO:0000250|UniProtKB:Q60823, ECO:0000269|PubMed:23444369, ECO:0000269|PubMed:31204173, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.; FUNCTION: Several AKT2-specific substrates have been identified, including ANKRD2, C2CD5, CLK2 and PITX2. May play a role in myoblast differentiation. In this context, may act through PITX2 phosphorylation. Unphosphorylated PITX2 associates with an ELAVL1/HuR-containing complex, which stabilizes CCND1 cyclin mRNA, ensuring cell proliferation. Phosphorylation by AKT2 impairs this association, leading to CCND1 mRNA destabilization and progression towards differentiation (By similarity). Also involved in the negative regulation of myogenesis in response to stress conditions. In this context, acts by phosphorylating ANKRD2 (By similarity). May also be a key regulator of glucose uptake. Regulates insulin-stimulated glucose transport by the increase of glucose transporter GLUT4 translocation from intracellular stores to the plasma membrane. In this context, acts by phosphorylating C2CD5/CDP138 on 'Ser-197' in insulin-stimulated adipocytes (By similarity). Through the phosphorylation of CLK2 on 'Thr-343', involved in insulin-regulated suppression of hepatic gluconeogenesis (By similarity). {ECO:0000250|UniProtKB:Q60823}. |
P35269 | GTF2F1 | S224 | ochoa | General transcription factor IIF subunit 1 (General transcription factor IIF 74 kDa subunit) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha) (Transcription initiation factor RAP74) | TFIIF is a general transcription initiation factor that binds to RNA polymerase II and helps to recruit it to the initiation complex in collaboration with TFIIB. It promotes transcription elongation. {ECO:0000269|PubMed:10428810}. |
P38398 | BRCA1 | S454 | ochoa | Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) | E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage (PubMed:10500182, PubMed:12887909, PubMed:12890688, PubMed:14976165, PubMed:16818604, PubMed:17525340, PubMed:19261748). It is unclear whether it also mediates the formation of other types of polyubiquitin chains (PubMed:12890688). The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability (PubMed:12890688, PubMed:14976165, PubMed:20351172). Regulates centrosomal microtubule nucleation (PubMed:18056443). Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle (PubMed:10724175, PubMed:11836499, PubMed:12183412, PubMed:19261748). Required for FANCD2 targeting to sites of DNA damage (PubMed:12887909). Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation (PubMed:16326698). Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks (PubMed:19369211). Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8 (PubMed:16818604). Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12183412, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172}. |
P40855 | PEX19 | S149 | ochoa | Peroxisomal biogenesis factor 19 (33 kDa housekeeping protein) (Peroxin-19) (Peroxisomal farnesylated protein) | Necessary for early peroxisomal biogenesis. Acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Binds and stabilizes newly synthesized PMPs in the cytoplasm by interacting with their hydrophobic membrane-spanning domains, and targets them to the peroxisome membrane by binding to the integral membrane protein PEX3. Excludes CDKN2A from the nucleus and prevents its interaction with MDM2, which results in active degradation of TP53. {ECO:0000269|PubMed:10051604, ECO:0000269|PubMed:10704444, ECO:0000269|PubMed:11259404, ECO:0000269|PubMed:11883941, ECO:0000269|PubMed:14709540, ECO:0000269|PubMed:15007061}. |
P41236 | PPP1R2 | S130 | ochoa | Protein phosphatase inhibitor 2 (IPP-2) | Inhibitor of protein-phosphatase 1. |
P42684 | ABL2 | S820 | ochoa | Tyrosine-protein kinase ABL2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson tyrosine-protein kinase 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) | Non-receptor tyrosine-protein kinase that plays an ABL1-overlapping role in key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion and receptor endocytosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like MYH10 (involved in movement); CTTN (involved in signaling); or TUBA1 and TUBB (microtubule subunits). Binds directly F-actin and regulates actin cytoskeletal structure through its F-actin-bundling activity. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as CRK, CRKL, DOK1 or ARHGAP35. Adhesion-dependent phosphorylation of ARHGAP35 promotes its association with RASA1, resulting in recruitment of ARHGAP35 to the cell periphery where it inhibits RHO. Phosphorylates multiple receptor tyrosine kinases like PDGFRB and other substrates which are involved in endocytosis regulation such as RIN1. In brain, may regulate neurotransmission by phosphorylating proteins at the synapse. ABL2 also acts as a regulator of multiple pathological signaling cascades during infection. Pathogens can highjack ABL2 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1. Positively regulates chemokine-mediated T-cell migration, polarization, and homing to lymph nodes and immune-challenged tissues, potentially via activation of NEDD9/HEF1 and RAP1 (By similarity). {ECO:0000250|UniProtKB:Q4JIM5, ECO:0000269|PubMed:15735735, ECO:0000269|PubMed:15886098, ECO:0000269|PubMed:16678104, ECO:0000269|PubMed:17306540, ECO:0000269|PubMed:18945674}. |
P42704 | LRPPRC | S1029 | ochoa | Leucine-rich PPR motif-containing protein, mitochondrial (130 kDa leucine-rich protein) (LRP 130) (GP130) | May play a role in RNA metabolism in both nuclei and mitochondria. In the nucleus binds to HNRPA1-associated poly(A) mRNAs and is part of nmRNP complexes at late stages of mRNA maturation which are possibly associated with nuclear mRNA export. Positively modulates nuclear export of mRNAs containing the EIF4E sensitivity element (4ESE) by binding simultaneously to both EIF4E and the 4ESE and acting as a platform for assembly for the RNA export complex (PubMed:19262567, PubMed:28325843). Also binds to exportin XPO1/CRM1 to engage the nuclear pore and traffic the bound mRNAs to the cytoplasm (PubMed:28325843). May bind mature mRNA in the nucleus outer membrane. In mitochondria binds to poly(A) mRNA. Plays a role in translation or stability of mitochondrially encoded cytochrome c oxidase (COX) subunits. May be involved in transcription regulation. Cooperates with PPARGC1A to regulate certain mitochondrially encoded genes and gluconeogenic genes and may regulate docking of PPARGC1A to transcription factors. Seems to be involved in the transcription regulation of the multidrug-related genes MDR1 and MVP. Part of a nuclear factor that binds to the invMED1 element of MDR1 and MVP gene promoters. Binds single-stranded DNA (By similarity). Required for maintaining mitochondrial potential (PubMed:23822101). Suppresses the initiation of basal levels of autophagy and mitophagy by sustaining BCL2 levels (PubMed:23822101). {ECO:0000250, ECO:0000269|PubMed:11585913, ECO:0000269|PubMed:12832482, ECO:0000269|PubMed:15081402, ECO:0000269|PubMed:15139850, ECO:0000269|PubMed:15272088, ECO:0000269|PubMed:17050673, ECO:0000269|PubMed:19262567, ECO:0000269|PubMed:23822101, ECO:0000269|PubMed:28325843}. |
P43146 | DCC | S1218 | ochoa | Netrin receptor DCC (Colorectal cancer suppressor) (Immunoglobulin superfamily DCC subclass member 1) (Tumor suppressor protein DCC) | Receptor for netrin required for axon guidance. Mediates axon attraction of neuronal growth cones in the developing nervous system upon ligand binding. Its association with UNC5 proteins may trigger signaling for axon repulsion. It also acts as a dependence receptor required for apoptosis induction when not associated with netrin ligand. Implicated as a tumor suppressor gene. {ECO:0000269|PubMed:8187090, ECO:0000269|PubMed:8861902}. |
P46821 | MAP1B | S831 | ochoa | Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain; MAP1 light chain LC1] | Facilitates tyrosination of alpha-tubulin in neuronal microtubules (By similarity). Phosphorylated MAP1B is required for proper microtubule dynamics and plays a role in the cytoskeletal changes that accompany neuronal differentiation and neurite extension (PubMed:33268592). Possibly MAP1B binds to at least two tubulin subunits in the polymer, and this bridging of subunits might be involved in nucleating microtubule polymerization and in stabilizing microtubules. Acts as a positive cofactor in DAPK1-mediated autophagic vesicle formation and membrane blebbing. {ECO:0000250, ECO:0000269|PubMed:18195017, ECO:0000269|PubMed:33268592}. |
P47710 | CSN1S1 | S41 | psp | Alpha-S1-casein [Cleaved into: Casoxin-D] | Important role in the capacity of milk to transport calcium phosphate.; FUNCTION: Casoxin D acts as opioid antagonist and has vasorelaxing activity mediated by bradykinin B1 receptors. |
P47710 | CSN1S1 | S89 | psp | Alpha-S1-casein [Cleaved into: Casoxin-D] | Important role in the capacity of milk to transport calcium phosphate.; FUNCTION: Casoxin D acts as opioid antagonist and has vasorelaxing activity mediated by bradykinin B1 receptors. |
P48634 | PRRC2A | S166 | ochoa | Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2) | May play a role in the regulation of pre-mRNA splicing. {ECO:0000269|PubMed:14667819}. |
P48681 | NES | S746 | ochoa | Nestin | Required for brain and eye development. Promotes the disassembly of phosphorylated vimentin intermediate filaments (IF) during mitosis and may play a role in the trafficking and distribution of IF proteins and other cellular factors to daughter cells during progenitor cell division. Required for survival, renewal and mitogen-stimulated proliferation of neural progenitor cells (By similarity). {ECO:0000250}. |
P49792 | RANBP2 | S1110 | ochoa | E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) | E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2 conjugation by UBE2I (PubMed:11792325, PubMed:12032081, PubMed:15378033, PubMed:15931224, PubMed:22194619). Involved in transport factor (Ran-GTP, karyopherin)-mediated protein import via the F-G repeat-containing domain which acts as a docking site for substrates (PubMed:7775481). Binds single-stranded RNA (in vitro) (PubMed:7775481). May bind DNA (PubMed:7775481). Component of the nuclear export pathway (PubMed:10078529). Specific docking site for the nuclear export factor exportin-1 (PubMed:10078529). Inhibits EIF4E-dependent mRNA export (PubMed:22902403). Sumoylates PML at 'Lys-490' which is essential for the proper assembly of PML-NB (PubMed:22155184). Recruits BICD2 to the nuclear envelope and cytoplasmic stacks of nuclear pore complex known as annulate lamellae during G2 phase of cell cycle (PubMed:20386726). Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity (PubMed:20676357, PubMed:23353830). {ECO:0000269|PubMed:11792325, ECO:0000269|PubMed:12032081, ECO:0000269|PubMed:15378033, ECO:0000269|PubMed:15931224, ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:22155184, ECO:0000269|PubMed:22194619, ECO:0000269|PubMed:22902403, ECO:0000269|PubMed:23353830, ECO:0000269|PubMed:7775481, ECO:0000303|PubMed:10078529}. |
P49815 | TSC2 | S1002 | ochoa | Tuberin (Tuberous sclerosis 2 protein) | Catalytic component of the TSC-TBC complex, a multiprotein complex that acts as a negative regulator of the canonical mTORC1 complex, an evolutionarily conserved central nutrient sensor that stimulates anabolic reactions and macromolecule biosynthesis to promote cellular biomass generation and growth (PubMed:12172553, PubMed:12271141, PubMed:12842888, PubMed:12906785, PubMed:15340059, PubMed:22819219, PubMed:24529379, PubMed:28215400, PubMed:33436626, PubMed:35772404). Within the TSC-TBC complex, TSC2 acts as a GTPase-activating protein (GAP) for the small GTPase RHEB, a direct activator of the protein kinase activity of mTORC1 (PubMed:12172553, PubMed:12820960, PubMed:12842888, PubMed:12906785, PubMed:15340059, PubMed:22819219, PubMed:24529379, PubMed:33436626). In absence of nutrients, the TSC-TBC complex inhibits mTORC1, thereby preventing phosphorylation of ribosomal protein S6 kinase (RPS6KB1 and RPS6KB2) and EIF4EBP1 (4E-BP1) by the mTORC1 signaling (PubMed:12172553, PubMed:12271141, PubMed:12842888, PubMed:12906785, PubMed:22819219, PubMed:24529379, PubMed:28215400, PubMed:35772404). The TSC-TBC complex is inactivated in response to nutrients, relieving inhibition of mTORC1 (PubMed:12172553, PubMed:24529379). Involved in microtubule-mediated protein transport via its ability to regulate mTORC1 signaling (By similarity). Also stimulates the intrinsic GTPase activity of the Ras-related proteins RAP1A and RAB5 (By similarity). {ECO:0000250|UniProtKB:P49816, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12271141, ECO:0000269|PubMed:12820960, ECO:0000269|PubMed:12842888, ECO:0000269|PubMed:12906785, ECO:0000269|PubMed:15340059, ECO:0000269|PubMed:22819219, ECO:0000269|PubMed:24529379, ECO:0000269|PubMed:28215400, ECO:0000269|PubMed:33436626, ECO:0000269|PubMed:35772404}. |
P49815 | TSC2 | S1341 | ochoa | Tuberin (Tuberous sclerosis 2 protein) | Catalytic component of the TSC-TBC complex, a multiprotein complex that acts as a negative regulator of the canonical mTORC1 complex, an evolutionarily conserved central nutrient sensor that stimulates anabolic reactions and macromolecule biosynthesis to promote cellular biomass generation and growth (PubMed:12172553, PubMed:12271141, PubMed:12842888, PubMed:12906785, PubMed:15340059, PubMed:22819219, PubMed:24529379, PubMed:28215400, PubMed:33436626, PubMed:35772404). Within the TSC-TBC complex, TSC2 acts as a GTPase-activating protein (GAP) for the small GTPase RHEB, a direct activator of the protein kinase activity of mTORC1 (PubMed:12172553, PubMed:12820960, PubMed:12842888, PubMed:12906785, PubMed:15340059, PubMed:22819219, PubMed:24529379, PubMed:33436626). In absence of nutrients, the TSC-TBC complex inhibits mTORC1, thereby preventing phosphorylation of ribosomal protein S6 kinase (RPS6KB1 and RPS6KB2) and EIF4EBP1 (4E-BP1) by the mTORC1 signaling (PubMed:12172553, PubMed:12271141, PubMed:12842888, PubMed:12906785, PubMed:22819219, PubMed:24529379, PubMed:28215400, PubMed:35772404). The TSC-TBC complex is inactivated in response to nutrients, relieving inhibition of mTORC1 (PubMed:12172553, PubMed:24529379). Involved in microtubule-mediated protein transport via its ability to regulate mTORC1 signaling (By similarity). Also stimulates the intrinsic GTPase activity of the Ras-related proteins RAP1A and RAB5 (By similarity). {ECO:0000250|UniProtKB:P49816, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12271141, ECO:0000269|PubMed:12820960, ECO:0000269|PubMed:12842888, ECO:0000269|PubMed:12906785, ECO:0000269|PubMed:15340059, ECO:0000269|PubMed:22819219, ECO:0000269|PubMed:24529379, ECO:0000269|PubMed:28215400, ECO:0000269|PubMed:33436626, ECO:0000269|PubMed:35772404}. |
P50851 | LRBA | S1084 | ochoa | Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein) | Involved in coupling signal transduction and vesicle trafficking to enable polarized secretion and/or membrane deposition of immune effector molecules (By similarity). Involved in phagophore growth during mitophagy by regulating ATG9A trafficking to mitochondria (PubMed:33773106). {ECO:0000250|UniProtKB:Q9ESE1, ECO:0000269|PubMed:33773106}. |
P51532 | SMARCA4 | S613 | ochoa|psp | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4 (SMARCA4) (EC 3.6.4.-) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (Transcription activator BRG1) | ATPase involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner (PubMed:15075294, PubMed:29374058, PubMed:30339381, PubMed:32459350). Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating the calcium-dependent release of a repressor complex and the recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by SMARCA4-dependent recruitment of a phospho-RB1-HDAC repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves the release of HDAC1 and recruitment of CREBBP (By similarity). Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development, a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth. SMARCA4/BAF190A may promote neural stem cell self-renewal/proliferation by enhancing Notch-dependent proliferative signals, while concurrently making the neural stem cell insensitive to SHH-dependent differentiating cues (By similarity). Acts as a corepressor of ZEB1 to regulate E-cadherin transcription and is required for induction of epithelial-mesenchymal transition (EMT) by ZEB1 (PubMed:20418909). Binds via DLX1 to enhancers located in the intergenic region between DLX5 and DLX6 and this binding is stabilized by the long non-coding RNA (lncRNA) Evf2 (By similarity). Binds to RNA in a promiscuous manner (By similarity). In brown adipose tissue, involved in the regulation of thermogenic genes expression (By similarity). {ECO:0000250|UniProtKB:Q3TKT4, ECO:0000250|UniProtKB:Q8K1P7, ECO:0000269|PubMed:15075294, ECO:0000269|PubMed:19571879, ECO:0000269|PubMed:20418909, ECO:0000269|PubMed:29374058, ECO:0000269|PubMed:30339381, ECO:0000269|PubMed:32459350, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}. |
P51636 | CAV2 | S23 | ochoa|psp | Caveolin-2 | May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. Acts as an accessory protein in conjunction with CAV1 in targeting to lipid rafts and driving caveolae formation. The Ser-36 phosphorylated form has a role in modulating mitosis in endothelial cells. Positive regulator of cellular mitogenesis of the MAPK signaling pathway. Required for the insulin-stimulated nuclear translocation and activation of MAPK1 and STAT3, and the subsequent regulation of cell cycle progression (By similarity). {ECO:0000250, ECO:0000269|PubMed:15504032, ECO:0000269|PubMed:18081315}. |
P51659 | HSD17B4 | S294 | ochoa | Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] | Bifunctional enzyme acting on the peroxisomal fatty acid beta-oxidation pathway. Catalyzes two of the four reactions in fatty acid degradation: hydration of 2-enoyl-CoA (trans-2-enoyl-CoA) to produce (3R)-3-hydroxyacyl-CoA, and dehydrogenation of (3R)-3-hydroxyacyl-CoA to produce 3-ketoacyl-CoA (3-oxoacyl-CoA), which is further metabolized by SCPx. Can use straight-chain and branched-chain fatty acids, as well as bile acid intermediates as substrates. {ECO:0000269|PubMed:10671535, ECO:0000269|PubMed:15060085, ECO:0000269|PubMed:8902629, ECO:0000269|PubMed:9089413}. |
P51955 | NEK2 | S368 | ochoa | Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) | Protein kinase which is involved in the control of centrosome separation and bipolar spindle formation in mitotic cells and chromatin condensation in meiotic cells. Regulates centrosome separation (essential for the formation of bipolar spindles and high-fidelity chromosome separation) by phosphorylating centrosomal proteins such as CROCC, CEP250 and NINL, resulting in their displacement from the centrosomes. Regulates kinetochore microtubule attachment stability in mitosis via phosphorylation of NDC80. Involved in regulation of mitotic checkpoint protein complex via phosphorylation of CDC20 and MAD2L1. Plays an active role in chromatin condensation during the first meiotic division through phosphorylation of HMGA2. Phosphorylates: PPP1CC; SGO1; NECAB3 and NPM1. Essential for localization of MAD2L1 to kinetochore and MAPK1 and NPM1 to the centrosome. Phosphorylates CEP68 and CNTLN directly or indirectly (PubMed:24554434). NEK2-mediated phosphorylation of CEP68 promotes CEP68 dissociation from the centrosome and its degradation at the onset of mitosis (PubMed:25704143). Involved in the regulation of centrosome disjunction (PubMed:26220856). Phosphorylates CCDC102B either directly or indirectly which causes CCDC102B to dissociate from the centrosome and allows for centrosome separation (PubMed:30404835). {ECO:0000269|PubMed:11742531, ECO:0000269|PubMed:12857871, ECO:0000269|PubMed:14978040, ECO:0000269|PubMed:15358203, ECO:0000269|PubMed:15388344, ECO:0000269|PubMed:17283141, ECO:0000269|PubMed:17621308, ECO:0000269|PubMed:17626005, ECO:0000269|PubMed:18086858, ECO:0000269|PubMed:18297113, ECO:0000269|PubMed:20034488, ECO:0000269|PubMed:21076410, ECO:0000269|PubMed:24554434, ECO:0000269|PubMed:25704143, ECO:0000269|PubMed:26220856, ECO:0000269|PubMed:30404835}.; FUNCTION: [Isoform 1]: Phosphorylates and activates NEK11 in G1/S-arrested cells. {ECO:0000269|PubMed:15161910}.; FUNCTION: [Isoform 2]: Not present in the nucleolus and, in contrast to isoform 1, does not phosphorylate and activate NEK11 in G1/S-arrested cells. {ECO:0000269|PubMed:15161910}. |
P52179 | MYOM1 | S125 | ochoa | Myomesin-1 (190 kDa connectin-associated protein) (190 kDa titin-associated protein) (Myomesin family member 1) | Major component of the vertebrate myofibrillar M band. Binds myosin, titin, and light meromyosin. This binding is dose dependent. |
P52732 | KIF11 | S39 | ochoa | Kinesin-like protein KIF11 (Kinesin-like protein 1) (Kinesin-like spindle protein HKSP) (Kinesin-related motor protein Eg5) (Thyroid receptor-interacting protein 5) (TR-interacting protein 5) (TRIP-5) | Motor protein required for establishing a bipolar spindle and thus contributing to chromosome congression during mitosis (PubMed:19001501, PubMed:37728657). Required in non-mitotic cells for transport of secretory proteins from the Golgi complex to the cell surface (PubMed:23857769). {ECO:0000269|PubMed:19001501, ECO:0000269|PubMed:23857769}. |
P53814 | SMTN | S579 | ochoa | Smoothelin | Structural protein of the cytoskeleton. |
P54819 | AK2 | S151 | ochoa | Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) [Cleaved into: Adenylate kinase 2, mitochondrial, N-terminally processed] | Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. Plays an important role in cellular energy homeostasis and in adenine nucleotide metabolism. Adenylate kinase activity is critical for regulation of the phosphate utilization and the AMP de novo biosynthesis pathways. Plays a key role in hematopoiesis. {ECO:0000255|HAMAP-Rule:MF_03168, ECO:0000269|PubMed:19043416}. |
P55196 | AFDN | S1510 | ochoa | Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6) (Afadin adherens junction formation factor) | Belongs to an adhesion system, probably together with the E-cadherin-catenin system, which plays a role in the organization of homotypic, interneuronal and heterotypic cell-cell adherens junctions (AJs) (By similarity). Nectin- and actin-filament-binding protein that connects nectin to the actin cytoskeleton (PubMed:11024295). May play a key role in the organization of epithelial structures of the embryonic ectoderm (By similarity). Essential for the organization of adherens junctions (PubMed:30463011). {ECO:0000250|UniProtKB:O35889, ECO:0000250|UniProtKB:Q9QZQ1, ECO:0000269|PubMed:11024295, ECO:0000269|PubMed:30463011}. |
P57679 | EVC | S138 | ochoa | EvC complex member EVC (DWF-1) (Ellis-van Creveld syndrome protein) | Component of the EvC complex that positively regulates ciliary Hedgehog (Hh) signaling. Involved in endochondral growth and skeletal development. {ECO:0000250|UniProtKB:P57680}. |
P57737 | CORO7 | Y883 | ochoa | Coronin-7 (Crn7) (70 kDa WD repeat tumor rejection antigen homolog) | F-actin regulator involved in anterograde Golgi to endosome transport: upon ubiquitination via 'Lys-33'-linked ubiquitin chains by the BCR(KLHL20) E3 ubiquitin ligase complex, interacts with EPS15 and localizes to the trans-Golgi network, where it promotes actin polymerization, thereby facilitating post-Golgi trafficking. May play a role in the maintenance of the Golgi apparatus morphology. {ECO:0000269|PubMed:16905771, ECO:0000269|PubMed:24768539}. |
P60709 | ACTB | T202 | ochoa | Actin, cytoplasmic 1 (EC 3.6.4.-) (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed] | Actin is a highly conserved protein that polymerizes to produce filaments that form cross-linked networks in the cytoplasm of cells (PubMed:25255767, PubMed:29581253). Actin exists in both monomeric (G-actin) and polymeric (F-actin) forms, both forms playing key functions, such as cell motility and contraction (PubMed:29581253). In addition to their role in the cytoplasmic cytoskeleton, G- and F-actin also localize in the nucleus, and regulate gene transcription and motility and repair of damaged DNA (PubMed:29925947). Plays a role in the assembly of the gamma-tubulin ring complex (gTuRC), which regulates the minus-end nucleation of alpha-beta tubulin heterodimers that grow into microtubule protafilaments (PubMed:39321809, PubMed:38609661). Part of the ACTR1A/ACTB filament around which the dynactin complex is built (By similarity). The dynactin multiprotein complex activates the molecular motor dynein for ultra-processive transport along microtubules (By similarity). {ECO:0000250|UniProtKB:Q6QAQ1, ECO:0000269|PubMed:25255767, ECO:0000269|PubMed:29581253, ECO:0000269|PubMed:29925947, ECO:0000269|PubMed:38609661, ECO:0000269|PubMed:39321809}. |
P61313 | RPL15 | S100 | ochoa | Large ribosomal subunit protein eL15 (60S ribosomal protein L15) | Component of the large ribosomal subunit. The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell. {ECO:0000269|PubMed:23636399, ECO:0000269|PubMed:32669547}. |
P62736 | ACTA2 | T204 | ochoa | Actin, aortic smooth muscle (EC 3.6.4.-) (Alpha-actin-2) (Cell growth-inhibiting gene 46 protein) [Cleaved into: Actin, aortic smooth muscle, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P63244 | RACK1 | S279 | ochoa | Small ribosomal subunit protein RACK1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) (Receptor of activated protein C kinase 1) [Cleaved into: Small ribosomal subunit protein RACK1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed) (Receptor of activated protein C kinase 1, N-terminally processed)] | Scaffolding protein involved in the recruitment, assembly and/or regulation of a variety of signaling molecules. Interacts with a wide variety of proteins and plays a role in many cellular processes. Component of the 40S ribosomal subunit involved in translational repression (PubMed:23636399). Involved in the initiation of the ribosome quality control (RQC), a pathway that takes place when a ribosome has stalled during translation, by promoting ubiquitination of a subset of 40S ribosomal subunits (PubMed:28132843). Binds to and stabilizes activated protein kinase C (PKC), increasing PKC-mediated phosphorylation. May recruit activated PKC to the ribosome, leading to phosphorylation of EIF6. Inhibits the activity of SRC kinases including SRC, LCK and YES1. Inhibits cell growth by prolonging the G0/G1 phase of the cell cycle. Enhances phosphorylation of BMAL1 by PRKCA and inhibits transcriptional activity of the BMAL1-CLOCK heterodimer. Facilitates ligand-independent nuclear translocation of AR following PKC activation, represses AR transactivation activity and is required for phosphorylation of AR by SRC. Modulates IGF1R-dependent integrin signaling and promotes cell spreading and contact with the extracellular matrix. Involved in PKC-dependent translocation of ADAM12 to the cell membrane. Promotes the ubiquitination and proteasome-mediated degradation of proteins such as CLEC1B and HIF1A. Required for VANGL2 membrane localization, inhibits Wnt signaling, and regulates cellular polarization and oriented cell division during gastrulation. Required for PTK2/FAK1 phosphorylation and dephosphorylation. Regulates internalization of the muscarinic receptor CHRM2. Promotes apoptosis by increasing oligomerization of BAX and disrupting the interaction of BAX with the anti-apoptotic factor BCL2L. Inhibits TRPM6 channel activity. Regulates cell surface expression of some GPCRs such as TBXA2R. Plays a role in regulation of FLT1-mediated cell migration. Involved in the transport of ABCB4 from the Golgi to the apical bile canalicular membrane (PubMed:19674157). Promotes migration of breast carcinoma cells by binding to and activating RHOA (PubMed:20499158). Acts as an adapter for the dephosphorylation and inactivation of AKT1 by promoting recruitment of PP2A phosphatase to AKT1 (By similarity). {ECO:0000250|UniProtKB:P68040, ECO:0000269|PubMed:11884618, ECO:0000269|PubMed:12589061, ECO:0000269|PubMed:12958311, ECO:0000269|PubMed:17108144, ECO:0000269|PubMed:17244529, ECO:0000269|PubMed:17956333, ECO:0000269|PubMed:18088317, ECO:0000269|PubMed:18258429, ECO:0000269|PubMed:18621736, ECO:0000269|PubMed:19423701, ECO:0000269|PubMed:19674157, ECO:0000269|PubMed:19785988, ECO:0000269|PubMed:20499158, ECO:0000269|PubMed:20541605, ECO:0000269|PubMed:20573744, ECO:0000269|PubMed:20976005, ECO:0000269|PubMed:21212275, ECO:0000269|PubMed:21347310, ECO:0000269|PubMed:23636399, ECO:0000269|PubMed:28132843, ECO:0000269|PubMed:9584165}.; FUNCTION: (Microbial infection) Binds to Y.pseudotuberculosis yopK which leads to inhibition of phagocytosis and survival of bacteria following infection of host cells. {ECO:0000269|PubMed:21347310}.; FUNCTION: (Microbial infection) Enhances phosphorylation of HIV-1 Nef by PKCs. {ECO:0000269|PubMed:11312657}.; FUNCTION: (Microbial infection) In case of poxvirus infection, remodels the ribosomes so that they become optimal for the viral mRNAs (containing poly-A leaders) translation but not for host mRNAs. {ECO:0000269|PubMed:28636603}.; FUNCTION: (Microbial infection) Contributes to the cap-independent internal ribosome entry site (IRES)-mediated translation by some RNA viruses. {ECO:0000269|PubMed:25416947}. |
P63261 | ACTG1 | T202 | ochoa | Actin, cytoplasmic 2 (EC 3.6.4.-) (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. May play a role in the repair of noise-induced stereocilia gaps thereby maintains hearing sensitivity following loud noise damage (By similarity). {ECO:0000250|UniProtKB:P63260, ECO:0000305|PubMed:29581253}. |
P63267 | ACTG2 | T203 | ochoa | Actin, gamma-enteric smooth muscle (EC 3.6.4.-) (Alpha-actin-3) (Gamma-2-actin) (Smooth muscle gamma-actin) [Cleaved into: Actin, gamma-enteric smooth muscle, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P68032 | ACTC1 | T204 | ochoa | Actin, alpha cardiac muscle 1 (EC 3.6.4.-) (Alpha-cardiac actin) [Cleaved into: Actin, alpha cardiac muscle 1, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P68133 | ACTA1 | T204 | ochoa | Actin, alpha skeletal muscle (EC 3.6.4.-) (Alpha-actin-1) [Cleaved into: Actin, alpha skeletal muscle, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P78316 | NOP14 | S96 | ochoa | Nucleolar protein 14 (Nucleolar complex protein 14) | Involved in nucleolar processing of pre-18S ribosomal RNA. Has a role in the nuclear export of 40S pre-ribosomal subunit to the cytoplasm (By similarity). {ECO:0000250}. |
P78332 | RBM6 | S373 | ochoa | RNA-binding protein 6 (Lung cancer antigen NY-LU-12) (Protein G16) (RNA-binding motif protein 6) (RNA-binding protein DEF-3) | Specifically binds poly(G) RNA homopolymers in vitro. |
Q00987 | MDM2 | S121 | psp | E3 ubiquitin-protein ligase Mdm2 (EC 2.3.2.27) (Double minute 2 protein) (Hdm2) (Oncoprotein Mdm2) (RING-type E3 ubiquitin transferase Mdm2) (p53-binding protein Mdm2) | E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome (PubMed:29681526). Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Also acts as a ubiquitin ligase E3 toward itself and ARRB1. Permits the nuclear export of p53/TP53. Promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma RB1 protein. Inhibits DAXX-mediated apoptosis by inducing its ubiquitination and degradation. Component of the TRIM28/KAP1-MDM2-p53/TP53 complex involved in stabilizing p53/TP53. Also a component of the TRIM28/KAP1-ERBB4-MDM2 complex which links growth factor and DNA damage response pathways. Mediates ubiquitination and subsequent proteasome degradation of DYRK2 in nucleus. Ubiquitinates IGF1R and SNAI1 and promotes them to proteasomal degradation (PubMed:12821780, PubMed:15053880, PubMed:15195100, PubMed:15632057, PubMed:16337594, PubMed:17290220, PubMed:19098711, PubMed:19219073, PubMed:19837670, PubMed:19965871, PubMed:20173098, PubMed:20385133, PubMed:20858735, PubMed:22128911). Ubiquitinates DCX, leading to DCX degradation and reduction of the dendritic spine density of olfactory bulb granule cells (By similarity). Ubiquitinates DLG4, leading to proteasomal degradation of DLG4 which is required for AMPA receptor endocytosis (By similarity). Negatively regulates NDUFS1, leading to decreased mitochondrial respiration, marked oxidative stress, and commitment to the mitochondrial pathway of apoptosis (PubMed:30879903). Binds NDUFS1 leading to its cytosolic retention rather than mitochondrial localization resulting in decreased supercomplex assembly (interactions between complex I and complex III), decreased complex I activity, ROS production, and apoptosis (PubMed:30879903). {ECO:0000250|UniProtKB:P23804, ECO:0000269|PubMed:12821780, ECO:0000269|PubMed:15053880, ECO:0000269|PubMed:15195100, ECO:0000269|PubMed:15632057, ECO:0000269|PubMed:16337594, ECO:0000269|PubMed:17290220, ECO:0000269|PubMed:19098711, ECO:0000269|PubMed:19219073, ECO:0000269|PubMed:19837670, ECO:0000269|PubMed:19965871, ECO:0000269|PubMed:20173098, ECO:0000269|PubMed:20385133, ECO:0000269|PubMed:20858735, ECO:0000269|PubMed:22128911, ECO:0000269|PubMed:29681526, ECO:0000269|PubMed:30879903}. |
Q01118 | SCN7A | S843 | ochoa | Sodium channel protein type 7 subunit alpha (Atypical sodium channel Nav2.1) (Nax channel) (Sodium channel protein type VII subunit alpha) | Sodium leak channel functioning as an osmosensor regulating sodium ion levels in various tissues and organs. While most sodium channels are voltage-gated, SCN7A is not and lets sodium flow through membrane along its concentration gradient (PubMed:26537257, PubMed:35301303). In glial cells of the central nervous system, senses body-fluid sodium levels and controls salt intake behavior as well as voluntary water intake through activation of nearby neurons to maintain appropriate sodium levels in the body (By similarity). By mediating sodium influx into keratinocytes, also plays a role in skin barrier homeostasis (PubMed:26537257). {ECO:0000250|UniProtKB:B1AYL1, ECO:0000269|PubMed:26537257, ECO:0000269|PubMed:35301303}. |
Q01484 | ANK2 | S1736 | ochoa | Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin) | Plays an essential role in the localization and membrane stabilization of ion transporters and ion channels in several cell types, including cardiomyocytes, as well as in striated muscle cells. In skeletal muscle, required for proper localization of DMD and DCTN4 and for the formation and/or stability of a special subset of microtubules associated with costameres and neuromuscular junctions. In cardiomyocytes, required for coordinate assembly of Na/Ca exchanger, SLC8A1/NCX1, Na/K ATPases ATP1A1 and ATP1A2 and inositol 1,4,5-trisphosphate (InsP3) receptors at sarcoplasmic reticulum/sarcolemma sites. Required for expression and targeting of SPTBN1 in neonatal cardiomyocytes and for the regulation of neonatal cardiomyocyte contraction rate (PubMed:12571597). In the inner segment of rod photoreceptors, required for the coordinated expression of the Na/K ATPase, Na/Ca exchanger and beta-2-spectrin (SPTBN1) (By similarity). Plays a role in endocytosis and intracellular protein transport. Associates with phosphatidylinositol 3-phosphate (PI3P)-positive organelles and binds dynactin to promote long-range motility of cells. Recruits RABGAP1L to (PI3P)-positive early endosomes, where RABGAP1L inactivates RAB22A, and promotes polarized trafficking to the leading edge of the migrating cells. Part of the ANK2/RABGAP1L complex which is required for the polarized recycling of fibronectin receptor ITGA5 ITGB1 to the plasma membrane that enables continuous directional cell migration (By similarity). {ECO:0000250|UniProtKB:Q8C8R3, ECO:0000269|PubMed:12571597}. |
Q02952 | AKAP12 | S568 | ochoa | A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen) | Anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA) and protein kinase C (PKC). |
Q02952 | AKAP12 | S569 | ochoa | A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen) | Anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA) and protein kinase C (PKC). |
Q02952 | AKAP12 | S1259 | ochoa | A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen) | Anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA) and protein kinase C (PKC). |
Q03188 | CENPC | S613 | ochoa | Centromere protein C (CENP-C) (Centromere autoantigen C) (Centromere protein C 1) (CENP-C 1) (Interphase centromere complex protein 7) | Component of the CENPA-NAC (nucleosome-associated) complex, a complex that plays a central role in assembly of kinetochore proteins, mitotic progression and chromosome segregation. The CENPA-NAC complex recruits the CENPA-CAD (nucleosome distal) complex and may be involved in incorporation of newly synthesized CENPA into centromeres. CENPC recruits DNA methylation and DNMT3B to both centromeric and pericentromeric satellite repeats and regulates the histone code in these regions. {ECO:0000269|PubMed:19482874, ECO:0000269|PubMed:21529714}. |
Q03468 | ERCC6 | S1348 | ochoa | DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB) | Essential factor involved in transcription-coupled nucleotide excision repair (TC-NER), a process during which RNA polymerase II-blocking lesions are rapidly removed from the transcribed strand of active genes (PubMed:16246722, PubMed:20541997, PubMed:22483866, PubMed:26620705, PubMed:32355176, PubMed:34526721, PubMed:38316879, PubMed:38600235, PubMed:38600236). Plays a central role in the initiation of the TC-NER process: specifically recognizes and binds RNA polymerase II stalled at a lesion, and mediates recruitment of ERCC8/CSA, initiating DNA damage excision by TFIIH recruitment (PubMed:32355176, PubMed:34526721, PubMed:38600235, PubMed:38600236). Upon DNA-binding, it locally modifies DNA conformation by wrapping the DNA around itself, thereby modifying the interface between stalled RNA polymerase II and DNA (PubMed:15548521). Acts as a chromatin remodeler at DSBs; DNA-dependent ATPase-dependent activity is essential for this function (PubMed:16246722, PubMed:9565609). Plays an important role in regulating the choice of the DNA double-strand breaks (DSBs) repair pathway and G2/M checkpoint activation; DNA-dependent ATPase activity is essential for this function (PubMed:25820262). Regulates the DNA repair pathway choice by inhibiting non-homologous end joining (NHEJ), thereby promoting the homologous recombination (HR)-mediated repair of DSBs during the S/G2 phases of the cell cycle (PubMed:25820262). Mediates the activation of the ATM- and CHEK2-dependent DNA damage responses thus preventing premature entry of cells into mitosis following the induction of DNA DSBs (PubMed:25820262). Remodels chromatin by evicting histones from chromatin flanking DSBs, limiting RIF1 accumulation at DSBs thereby promoting BRCA1-mediated HR (PubMed:29203878). Required for stable recruitment of ELOA and CUL5 to DNA damage sites (PubMed:28292928). Also involved in UV-induced translocation of ERCC8 to the nuclear matrix (PubMed:26620705). Essential for neuronal differentiation and neuritogenesis; regulates transcription and chromatin remodeling activities required during neurogenesis (PubMed:24874740). {ECO:0000269|PubMed:15548521, ECO:0000269|PubMed:16246722, ECO:0000269|PubMed:20541997, ECO:0000269|PubMed:22483866, ECO:0000269|PubMed:24874740, ECO:0000269|PubMed:25820262, ECO:0000269|PubMed:26620705, ECO:0000269|PubMed:28292928, ECO:0000269|PubMed:29203878, ECO:0000269|PubMed:32355176, ECO:0000269|PubMed:34526721, ECO:0000269|PubMed:38316879, ECO:0000269|PubMed:38600235, ECO:0000269|PubMed:38600236, ECO:0000269|PubMed:9565609}. |
Q05519 | SRSF11 | S215 | ochoa | Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) | May function in pre-mRNA splicing. |
Q06187 | BTK | Y345 | ochoa | Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) | Non-receptor tyrosine kinase indispensable for B lymphocyte development, differentiation and signaling (PubMed:19290921). Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation (PubMed:19290921). After BCR engagement and activation at the plasma membrane, phosphorylates PLCG2 at several sites, igniting the downstream signaling pathway through calcium mobilization, followed by activation of the protein kinase C (PKC) family members (PubMed:11606584). PLCG2 phosphorylation is performed in close cooperation with the adapter protein B-cell linker protein BLNK (PubMed:11606584). BTK acts as a platform to bring together a diverse array of signaling proteins and is implicated in cytokine receptor signaling pathways (PubMed:16517732, PubMed:17932028). Plays an important role in the function of immune cells of innate as well as adaptive immunity, as a component of the Toll-like receptors (TLR) pathway (PubMed:16517732). The TLR pathway acts as a primary surveillance system for the detection of pathogens and are crucial to the activation of host defense (PubMed:16517732). Especially, is a critical molecule in regulating TLR9 activation in splenic B-cells (PubMed:16517732, PubMed:17932028). Within the TLR pathway, induces tyrosine phosphorylation of TIRAP which leads to TIRAP degradation (PubMed:16415872). BTK also plays a critical role in transcription regulation (PubMed:19290921). Induces the activity of NF-kappa-B, which is involved in regulating the expression of hundreds of genes (PubMed:19290921). BTK is involved on the signaling pathway linking TLR8 and TLR9 to NF-kappa-B (PubMed:19290921). Acts as an activator of NLRP3 inflammasome assembly by mediating phosphorylation of NLRP3 (PubMed:34554188). Transiently phosphorylates transcription factor GTF2I on tyrosine residues in response to BCR (PubMed:9012831). GTF2I then translocates to the nucleus to bind regulatory enhancer elements to modulate gene expression (PubMed:9012831). ARID3A and NFAT are other transcriptional target of BTK (PubMed:16738337). BTK is required for the formation of functional ARID3A DNA-binding complexes (PubMed:16738337). There is however no evidence that BTK itself binds directly to DNA (PubMed:16738337). BTK has a dual role in the regulation of apoptosis (PubMed:9751072). Plays a role in STING1-mediated induction of type I interferon (IFN) response by phosphorylating DDX41 (PubMed:25704810). {ECO:0000269|PubMed:11606584, ECO:0000269|PubMed:16415872, ECO:0000269|PubMed:16517732, ECO:0000269|PubMed:16738337, ECO:0000269|PubMed:17932028, ECO:0000269|PubMed:25704810, ECO:0000269|PubMed:34554188, ECO:0000269|PubMed:9012831, ECO:0000303|PubMed:19290921, ECO:0000303|PubMed:9751072}. |
Q07021 | C1QBP | S213 | ochoa | Complement component 1 Q subcomponent-binding protein, mitochondrial (ASF/SF2-associated protein p32) (Glycoprotein gC1qBP) (C1qBP) (Hyaluronan-binding protein 1) (Mitochondrial matrix protein p32) (gC1q-R protein) (p33) (SF2AP32) | Multifunctional and multicompartmental protein involved in inflammation and infection processes, ribosome biogenesis, protein synthesis in mitochondria, regulation of apoptosis, transcriptional regulation and pre-mRNA splicing (PubMed:10022843, PubMed:10479529, PubMed:10722602, PubMed:11086025, PubMed:11859136, PubMed:15243141, PubMed:16140380, PubMed:16177118, PubMed:17881511, PubMed:18676636, PubMed:19004836, PubMed:19164550, PubMed:20810993, PubMed:21536856, PubMed:21544310, PubMed:22700724, PubMed:28942965, PubMed:8662673, PubMed:8710908, PubMed:9461517). At the cell surface is thought to act as an endothelial receptor for plasma proteins of the complement and kallikrein-kinin cascades (PubMed:10479529, PubMed:11859136, PubMed:8662673, PubMed:8710908). Putative receptor for C1q; specifically binds to the globular 'heads' of C1q thus inhibiting C1; may perform the receptor function through a complex with C1qR/CD93 (PubMed:20810993, PubMed:8195709). In complex with cytokeratin-1/KRT1 is a high affinity receptor for kininogen-1/HMWK (PubMed:21544310). Can also bind other plasma proteins, such as coagulation factor XII leading to its autoactivation. May function to bind initially fluid kininogen-1 to the cell membrane. The secreted form may enhance both extrinsic and intrinsic coagulation pathways. It is postulated that the cell surface form requires docking with transmembrane proteins for downstream signaling which might be specific for a cell-type or response. By acting as C1q receptor is involved in chemotaxis of immature dendritic cells and neutrophils and is proposed to signal through CD209/DC-SIGN on immature dendritic cells, through integrin alpha-4/beta-1 during trophoblast invasion of the decidua, and through integrin beta-1 during endothelial cell adhesion and spreading (PubMed:16140380, PubMed:22700724, PubMed:9461517). Signaling involved in inhibition of innate immune response is implicating the PI3K-AKT/PKB pathway (PubMed:16177118). Required for protein synthesis in mitochondria (PubMed:28942965). In mitochondrial translation may be involved in formation of functional 55S mitoribosomes; the function seems to involve its RNA-binding activity (By similarity). Acts as a RNA modification reader, which specifically recognizes and binds mitochondrial RNAs modified by C5-methylcytosine (m5C) in response to stress, and promotes recruitment of the mitochondrial degradosome complex, leading to their degradation (PubMed:39019044). May be involved in the nucleolar ribosome maturation process; the function may involve the exchange of FBL for RRP1 in the association with pre-ribosome particles (By similarity). Involved in regulation of RNA splicing by inhibiting the RNA-binding capacity of SRSF1 and its phosphorylation (PubMed:10022843, PubMed:21536856). Is required for the nuclear translocation of splicing factor U2AF1L4 (By similarity). Involved in regulation of CDKN2A- and HRK-mediated apoptosis. Stabilizes mitochondrial CDKN2A isoform smARF (PubMed:17486078). May be involved in regulation of FOXC1 transcriptional activity and NFY/CCAAT-binding factor complex-mediated transcription (PubMed:15243141, PubMed:18676636). May play a role in antibacterial defense as it can bind to cell surface hyaluronan and inhibit Streptococcus pneumoniae hyaluronate lyase (PubMed:19004836). May be involved in modulation of the immune response; ligation by HCV core protein is resulting in suppression of interleukin-12 production in monocyte-derived dendritic cells (PubMed:11086025, PubMed:17881511). Involved in regulation of antiviral response by inhibiting RIGI- and IFIH1-mediated signaling pathways probably involving its association with MAVS after viral infection (PubMed:19164550). Acts as a regulator of DNA repair via homologous recombination by inhibiting the activity of MRE11: interacts with unphosphorylated MRE11 and RAD50 in absence of DNA damage, preventing formation and activity of the MRN complex. Following DNA damage, dissociates from phosphorylated MRE11, allowing formation of the MRN complex (PubMed:31353207). {ECO:0000250|UniProtKB:O35658, ECO:0000269|PubMed:10022843, ECO:0000269|PubMed:10479529, ECO:0000269|PubMed:10722602, ECO:0000269|PubMed:11086025, ECO:0000269|PubMed:11859136, ECO:0000269|PubMed:15243141, ECO:0000269|PubMed:16140380, ECO:0000269|PubMed:16177118, ECO:0000269|PubMed:17486078, ECO:0000269|PubMed:17881511, ECO:0000269|PubMed:18676636, ECO:0000269|PubMed:19004836, ECO:0000269|PubMed:19164550, ECO:0000269|PubMed:20810993, ECO:0000269|PubMed:21536856, ECO:0000269|PubMed:21544310, ECO:0000269|PubMed:22700724, ECO:0000269|PubMed:28942965, ECO:0000269|PubMed:31353207, ECO:0000269|PubMed:39019044, ECO:0000269|PubMed:8195709, ECO:0000269|PubMed:8662673, ECO:0000269|PubMed:8710908, ECO:0000269|PubMed:9461517}.; FUNCTION: (Microbial infection) Involved in HIV-1 replication, presumably by contributing to splicing of viral RNA. {ECO:0000269|PubMed:12833064}.; FUNCTION: (Microbial infection) In infection processes acts as an attachment site for microbial proteins, including Listeria monocytogenes internalin B (InlB) and Staphylococcus aureus protein A. {ECO:0000269|PubMed:10722602, ECO:0000269|PubMed:10747014, ECO:0000269|PubMed:12411480}.; FUNCTION: (Microbial infection) Involved in replication of Rubella virus. {ECO:0000269|PubMed:12034482}. |
Q08170 | SRSF4 | S423 | ochoa | Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4) | Plays a role in alternative splice site selection during pre-mRNA splicing. Represses the splicing of MAPT/Tau exon 10. {ECO:0000269|PubMed:15009664}. |
Q08AD1 | CAMSAP2 | S1343 | ochoa | Calmodulin-regulated spectrin-associated protein 2 (Calmodulin-regulated spectrin-associated protein 1-like protein 1) | Key microtubule-organizing protein that specifically binds the minus-end of non-centrosomal microtubules and regulates their dynamics and organization (PubMed:23169647, PubMed:24486153, PubMed:24706919). Specifically recognizes growing microtubule minus-ends and autonomously decorates and stabilizes microtubule lattice formed by microtubule minus-end polymerization (PubMed:24486153, PubMed:24706919). Acts on free microtubule minus-ends that are not capped by microtubule-nucleating proteins or other factors and protects microtubule minus-ends from depolymerization (PubMed:24486153, PubMed:24706919). In addition, it also reduces the velocity of microtubule polymerization (PubMed:24486153, PubMed:24706919). Through the microtubule cytoskeleton, also regulates the organization of cellular organelles including the Golgi and the early endosomes (PubMed:27666745). Essential for the tethering, but not for nucleation of non-centrosomal microtubules at the Golgi: together with Golgi-associated proteins AKAP9 and PDE4DIP, required to tether non-centrosomal minus-end microtubules to the Golgi, an important step for polarized cell movement (PubMed:27666745). Also acts as a regulator of neuronal polarity and development: localizes to non-centrosomal microtubule minus-ends in neurons and stabilizes non-centrosomal microtubules, which is required for neuronal polarity, axon specification and dendritic branch formation (PubMed:24908486). Through the microtubule cytoskeleton, regulates the autophagosome transport (PubMed:28726242). {ECO:0000269|PubMed:23169647, ECO:0000269|PubMed:24486153, ECO:0000269|PubMed:24706919, ECO:0000269|PubMed:24908486, ECO:0000269|PubMed:27666745, ECO:0000269|PubMed:28726242}. |
Q12802 | AKAP13 | S1645 | ochoa | A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47) | Scaffold protein that plays an important role in assembling signaling complexes downstream of several types of G protein-coupled receptors. Activates RHOA in response to signaling via G protein-coupled receptors via its function as Rho guanine nucleotide exchange factor (PubMed:11546812, PubMed:15229649, PubMed:23090968, PubMed:24993829, PubMed:25186459). May also activate other Rho family members (PubMed:11546812). Part of a kinase signaling complex that links ADRA1A and ADRA1B adrenergic receptor signaling to the activation of downstream p38 MAP kinases, such as MAPK11 and MAPK14 (PubMed:17537920, PubMed:21224381, PubMed:23716597). Part of a signaling complex that links ADRA1B signaling to the activation of RHOA and IKBKB/IKKB, leading to increased NF-kappa-B transcriptional activity (PubMed:23090968). Part of a RHOA-dependent signaling cascade that mediates responses to lysophosphatidic acid (LPA), a signaling molecule that activates G-protein coupled receptors and potentiates transcriptional activation of the glucocorticoid receptor NR3C1 (PubMed:16469733). Part of a signaling cascade that stimulates MEF2C-dependent gene expression in response to lysophosphatidic acid (LPA) (By similarity). Part of a signaling pathway that activates MAPK11 and/or MAPK14 and leads to increased transcription activation of the estrogen receptors ESR1 and ESR2 (PubMed:11579095, PubMed:9627117). Part of a signaling cascade that links cAMP and EGFR signaling to BRAF signaling and to PKA-mediated phosphorylation of KSR1, leading to the activation of downstream MAP kinases, such as MAPK1 or MAPK3 (PubMed:21102438). Functions as a scaffold protein that anchors cAMP-dependent protein kinase (PKA) and PRKD1. This promotes activation of PRKD1, leading to increased phosphorylation of HDAC5 and ultimately cardiomyocyte hypertrophy (By similarity). Has no guanine nucleotide exchange activity on CDC42, Ras or Rac (PubMed:11546812). Required for normal embryonic heart development, and in particular for normal sarcomere formation in the developing cardiomyocytes (By similarity). Plays a role in cardiomyocyte growth and cardiac hypertrophy in response to activation of the beta-adrenergic receptor by phenylephrine or isoproterenol (PubMed:17537920, PubMed:23090968). Required for normal adaptive cardiac hypertrophy in response to pressure overload (PubMed:23716597). Plays a role in osteogenesis (By similarity). {ECO:0000250|UniProtKB:E9Q394, ECO:0000269|PubMed:11546812, ECO:0000269|PubMed:11579095, ECO:0000269|PubMed:17537920, ECO:0000269|PubMed:21224381, ECO:0000269|PubMed:23716597, ECO:0000269|PubMed:24993829, ECO:0000269|PubMed:25186459, ECO:0000269|PubMed:9627117, ECO:0000269|PubMed:9891067}. |
Q12888 | TP53BP1 | S323 | ochoa | TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1) | Double-strand break (DSB) repair protein involved in response to DNA damage, telomere dynamics and class-switch recombination (CSR) during antibody genesis (PubMed:12364621, PubMed:17190600, PubMed:21144835, PubMed:22553214, PubMed:23333306, PubMed:27153538, PubMed:28241136, PubMed:31135337, PubMed:37696958). Plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs and specifically counteracting the function of the homologous recombination (HR) repair protein BRCA1 (PubMed:22553214, PubMed:23333306, PubMed:23727112, PubMed:27153538, PubMed:31135337). In response to DSBs, phosphorylation by ATM promotes interaction with RIF1 and dissociation from NUDT16L1/TIRR, leading to recruitment to DSBs sites (PubMed:28241136). Recruited to DSBs sites by recognizing and binding histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed:17190600, PubMed:23760478, PubMed:27153538, PubMed:28241136). Required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed:23345425). Participates in the repair and the orientation of the broken DNA ends during CSR (By similarity). In contrast, it is not required for classic NHEJ and V(D)J recombination (By similarity). Promotes NHEJ of dysfunctional telomeres via interaction with PAXIP1 (PubMed:23727112). {ECO:0000250|UniProtKB:P70399, ECO:0000269|PubMed:12364621, ECO:0000269|PubMed:17190600, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22553214, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:23345425, ECO:0000269|PubMed:23727112, ECO:0000269|PubMed:23760478, ECO:0000269|PubMed:27153538, ECO:0000269|PubMed:28241136, ECO:0000269|PubMed:31135337, ECO:0000269|PubMed:37696958}. |
Q12888 | TP53BP1 | S1219 | ochoa|psp | TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1) | Double-strand break (DSB) repair protein involved in response to DNA damage, telomere dynamics and class-switch recombination (CSR) during antibody genesis (PubMed:12364621, PubMed:17190600, PubMed:21144835, PubMed:22553214, PubMed:23333306, PubMed:27153538, PubMed:28241136, PubMed:31135337, PubMed:37696958). Plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs and specifically counteracting the function of the homologous recombination (HR) repair protein BRCA1 (PubMed:22553214, PubMed:23333306, PubMed:23727112, PubMed:27153538, PubMed:31135337). In response to DSBs, phosphorylation by ATM promotes interaction with RIF1 and dissociation from NUDT16L1/TIRR, leading to recruitment to DSBs sites (PubMed:28241136). Recruited to DSBs sites by recognizing and binding histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed:17190600, PubMed:23760478, PubMed:27153538, PubMed:28241136). Required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed:23345425). Participates in the repair and the orientation of the broken DNA ends during CSR (By similarity). In contrast, it is not required for classic NHEJ and V(D)J recombination (By similarity). Promotes NHEJ of dysfunctional telomeres via interaction with PAXIP1 (PubMed:23727112). {ECO:0000250|UniProtKB:P70399, ECO:0000269|PubMed:12364621, ECO:0000269|PubMed:17190600, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22553214, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:23345425, ECO:0000269|PubMed:23727112, ECO:0000269|PubMed:23760478, ECO:0000269|PubMed:27153538, ECO:0000269|PubMed:28241136, ECO:0000269|PubMed:31135337, ECO:0000269|PubMed:37696958}. |
Q12959 | DLG1 | S687 | ochoa | Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97) (hDlg) | Essential multidomain scaffolding protein required for normal development (By similarity). Recruits channels, receptors and signaling molecules to discrete plasma membrane domains in polarized cells. Promotes epithelial cell layer barrier function via maintaining cell-cell adhesion (By similarity). May also play a role in adherens junction assembly, signal transduction, cell proliferation, synaptogenesis and lymphocyte activation. Regulates the excitability of cardiac myocytes by modulating the functional expression of Kv4 channels. Functional regulator of Kv1.5 channel. During long-term depression in hippocampal neurons, it recruits ADAM10 to the plasma membrane (PubMed:23676497). {ECO:0000250|UniProtKB:A0A8C0TYJ0, ECO:0000250|UniProtKB:Q811D0, ECO:0000269|PubMed:10656683, ECO:0000269|PubMed:12445884, ECO:0000269|PubMed:14699157, ECO:0000269|PubMed:15263016, ECO:0000269|PubMed:19213956, ECO:0000269|PubMed:20605917, ECO:0000269|PubMed:23676497}. |
Q13017 | ARHGAP5 | S1176 | ochoa | Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B) | GTPase-activating protein for Rho family members (PubMed:8537347). {ECO:0000269|PubMed:8537347}. |
Q13023 | AKAP6 | S1566 | ochoa | A-kinase anchor protein 6 (AKAP-6) (A-kinase anchor protein 100 kDa) (AKAP 100) (Protein kinase A-anchoring protein 6) (PRKA6) (mAKAP) | Binds to type II regulatory subunits of protein kinase A and anchors/targets them to the nuclear membrane or sarcoplasmic reticulum. May act as an adapter for assembling multiprotein complexes. |
Q13177 | PAK2 | S58 | ochoa | Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)] | Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell motility, cell cycle progression, apoptosis or proliferation (PubMed:12853446, PubMed:16617111, PubMed:19273597, PubMed:19923322, PubMed:33693784, PubMed:7744004, PubMed:9171063). Acts as a downstream effector of the small GTPases CDC42 and RAC1 (PubMed:7744004). Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues (PubMed:7744004). Full-length PAK2 stimulates cell survival and cell growth (PubMed:7744004). Phosphorylates MAPK4 and MAPK6 and activates the downstream target MAPKAPK5, a regulator of F-actin polymerization and cell migration (PubMed:21317288). Phosphorylates JUN and plays an important role in EGF-induced cell proliferation (PubMed:21177766). Phosphorylates many other substrates including histone H4 to promote assembly of H3.3 and H4 into nucleosomes, BAD, ribosomal protein S6, or MBP (PubMed:21724829). Phosphorylates CASP7, thereby preventing its activity (PubMed:21555521, PubMed:27889207). Additionally, associates with ARHGEF7 and GIT1 to perform kinase-independent functions such as spindle orientation control during mitosis (PubMed:19273597, PubMed:19923322). On the other hand, apoptotic stimuli such as DNA damage lead to caspase-mediated cleavage of PAK2, generating PAK-2p34, an active p34 fragment that translocates to the nucleus and promotes cellular apoptosis involving the JNK signaling pathway (PubMed:12853446, PubMed:16617111, PubMed:9171063). Caspase-activated PAK2 phosphorylates MKNK1 and reduces cellular translation (PubMed:15234964). {ECO:0000269|PubMed:12853446, ECO:0000269|PubMed:15234964, ECO:0000269|PubMed:16617111, ECO:0000269|PubMed:19273597, ECO:0000269|PubMed:19923322, ECO:0000269|PubMed:21177766, ECO:0000269|PubMed:21317288, ECO:0000269|PubMed:21555521, ECO:0000269|PubMed:21724829, ECO:0000269|PubMed:27889207, ECO:0000269|PubMed:33693784, ECO:0000269|PubMed:7744004, ECO:0000269|PubMed:9171063}. |
Q13492 | PICALM | S311 | ochoa | Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein) | Cytoplasmic adapter protein that plays a critical role in clathrin-mediated endocytosis which is important in processes such as internalization of cell receptors, synaptic transmission or removal of apoptotic cells. Recruits AP-2 and attaches clathrin triskelions to the cytoplasmic side of plasma membrane leading to clathrin-coated vesicles (CCVs) assembly (PubMed:10436022, PubMed:16262731, PubMed:27574975). Furthermore, regulates clathrin-coated vesicle size and maturation by directly sensing and driving membrane curvature (PubMed:25898166). In addition to binding to clathrin, mediates the endocytosis of small R-SNARES (Soluble NSF Attachment Protein REceptors) between plasma membranes and endosomes including VAMP2, VAMP3, VAMP4, VAMP7 or VAMP8 (PubMed:21808019, PubMed:22118466, PubMed:23741335). In turn, PICALM-dependent SNARE endocytosis is required for the formation and maturation of autophagic precursors (PubMed:25241929). Modulates thereby autophagy and the turnover of autophagy substrates such as MAPT/TAU or amyloid precursor protein cleaved C-terminal fragment (APP-CTF) (PubMed:24067654, PubMed:25241929). {ECO:0000269|PubMed:10436022, ECO:0000269|PubMed:16262731, ECO:0000269|PubMed:21808019, ECO:0000269|PubMed:22118466, ECO:0000269|PubMed:23741335, ECO:0000269|PubMed:24067654, ECO:0000269|PubMed:25241929, ECO:0000269|PubMed:25898166, ECO:0000269|PubMed:27574975}. |
Q13501 | SQSTM1 | S152 | ochoa | Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62) (p62) | Molecular adapter required for selective macroautophagy (aggrephagy) by acting as a bridge between polyubiquitinated proteins and autophagosomes (PubMed:15340068, PubMed:15953362, PubMed:16286508, PubMed:17580304, PubMed:20168092, PubMed:22017874, PubMed:22622177, PubMed:24128730, PubMed:28404643, PubMed:29343546, PubMed:29507397, PubMed:31857589, PubMed:33509017, PubMed:34471133, PubMed:34893540, PubMed:35831301, PubMed:37306101, PubMed:37802024). Promotes the recruitment of ubiquitinated cargo proteins to autophagosomes via multiple domains that bridge proteins and organelles in different steps (PubMed:16286508, PubMed:20168092, PubMed:22622177, PubMed:24128730, PubMed:28404643, PubMed:29343546, PubMed:29507397, PubMed:34893540, PubMed:37802024). SQSTM1 first mediates the assembly and removal of ubiquitinated proteins by undergoing liquid-liquid phase separation upon binding to ubiquitinated proteins via its UBA domain, leading to the formation of insoluble cytoplasmic inclusions, known as p62 bodies (PubMed:15911346, PubMed:20168092, PubMed:22017874, PubMed:24128730, PubMed:29343546, PubMed:29507397, PubMed:31857589, PubMed:37802024). SQSTM1 then interacts with ATG8 family proteins on autophagosomes via its LIR motif, leading to p62 body recruitment to autophagosomes, followed by autophagic clearance of ubiquitinated proteins (PubMed:16286508, PubMed:17580304, PubMed:20168092, PubMed:22622177, PubMed:24128730, PubMed:28404643, PubMed:37802024). SQSTM1 is itself degraded along with its ubiquitinated cargos (PubMed:16286508, PubMed:17580304, PubMed:37802024). Also required to recruit ubiquitinated proteins to PML bodies in the nucleus (PubMed:20168092). Also involved in autophagy of peroxisomes (pexophagy) in response to reactive oxygen species (ROS) by acting as a bridge between ubiquitinated PEX5 receptor and autophagosomes (PubMed:26344566). Acts as an activator of the NFE2L2/NRF2 pathway via interaction with KEAP1: interaction inactivates the BCR(KEAP1) complex by sequestering the complex in inclusion bodies, promoting nuclear accumulation of NFE2L2/NRF2 and subsequent expression of cytoprotective genes (PubMed:20452972, PubMed:28380357, PubMed:33393215, PubMed:37306101). Promotes relocalization of 'Lys-63'-linked ubiquitinated STING1 to autophagosomes (PubMed:29496741). Involved in endosome organization by retaining vesicles in the perinuclear cloud: following ubiquitination by RNF26, attracts specific vesicle-associated adapters, forming a molecular bridge that restrains cognate vesicles in the perinuclear region and organizes the endosomal pathway for efficient cargo transport (PubMed:27368102, PubMed:33472082). Sequesters tensin TNS2 into cytoplasmic puncta, promoting TNS2 ubiquitination and proteasomal degradation (PubMed:25101860). May regulate the activation of NFKB1 by TNF-alpha, nerve growth factor (NGF) and interleukin-1 (PubMed:10356400, PubMed:10747026, PubMed:11244088, PubMed:12471037, PubMed:16079148, PubMed:19931284). May play a role in titin/TTN downstream signaling in muscle cells (PubMed:15802564). Adapter that mediates the interaction between TRAF6 and CYLD (By similarity). {ECO:0000250|UniProtKB:Q64337, ECO:0000269|PubMed:10356400, ECO:0000269|PubMed:10747026, ECO:0000269|PubMed:11244088, ECO:0000269|PubMed:12471037, ECO:0000269|PubMed:15340068, ECO:0000269|PubMed:15802564, ECO:0000269|PubMed:15911346, ECO:0000269|PubMed:15953362, ECO:0000269|PubMed:16079148, ECO:0000269|PubMed:16286508, ECO:0000269|PubMed:17580304, ECO:0000269|PubMed:19931284, ECO:0000269|PubMed:20168092, ECO:0000269|PubMed:20452972, ECO:0000269|PubMed:22017874, ECO:0000269|PubMed:22622177, ECO:0000269|PubMed:24128730, ECO:0000269|PubMed:25101860, ECO:0000269|PubMed:26344566, ECO:0000269|PubMed:27368102, ECO:0000269|PubMed:28380357, ECO:0000269|PubMed:28404643, ECO:0000269|PubMed:29343546, ECO:0000269|PubMed:29496741, ECO:0000269|PubMed:29507397, ECO:0000269|PubMed:31857589, ECO:0000269|PubMed:33393215, ECO:0000269|PubMed:33472082, ECO:0000269|PubMed:33509017, ECO:0000269|PubMed:34471133, ECO:0000269|PubMed:34893540, ECO:0000269|PubMed:35831301, ECO:0000269|PubMed:37306101, ECO:0000269|PubMed:37802024}. |
Q13523 | PRP4K | S23 | ochoa | Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog) | Serine/threonine kinase involved in spliceosomal assembly as well as mitosis and signaling regulation (PubMed:10799319, PubMed:12077342, PubMed:17513757, PubMed:17998396). Connects chromatin mediated regulation of transcription and pre-mRNA splicing (PubMed:12077342). During spliceosomal assembly, interacts with and phosphorylates PRPF6 and PRPF31, components of the U4/U6-U5 tri-small nuclear ribonucleoprotein (snRNP), to facilitate the formation of the spliceosome B complex. Plays a role in regulating transcription and the spindle assembly checkpoint (SAC) (PubMed:20118938). Associates with U5 snRNP and NCOR1 deacetylase complexes which may allow a coordination of pre-mRNA splicing with chromatin remodeling events involved in transcriptional regulation (PubMed:12077342). Associates and probably phosphorylates SMARCA4 and NCOR1 (PubMed:12077342). Phosphorylates SRSF1 (PubMed:11418604). Associates with kinetochores during mitosis and is necessary for recruitment and maintenance of the checkpoint proteins such as MAD1L1 and MAD12L1 at the kinetochores (PubMed:17998396). Phosphorylates and regulates the activity of the transcription factors such as ELK1 and KLF13 (PubMed:10799319, PubMed:17513757). Phosphorylates nuclear YAP1 and WWTR1/TAZ which induces nuclear exclusion and regulates Hippo signaling pathway, involved in tissue growth control (PubMed:29695716). {ECO:0000269|PubMed:10799319, ECO:0000269|PubMed:11418604, ECO:0000269|PubMed:12077342, ECO:0000269|PubMed:17513757, ECO:0000269|PubMed:17998396, ECO:0000269|PubMed:20118938, ECO:0000269|PubMed:29695716}. |
Q13530 | SERINC3 | S383 | ochoa|psp | Serine incorporator 3 (Tumor differentially expressed protein 1) | Restriction factor required to restrict infectivity of lentiviruses, such as HIV-1: acts by inhibiting an early step of viral infection. Impairs the penetration of the viral particle into the cytoplasm (PubMed:26416733, PubMed:26416734). Non-ATP-dependent, non-specific lipid transporter for phosphatidylserine, phosphatidylcholine, and phosphatidylethanolamine. Functions as a scramblase that flips lipids in both directions across the membrane. Phospholipid scrambling results in HIV-1 surface exposure of phosphatidylserine and loss of membrane asymmetry, which leads to changes in HIV-1 Env conformation and loss of infectivity (PubMed:37474505). {ECO:0000269|PubMed:26416733, ECO:0000269|PubMed:26416734, ECO:0000269|PubMed:37474505}. |
Q13563 | PKD2 | S835 | ochoa | Polycystin-2 (PC2) (Autosomal dominant polycystic kidney disease type II protein) (Polycystic kidney disease 2 protein) (Polycystwin) (R48321) (Transient receptor potential cation channel subfamily P member 2) | Forms a nonselective cation channel (PubMed:11854751, PubMed:11991947, PubMed:15692563, PubMed:26269590, PubMed:27071085, PubMed:31441214, PubMed:39009345). Can function as a homotetrameric ion channel or can form heteromer with PKD1 (PubMed:31441214, PubMed:33164752). Displays distinct function depending on its subcellular localization and regulation by its binding partners (PubMed:11854751, PubMed:11991947, PubMed:27214281, PubMed:29899465). In primary cilium functions as a cation channel, with a preference for monovalent cations over divalent cations that allows K(+), Na(+) and Ca(2+) influx, with low selectivity for Ca(2+) (PubMed:27071085). Involved in fluid-flow mechanosensation by the primary cilium in renal epithelium (By similarity). In the endoplasmic reticulum, likely functions as a K(+) channel to facilitate Ca(2+) release (By similarity). The heterotetrameric PKD1/PKD2 channel has higher Ca(2+) permeability than homomeric PKD2 channel and acts as a primarily Ca(2+)-permeable channel (PubMed:31441214). Interacts with and acts as a regulator of a number of other channels, such as TRPV4, TRPC1, IP3R, RYR2, ultimately further affecting intracellular signaling, to modulate intracellular Ca(2+) signaling (PubMed:11854751, PubMed:11991947, PubMed:27214281, PubMed:29899465). Together with TRPV4, forms mechano- and thermosensitive channels in cilium (PubMed:18695040). In cardiomyocytes, PKD2 modulates Ca(2+) release from stimulated RYR2 receptors through direct association (By similarity). Also involved in left-right axis specification via its role in sensing nodal flow; forms a complex with PKD1L1 in cilia to facilitate flow detection in left-right patterning (By similarity). Acts as a regulator of cilium length together with PKD1 (By similarity). Mediates systemic blood pressure and contributes to the myogenic response in cerebral arteries though vasoconstriction (By similarity). {ECO:0000250|UniProtKB:O35245, ECO:0000269|PubMed:11854751, ECO:0000269|PubMed:11991947, ECO:0000269|PubMed:15692563, ECO:0000269|PubMed:18695040, ECO:0000269|PubMed:26269590, ECO:0000269|PubMed:27071085, ECO:0000269|PubMed:27214281, ECO:0000269|PubMed:29899465, ECO:0000269|PubMed:31441214, ECO:0000269|PubMed:33164752, ECO:0000269|PubMed:39009345}. |
Q13625 | TP53BP2 | S783 | ochoa | Apoptosis-stimulating of p53 protein 2 (Bcl2-binding protein) (Bbp) (Renal carcinoma antigen NY-REN-51) (Tumor suppressor p53-binding protein 2) (53BP2) (p53-binding protein 2) (p53BP2) | Regulator that plays a central role in regulation of apoptosis and cell growth via its interactions with proteins such as TP53 (PubMed:12524540). Regulates TP53 by enhancing the DNA binding and transactivation function of TP53 on the promoters of proapoptotic genes in vivo. Inhibits the ability of NAE1 to conjugate NEDD8 to CUL1, and thereby decreases NAE1 ability to induce apoptosis. Impedes cell cycle progression at G2/M. Its apoptosis-stimulating activity is inhibited by its interaction with DDX42. {ECO:0000269|PubMed:11684014, ECO:0000269|PubMed:12524540, ECO:0000269|PubMed:12694406, ECO:0000269|PubMed:19377511}. |
Q14149 | MORC3 | S503 | ochoa | MORC family CW-type zinc finger protein 3 (Nuclear matrix protein 2) (Zinc finger CW-type coiled-coil domain protein 3) | Nuclear matrix protein which forms MORC3-NBs (nuclear bodies) via an ATP-dependent mechanism and plays a role in innate immunity by restricting different viruses through modulation of the IFN response (PubMed:27440897, PubMed:34759314). Mechanistically, possesses a primary antiviral function through a MORC3-regulated element that activates IFNB1, and this function is guarded by a secondary IFN-repressing function (PubMed:34759314). Sumoylated MORC3-NBs associates with PML-NBs and recruits TP53 and SP100, thus regulating TP53 activity (PubMed:17332504, PubMed:20501696). Binds RNA in vitro (PubMed:11927593). Histone methylation reader which binds to non-methylated (H3K4me0), monomethylated (H3K4me1), dimethylated (H3K4me2) and trimethylated (H3K4me3) 'Lys-4' on histone H3 (PubMed:26933034). The order of binding preference is H3K4me3 > H3K4me2 > H3K4me1 > H3K4me0 (PubMed:26933034). {ECO:0000269|PubMed:11927593, ECO:0000269|PubMed:17332504, ECO:0000269|PubMed:20501696, ECO:0000269|PubMed:26933034, ECO:0000269|PubMed:27440897, ECO:0000269|PubMed:34759314}.; FUNCTION: (Microbial infection) May be required for influenza A transcription during viral infection (PubMed:26202233). {ECO:0000269|PubMed:26202233}. |
Q15003 | NCAPH | S28 | ochoa | Condensin complex subunit 2 (Barren homolog protein 1) (Chromosome-associated protein H) (hCAP-H) (Non-SMC condensin I complex subunit H) (XCAP-H homolog) | Regulatory subunit of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases (PubMed:11136719). Early in neurogenesis, may play an essential role to ensure accurate mitotic chromosome condensation in neuron stem cells, ultimately affecting neuron pool and cortex size (PubMed:27737959). {ECO:0000269|PubMed:11136719, ECO:0000269|PubMed:27737959}. |
Q15021 | NCAPD2 | S1370 | ochoa | Condensin complex subunit 1 (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2) (hCAP-D2) (Non-SMC condensin I complex subunit D2) (XCAP-D2 homolog) | Regulatory subunit of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases. May target the condensin complex to DNA via its C-terminal domain (PubMed:11136719). May promote the resolution of double-strand DNA catenanes (intertwines) between sister chromatids. Condensin-mediated compaction likely increases tension in catenated sister chromatids, providing directionality for type II topoisomerase-mediated strand exchanges toward chromatid decatenation. Required for decatenation of non-centromeric ultrafine DNA bridges during anaphase. Early in neurogenesis, may play an essential role to ensure accurate mitotic chromosome condensation in neuron stem cells, ultimately affecting neuron pool and cortex size (PubMed:27737959). {ECO:0000269|PubMed:11136719, ECO:0000269|PubMed:27737959}. |
Q15057 | ACAP2 | S584 | ochoa | Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2) | GTPase-activating protein (GAP) for ADP ribosylation factor 6 (ARF6). Doesn't show GAP activity for RAB35 (PubMed:30905672). {ECO:0000269|PubMed:11062263, ECO:0000269|PubMed:30905672}. |
Q15075 | EEA1 | S52 | ochoa | Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2) | Binds phospholipid vesicles containing phosphatidylinositol 3-phosphate and participates in endosomal trafficking. |
Q15172 | PPP2R5A | S49 | ochoa | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha) | The B regulatory subunit might modulate substrate selectivity and catalytic activity, and might also direct the localization of the catalytic enzyme to a particular subcellular compartment. |
Q16799 | RTN1 | S166 | ochoa | Reticulon-1 (Neuroendocrine-specific protein) | Inhibits amyloid precursor protein processing, probably by blocking BACE1 activity. {ECO:0000269|PubMed:15286784}. |
Q16890 | TPD52L1 | S149 | ochoa | Tumor protein D53 (hD53) (Tumor protein D52-like 1) | None |
Q16891 | IMMT | S193 | ochoa | MICOS complex subunit MIC60 (Cell proliferation-inducing gene 4/52 protein) (Mitochondrial inner membrane protein) (Mitofilin) (p87/89) | Component of the MICOS complex, a large protein complex of the mitochondrial inner membrane that plays crucial roles in the maintenance of crista junctions, inner membrane architecture, and formation of contact sites to the outer membrane (PubMed:22114354, PubMed:25781180, PubMed:32567732, PubMed:33130824). Plays an important role in the maintenance of the MICOS complex stability and the mitochondrial cristae morphology (PubMed:22114354, PubMed:25781180, PubMed:32567732, PubMed:33130824). {ECO:0000269|PubMed:22114354, ECO:0000269|PubMed:25781180, ECO:0000269|PubMed:32567732, ECO:0000269|PubMed:33130824}. |
Q2M1K9 | ZNF423 | S50 | ochoa | Zinc finger protein 423 (Olf1/EBF-associated zinc finger protein) (hOAZ) (Smad- and Olf-interacting zinc finger protein) | Transcription factor that can both act as an activator or a repressor depending on the context. Plays a central role in BMP signaling and olfactory neurogenesis. Associates with SMADs in response to BMP2 leading to activate transcription of BMP target genes. Acts as a transcriptional repressor via its interaction with EBF1, a transcription factor involved in terminal olfactory receptor neurons differentiation; this interaction preventing EBF1 to bind DNA and activate olfactory-specific genes. Involved in olfactory neurogenesis by participating in a developmental switch that regulates the transition from differentiation to maturation in olfactory receptor neurons. Controls proliferation and differentiation of neural precursors in cerebellar vermis formation. {ECO:0000269|PubMed:10660046}. |
Q2M2Z5 | KIZ | S439 | ochoa | Centrosomal protein kizuna (Polo-like kinase 1 substrate 1) | Centrosomal protein required for establishing a robust mitotic centrosome architecture that can endure the forces that converge on the centrosomes during spindle formation. Required for stabilizing the expanded pericentriolar material around the centriole. {ECO:0000269|PubMed:16980960}. |
Q2PPJ7 | RALGAPA2 | S379 | ochoa | Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt) (AS250) (p220) | Catalytic subunit of the heterodimeric RalGAP2 complex which acts as a GTPase activator for the Ras-like small GTPases RALA and RALB. {ECO:0000250}. |
Q4G0J3 | LARP7 | S261 | ochoa | La-related protein 7 (La ribonucleoprotein domain family member 7) (hLARP7) (P-TEFb-interaction protein for 7SK stability) (PIP7S) | RNA-binding protein that specifically binds distinct small nuclear RNA (snRNAs) and regulates their processing and function (PubMed:18249148, PubMed:32017898). Specifically binds the 7SK snRNA (7SK RNA) and acts as a core component of the 7SK ribonucleoprotein (RNP) complex, thereby acting as a negative regulator of transcription elongation by RNA polymerase II (PubMed:18249148, PubMed:18483487). The 7SK RNP complex sequesters the positive transcription elongation factor b (P-TEFb) in a large inactive 7SK RNP complex preventing RNA polymerase II phosphorylation and subsequent transcriptional elongation (PubMed:18249148, PubMed:18483487). The 7SK RNP complex also promotes snRNA gene transcription by RNA polymerase II via interaction with the little elongation complex (LEC) (PubMed:28254838). LARP7 specifically binds to the highly conserved 3'-terminal U-rich stretch of 7SK RNA; on stimulation, remains associated with 7SK RNA, whereas P-TEFb is released from the complex (PubMed:18281698, PubMed:18483487). LARP7 also acts as a regulator of mRNA splicing fidelity by promoting U6 snRNA processing (PubMed:32017898). Specifically binds U6 snRNAs and associates with a subset of box C/D RNP complexes: promotes U6 snRNA 2'-O-methylation by facilitating U6 snRNA loading into box C/D RNP complexes (PubMed:32017898). U6 snRNA 2'-O-methylation is required for mRNA splicing fidelity (PubMed:32017898). Binds U6 snRNAs with a 5'-CAGGG-3' sequence motif (PubMed:32017898). U6 snRNA processing is required for spermatogenesis (By similarity). {ECO:0000250|UniProtKB:Q05CL8, ECO:0000269|PubMed:18249148, ECO:0000269|PubMed:18281698, ECO:0000269|PubMed:18483487, ECO:0000269|PubMed:28254838, ECO:0000269|PubMed:32017898}. |
Q53EL6 | PDCD4 | S49 | ochoa | Programmed cell death protein 4 (Neoplastic transformation inhibitor protein) (Nuclear antigen H731-like) (Protein 197/15a) | Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA (By similarity). {ECO:0000250, ECO:0000269|PubMed:16357133, ECO:0000269|PubMed:16449643, ECO:0000269|PubMed:17053147, ECO:0000269|PubMed:18296639, ECO:0000269|PubMed:19153607, ECO:0000269|PubMed:19204291}. |
Q562E7 | WDR81 | S1118 | ochoa | WD repeat-containing protein 81 | Functions as a negative regulator of the PI3 kinase/PI3K activity associated with endosomal membranes via BECN1, a core subunit of the PI3K complex. By modifying the phosphatidylinositol 3-phosphate/PtdInsP3 content of endosomal membranes may regulate endosome fusion, recycling, sorting and early to late endosome transport (PubMed:26783301). It is for instance, required for the delivery of cargos like BST2/tetherin from early to late endosome and thereby participates indirectly to their degradation by the lysosome (PubMed:27126989). May also play a role in aggrephagy, the macroautophagic degradation of ubiquitinated protein aggregates. In this process, may regulate the interaction of SQSTM1 with ubiquitinated proteins and also recruit MAP1LC3C (PubMed:28404643). May also be involved in maintenance of normal mitochondrial structure and organization (By similarity). {ECO:0000250|UniProtKB:Q5ND34, ECO:0000269|PubMed:26783301, ECO:0000269|PubMed:27126989, ECO:0000269|PubMed:28404643}. |
Q567U6 | CCDC93 | S151 | ochoa | Coiled-coil domain-containing protein 93 | Component of the commander complex that is essential for endosomal recycling of transmembrane cargos; the commander complex is composed of composed of the CCC subcomplex and the retriever subcomplex (PubMed:37172566, PubMed:38459129). Component of the CCC complex, which is involved in the regulation of endosomal recycling of surface proteins, including integrins, signaling receptor and channels (PubMed:37172566, PubMed:38459129). The CCC complex associates with SNX17, retriever and WASH complexes to prevent lysosomal degradation and promote cell surface recycling of numerous cargos such as integrins ITGA5:ITGB1 (PubMed:25355947, PubMed:28892079). Involved in copper-dependent ATP7A trafficking between the trans-Golgi network and vesicles in the cell periphery; the function is proposed to depend on its association within the CCC complex and cooperation with the WASH complex on early endosomes and is dependent on its interaction with WASHC2C (PubMed:25355947). {ECO:0000269|PubMed:25355947, ECO:0000269|PubMed:28892079, ECO:0000269|PubMed:37172566, ECO:0000269|PubMed:38459129}.; FUNCTION: (Microbial infection) The CCC complex, in collaboration with the heterotrimeric retriever complex, mediates the exit of human papillomavirus to the cell surface. {ECO:0000269|PubMed:28892079}. |
Q5BKY9 | FAM133B | S194 | ochoa | Protein FAM133B | None |
Q5HYJ3 | FAM76B | S193 | ochoa | Protein FAM76B | Negatively regulates the NF-kappa-B-mediated inflammatory pathway by preventing the translocation of HNRNPA2B1 from the nucleus to the cytoplasm (PubMed:37643469). Inhibits the PI3K/Akt/NF-kappa-B pathway-mediated polarization of M1 macrophages by binding to and stabilizing PIK3CD mRNA, resulting in increased levels of PIK3CD protein and increased levels of phosphorylated downstream target AKT which leads to decreased NF-kappa-B signaling (PubMed:38421448). {ECO:0000269|PubMed:37643469, ECO:0000269|PubMed:38421448}. |
Q5JSZ5 | PRRC2B | S1139 | ochoa | Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B) | None |
Q5JTZ5 | C9orf152 | S90 | ochoa | Uncharacterized protein C9orf152 | None |
Q5QJE6 | DNTTIP2 | S178 | ochoa | Deoxynucleotidyltransferase terminal-interacting protein 2 (Estrogen receptor-binding protein) (LPTS-interacting protein 2) (LPTS-RP2) (Terminal deoxynucleotidyltransferase-interacting factor 2) (TdIF2) (TdT-interacting factor 2) | Regulates the transcriptional activity of DNTT and ESR1. May function as a chromatin remodeling protein (PubMed:12786946, PubMed:15047147). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797). {ECO:0000269|PubMed:12786946, ECO:0000269|PubMed:15047147, ECO:0000269|PubMed:34516797}. |
Q5T8I3 | EEIG2 | S320 | ochoa | EEIG family member 2 (EEIG2) | None |
Q5TGY3 | AHDC1 | S1190 | ochoa | Transcription factor Gibbin (AT-hook DNA-binding motif-containing protein 1) | Transcription factor required for the proper patterning of the epidermis, which plays a key role in early epithelial morphogenesis (PubMed:35585237). Directly binds promoter and enhancer regions and acts by maintaining local enhancer-promoter chromatin architecture (PubMed:35585237). Interacts with many sequence-specific zinc-finger transcription factors and methyl-CpG-binding proteins to regulate the expression of mesoderm genes that wire surface ectoderm stratification (PubMed:35585237). {ECO:0000269|PubMed:35585237}. |
Q5THJ4 | VPS13D | S1727 | ochoa | Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D) | Mediates the transfer of lipids between membranes at organelle contact sites (By similarity). Functions in promoting mitochondrial clearance by mitochondrial autophagy (mitophagy), also possibly by positively regulating mitochondrial fission (PubMed:29307555, PubMed:29604224). Mitophagy plays an important role in regulating cell health and mitochondrial size and homeostasis. {ECO:0000250|UniProtKB:Q07878, ECO:0000269|PubMed:29307555, ECO:0000269|PubMed:29604224}. |
Q5U3C3 | TMEM164 | S74 | ochoa | Transmembrane protein 164 (Arachidonoyl ether phospholipid synthase) | Positive regulator of ferroptosis (PubMed:35947500, PubMed:36782012). Involved in the acylation of ether lysophospholipids with the arachidonoyl chain (5Z,8Z,11Z,14Z-eicosatetraenoyl; C20:4) of diacylglycerophospholipids, generating C20:4 ether glycerophospholipids (ePEs) such as 1-(1Z-octadecenyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine (PE (P-18:0/20:4)), which promotes ferroptosis (PubMed:36782012). Selectively mediates ATG5-dependent autophagosome formation during ferroptosis, rather than during starvation, and regulates the degradation of ferritin, GPX4 and lipid droplets to increase iron accumulation and lipid peroxidation, thereby promoting ferroptotic cell death (PubMed:35947500). {ECO:0000269|PubMed:35947500, ECO:0000269|PubMed:36782012}. |
Q5UIP0 | RIF1 | S1427 | ochoa | Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) | Key regulator of TP53BP1 that plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage: acts by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs (PubMed:15342490, PubMed:28241136). In response to DNA damage, interacts with ATM-phosphorylated TP53BP1 (PubMed:23333306, PubMed:28241136). Interaction with TP53BP1 leads to dissociate the interaction between NUDT16L1/TIRR and TP53BP1, thereby unmasking the tandem Tudor-like domain of TP53BP1 and allowing recruitment to DNA DSBs (PubMed:28241136). Once recruited to DSBs, RIF1 and TP53BP1 act by promoting NHEJ-mediated repair of DSBs (PubMed:23333306). In the same time, RIF1 and TP53BP1 specifically counteract the function of BRCA1 by blocking DSBs resection via homologous recombination (HR) during G1 phase (PubMed:23333306). Also required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (By similarity). Promotes NHEJ of dysfunctional telomeres (By similarity). {ECO:0000250|UniProtKB:Q6PR54, ECO:0000269|PubMed:15342490, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:28241136}. |
Q5UIP0 | RIF1 | S1854 | ochoa | Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) | Key regulator of TP53BP1 that plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage: acts by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs (PubMed:15342490, PubMed:28241136). In response to DNA damage, interacts with ATM-phosphorylated TP53BP1 (PubMed:23333306, PubMed:28241136). Interaction with TP53BP1 leads to dissociate the interaction between NUDT16L1/TIRR and TP53BP1, thereby unmasking the tandem Tudor-like domain of TP53BP1 and allowing recruitment to DNA DSBs (PubMed:28241136). Once recruited to DSBs, RIF1 and TP53BP1 act by promoting NHEJ-mediated repair of DSBs (PubMed:23333306). In the same time, RIF1 and TP53BP1 specifically counteract the function of BRCA1 by blocking DSBs resection via homologous recombination (HR) during G1 phase (PubMed:23333306). Also required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (By similarity). Promotes NHEJ of dysfunctional telomeres (By similarity). {ECO:0000250|UniProtKB:Q6PR54, ECO:0000269|PubMed:15342490, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:28241136}. |
Q5VT52 | RPRD2 | S1188 | ochoa | Regulation of nuclear pre-mRNA domain-containing protein 2 | None |
Q5VZL5 | ZMYM4 | S1071 | ochoa | Zinc finger MYM-type protein 4 (Zinc finger protein 262) | Plays a role in the regulation of cell morphology and cytoskeletal organization. {ECO:0000269|PubMed:21834987}. |
Q6IA17 | SIGIRR | S376 | ochoa | Single Ig IL-1-related receptor (Single Ig IL-1R-related molecule) (Single immunoglobulin domain-containing IL1R-related protein) (Toll/interleukin-1 receptor 8) (TIR8) | Acts as a negative regulator of the Toll-like and IL-1R receptor signaling pathways. Attenuates the recruitment of receptor-proximal signaling components to the TLR4 receptor, probably through an TIR-TIR domain interaction with TLR4. Through its extracellular domain interferes with the heterodimerization of Il1R1 and IL1RAP. {ECO:0000269|PubMed:12925853, ECO:0000269|PubMed:14715412, ECO:0000269|PubMed:15866876, ECO:0000269|PubMed:25963006}. |
Q6NXS1 | PPP1R2B | S130 | ochoa | Protein phosphatase inhibitor 2 family member B (PPP1R2 family member B) (Protein phosphatase 1, regulatory subunit 2 pseudogene 3) (Protein phosphatase inhibitor 2-like protein 3) | Inhibitor of protein-phosphatase 1. {ECO:0000269|PubMed:23506001}. |
Q6P0N0 | MIS18BP1 | S776 | ochoa | Mis18-binding protein 1 (Kinetochore-associated protein KNL-2 homolog) (HsKNL-2) (P243) | Required for recruitment of CENPA to centromeres and normal chromosome segregation during mitosis. {ECO:0000269|PubMed:17199038, ECO:0000269|PubMed:17339379}. |
Q6P2Q9 | PRPF8 | S1358 | ochoa | Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220) | Plays a role in pre-mRNA splicing as core component of precatalytic, catalytic and postcatalytic spliceosomal complexes, both of the predominant U2-type spliceosome and the minor U12-type spliceosome (PubMed:10411133, PubMed:11971955, PubMed:28076346, PubMed:28502770, PubMed:28781166, PubMed:29301961, PubMed:29360106, PubMed:29361316, PubMed:30315277, PubMed:30705154, PubMed:30728453). Functions as a scaffold that mediates the ordered assembly of spliceosomal proteins and snRNAs. Required for the assembly of the U4/U6-U5 tri-snRNP complex, a building block of the spliceosome. Functions as a scaffold that positions spliceosomal U2, U5 and U6 snRNAs at splice sites on pre-mRNA substrates, so that splicing can occur. Interacts with both the 5' and the 3' splice site. {ECO:0000269|PubMed:10411133, ECO:0000269|PubMed:11971955, ECO:0000269|PubMed:20595234, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:28781166, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30315277, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:30728453, ECO:0000303|PubMed:15840809}. |
Q6P4F7 | ARHGAP11A | S585 | ochoa | Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A) | GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. {ECO:0000269|PubMed:27957544}. |
Q6PKG0 | LARP1 | S228 | ochoa | La-related protein 1 (La ribonucleoprotein domain family member 1) | RNA-binding protein that regulates the translation of specific target mRNA species downstream of the mTORC1 complex, in function of growth signals and nutrient availability (PubMed:20430826, PubMed:23711370, PubMed:24532714, PubMed:25940091, PubMed:28650797, PubMed:28673543, PubMed:29244122). Interacts on the one hand with the 3' poly-A tails that are present in all mRNA molecules, and on the other hand with the 7-methylguanosine cap structure of mRNAs containing a 5' terminal oligopyrimidine (5'TOP) motif, which is present in mRNAs encoding ribosomal proteins and several components of the translation machinery (PubMed:23711370, PubMed:25940091, PubMed:26206669, PubMed:28379136, PubMed:28650797, PubMed:29244122). The interaction with the 5' end of mRNAs containing a 5'TOP motif leads to translational repression by preventing the binding of EIF4G1 (PubMed:25940091, PubMed:28379136, PubMed:28650797, PubMed:29244122). When mTORC1 is activated, LARP1 is phosphorylated and dissociates from the 5' untranslated region (UTR) of mRNA (PubMed:25940091, PubMed:28650797). Does not prevent binding of EIF4G1 to mRNAs that lack a 5'TOP motif (PubMed:28379136). Interacts with the free 40S ribosome subunit and with ribosomes, both monosomes and polysomes (PubMed:20430826, PubMed:24532714, PubMed:25940091, PubMed:28673543). Under normal nutrient availability, interacts primarily with the 3' untranslated region (UTR) of mRNAs encoding ribosomal proteins and increases protein synthesis (PubMed:23711370, PubMed:28650797). Associates with actively translating ribosomes and stimulates translation of mRNAs containing a 5'TOP motif, thereby regulating protein synthesis, and as a consequence, cell growth and proliferation (PubMed:20430826, PubMed:24532714). Stabilizes mRNAs species with a 5'TOP motif, which is required to prevent apoptosis (PubMed:20430826, PubMed:23711370, PubMed:25940091, PubMed:28673543). {ECO:0000269|PubMed:20430826, ECO:0000269|PubMed:23711370, ECO:0000269|PubMed:24532714, ECO:0000269|PubMed:25940091, ECO:0000269|PubMed:26206669, ECO:0000269|PubMed:28379136, ECO:0000269|PubMed:28650797, ECO:0000269|PubMed:28673543, ECO:0000269|PubMed:29244122}.; FUNCTION: (Microbial infection) Positively regulates the replication of dengue virus (DENV). {ECO:0000269|PubMed:26735137}. |
Q6R327 | RICTOR | S1177 | ochoa|psp | Rapamycin-insensitive companion of mTOR (AVO3 homolog) (hAVO3) | Component of the mechanistic target of rapamycin complex 2 (mTORC2), which transduces signals from growth factors to pathways involved in proliferation, cytoskeletal organization, lipogenesis and anabolic output (PubMed:15268862, PubMed:15718470, PubMed:19720745, PubMed:19995915, PubMed:21343617, PubMed:33158864, PubMed:35904232, PubMed:35926713). In response to growth factors, mTORC2 phosphorylates and activates AGC protein kinase family members, including AKT (AKT1, AKT2 and AKT3), PKC (PRKCA, PRKCB and PRKCE) and SGK1 (PubMed:19720745, PubMed:19935711, PubMed:19995915). In contrast to mTORC1, mTORC2 is nutrient-insensitive (PubMed:15467718, PubMed:21343617). Within the mTORC2 complex, RICTOR probably acts as a molecular adapter (PubMed:21343617, PubMed:33158864, PubMed:35926713). RICTOR is responsible for the FKBP12-rapamycin-insensitivity of mTORC2 (PubMed:33158864). mTORC2 plays a critical role in AKT1 activation by mediating phosphorylation of different sites depending on the context, such as 'Thr-450', 'Ser-473', 'Ser-477' or 'Thr-479', facilitating the phosphorylation of the activation loop of AKT1 on 'Thr-308' by PDPK1/PDK1 which is a prerequisite for full activation (PubMed:15718470, PubMed:19720745, PubMed:19935711, PubMed:35926713). mTORC2 catalyzes the phosphorylation of SGK1 at 'Ser-422' and of PRKCA on 'Ser-657' (By similarity). The mTORC2 complex also phosphorylates various proteins involved in insulin signaling, such as FBXW8 and IGF2BP1 (By similarity). mTORC2 acts upstream of Rho GTPases to regulate the actin cytoskeleton, probably by activating one or more Rho-type guanine nucleotide exchange factors (PubMed:15467718). mTORC2 promotes the serum-induced formation of stress-fibers or F-actin (PubMed:15467718). {ECO:0000250|UniProtKB:Q6QI06, ECO:0000269|PubMed:15268862, ECO:0000269|PubMed:15467718, ECO:0000269|PubMed:15718470, ECO:0000269|PubMed:19720745, ECO:0000269|PubMed:19935711, ECO:0000269|PubMed:19995915, ECO:0000269|PubMed:21343617, ECO:0000269|PubMed:33158864, ECO:0000269|PubMed:35904232, ECO:0000269|PubMed:35926713}. |
Q6UB99 | ANKRD11 | S411 | ochoa | Ankyrin repeat domain-containing protein 11 (Ankyrin repeat-containing cofactor 1) | Chromatin regulator which modulates histone acetylation and gene expression in neural precursor cells (By similarity). May recruit histone deacetylases (HDACs) to the p160 coactivators/nuclear receptor complex to inhibit ligand-dependent transactivation (PubMed:15184363). Has a role in proliferation and development of cortical neural precursors (PubMed:25556659). May also regulate bone homeostasis (By similarity). {ECO:0000250|UniProtKB:E9Q4F7, ECO:0000269|PubMed:15184363, ECO:0000269|PubMed:25556659}. |
Q6ZUJ8 | PIK3AP1 | S740 | ochoa | Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1) | Signaling adapter that contributes to B-cell development by linking B-cell receptor (BCR) signaling to the phosphoinositide 3-kinase (PI3K)-Akt signaling pathway. Has a complementary role to the BCR coreceptor CD19, coupling BCR and PI3K activation by providing a docking site for the PI3K subunit PIK3R1. Alternatively, links Toll-like receptor (TLR) signaling to PI3K activation, a process preventing excessive inflammatory cytokine production. Also involved in the activation of PI3K in natural killer cells. May be involved in the survival of mature B-cells via activation of REL. {ECO:0000269|PubMed:15893754}. |
Q6ZVL6 | KIAA1549L | S1546 | ochoa | UPF0606 protein KIAA1549L | None |
Q702N8 | XIRP1 | S208 | ochoa | Xin actin-binding repeat-containing protein 1 (Cardiomyopathy-associated protein 1) | Protects actin filaments from depolymerization (PubMed:15454575). Required for correct cardiac intercalated disk ultrastructure via maintenance of cell-cell adhesion stability, and as a result maintains cardiac organ morphology, conductance and heart beat rhythm (By similarity). Required for development of normal skeletal muscle morphology and muscle fiber type composition (By similarity). Plays a role in regulating muscle satellite cell activation and survival, as a result promotes muscle fiber recovery from injury and fatigue (By similarity). {ECO:0000250|UniProtKB:O70373, ECO:0000269|PubMed:15454575}. |
Q76I76 | SSH2 | S466 | ochoa | Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (hSSH-2L) | Protein phosphatase which regulates actin filament dynamics. Dephosphorylates and activates the actin binding/depolymerizing factor cofilin, which subsequently binds to actin filaments and stimulates their disassembly. Inhibitory phosphorylation of cofilin is mediated by LIMK1, which may also be dephosphorylated and inactivated by this protein (PubMed:11832213). Required for spermatogenesis (By similarity). Involved in acrosome biogenesis, probably by regulating cofilin-mediated actin cytoskeleton remodeling during proacrosomal vesicle fusion and/or Golgi to perinuclear vesicle trafficking (By similarity). {ECO:0000250|UniProtKB:Q5SW75, ECO:0000269|PubMed:11832213}. |
Q7KZ85 | SUPT6H | S1048 | ochoa | Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein) | Histone H3-H4 chaperone that plays a key role in the regulation of transcription elongation and mRNA processing. Enhances the transcription elongation by RNA polymerase II (RNAPII) and is also required for the efficient activation of transcriptional elongation by the HIV-1 nuclear transcriptional activator, Tat. Besides chaperoning histones in transcription, acts to transport and splice mRNA by forming a complex with IWS1 and the C-terminal domain (CTD) of the RNAPII subunit RPB1 (POLR2A). The SUPT6H:IWS1:CTD complex recruits mRNA export factors (ALYREF/THOC4, EXOSC10) as well as histone modifying enzymes (such as SETD2), to ensure proper mRNA splicing, efficient mRNA export and elongation-coupled H3K36 methylation, a signature chromatin mark of active transcription. SUPT6H via its association with SETD1A, regulates both class-switch recombination and somatic hypermutation through formation of H3K4me3 epigenetic marks on activation-induced cytidine deaminase (AICDA) target loci. Promotes the activation of the myogenic gene program by entailing erasure of the repressive H3K27me3 epigenetic mark through stabilization of the chromatin interaction of the H3K27 demethylase KDM6A. {ECO:0000269|PubMed:15060154, ECO:0000269|PubMed:17234882, ECO:0000269|PubMed:22316138, ECO:0000269|PubMed:23503590, ECO:0000269|PubMed:9514752}. |
Q7KZI7 | MARK2 | S43 | ochoa | Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) | Serine/threonine-protein kinase (PubMed:23666762). Involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4 and RAB11FIP2. Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:23666762). Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells. {ECO:0000269|PubMed:11433294, ECO:0000269|PubMed:12429843, ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:15158914, ECO:0000269|PubMed:15324659, ECO:0000269|PubMed:15365179, ECO:0000269|PubMed:16775013, ECO:0000269|PubMed:16980613, ECO:0000269|PubMed:18626018, ECO:0000269|PubMed:20194617, ECO:0000269|PubMed:23666762}. |
Q7L8S5 | OTUD6A | S74 | psp | OTU domain-containing protein 6A (EC 3.4.19.12) (DUBA-2) | Deubiquitinating enzyme that hydrolyzes 'Lys-27'-, 'Lys-29'- and 'Lys-33'-linked polyubiquitin chains. Also able to hydrolyze 'Lys-11'-linked ubiquitin chains. {ECO:0000269|PubMed:23827681}. |
Q7Z309 | PABIR2 | S58 | ochoa | PABIR family member 2 | None |
Q7Z591 | AKNA | S1173 | ochoa | Microtubule organization protein AKNA (AT-hook-containing transcription factor) | Centrosomal protein that plays a key role in cell delamination by regulating microtubule organization (By similarity). Required for the delamination and retention of neural stem cells from the subventricular zone during neurogenesis (By similarity). Also regulates the epithelial-to-mesenchymal transition in other epithelial cells (By similarity). Acts by increasing centrosomal microtubule nucleation and recruiting nucleation factors and minus-end stabilizers, thereby destabilizing microtubules at the adherens junctions and mediating constriction of the apical endfoot (By similarity). In addition, may also act as a transcription factor that specifically activates the expression of the CD40 receptor and its ligand CD40L/CD154, two cell surface molecules on lymphocytes that are critical for antigen-dependent-B-cell development (PubMed:11268217). Binds to A/T-rich promoters (PubMed:11268217). It is unclear how it can both act as a microtubule organizer and as a transcription factor; additional evidences are required to reconcile these two apparently contradictory functions (Probable). {ECO:0000250|UniProtKB:Q80VW7, ECO:0000269|PubMed:11268217, ECO:0000305}. |
Q86TC9 | MYPN | S131 | ochoa | Myopalladin (145 kDa sarcomeric protein) | Component of the sarcomere that tethers together nebulin (skeletal muscle) and nebulette (cardiac muscle) to alpha-actinin, at the Z lines. {ECO:0000269|PubMed:11309420}. |
Q86TP1 | PRUNE1 | S399 | ochoa | Exopolyphosphatase PRUNE1 (EC 3.6.1.1) (Drosophila-related expressed sequence 17) (DRES-17) (DRES17) (HTcD37) (Protein prune homolog 1) (hPrune) | Phosphodiesterase (PDE) that has higher activity toward cAMP than cGMP, as substrate. Plays a role in cell proliferation, migration and differentiation, and acts as a negative regulator of NME1. Plays a role in the regulation of neurogenesis (PubMed:28334956). Involved in the regulation of microtubule polymerization (PubMed:28334956). {ECO:0000269|PubMed:10602478, ECO:0000269|PubMed:11687967, ECO:0000269|PubMed:14998490, ECO:0000269|PubMed:16428445, ECO:0000269|PubMed:17906697, ECO:0000269|PubMed:28334956}. |
Q86U86 | PBRM1 | S319 | ochoa | Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D) | Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Required for the stability of the SWI/SNF chromatin remodeling complex SWI/SNF-B (PBAF). Acts as a negative regulator of cell proliferation. {ECO:0000269|PubMed:21248752, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}. |
Q86U86 | PBRM1 | S1119 | ochoa | Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D) | Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Required for the stability of the SWI/SNF chromatin remodeling complex SWI/SNF-B (PBAF). Acts as a negative regulator of cell proliferation. {ECO:0000269|PubMed:21248752, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}. |
Q86UE4 | MTDH | S298 | ochoa | Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein) (AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein) | Down-regulates SLC1A2/EAAT2 promoter activity when expressed ectopically. Activates the nuclear factor kappa-B (NF-kappa-B) transcription factor. Promotes anchorage-independent growth of immortalized melanocytes and astrocytes which is a key component in tumor cell expansion. Promotes lung metastasis and also has an effect on bone and brain metastasis, possibly by enhancing the seeding of tumor cells to the target organ endothelium. Induces chemoresistance. {ECO:0000269|PubMed:15927426, ECO:0000269|PubMed:16452207, ECO:0000269|PubMed:18316612, ECO:0000269|PubMed:19111877}. |
Q86UU1 | PHLDB1 | S191 | ochoa | Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha) | None |
Q86V15 | CASZ1 | S1722 | ochoa | Zinc finger protein castor homolog 1 (Castor-related protein) (Putative survival-related protein) (Zinc finger protein 693) | Transcriptional activator (PubMed:23639441, PubMed:27693370). Involved in vascular assembly and morphogenesis through direct transcriptional regulation of EGFL7 (PubMed:23639441). {ECO:0000269|PubMed:23639441, ECO:0000269|PubMed:27693370}. |
Q86VP3 | PACS2 | S343 | ochoa | Phosphofurin acidic cluster sorting protein 2 (PACS-2) (PACS1-like protein) | Multifunctional sorting protein that controls the endoplasmic reticulum (ER)-mitochondria communication, including the apposition of mitochondria with the ER and ER homeostasis. In addition, in response to apoptotic inducer, translocates BIB to mitochondria, which initiates a sequence of events including the formation of mitochondrial truncated BID, the release of cytochrome c, the activation of caspase-3 thereby causing cell death. May also be involved in ion channel trafficking, directing acidic cluster-containing ion channels to distinct subcellular compartments. {ECO:0000269|PubMed:15692563, ECO:0000269|PubMed:15692567}. |
Q86XZ4 | SPATS2 | S146 | ochoa | Spermatogenesis-associated serine-rich protein 2 (Serine-rich spermatocytes and round spermatid 59 kDa protein) (p59scr) | None |
Q8IWB9 | TEX2 | S751 | ochoa | Testis-expressed protein 2 (Transmembrane protein 96) | During endoplasmic reticulum (ER) stress or when cellular ceramide levels increase, may induce contacts between the ER and medial-Golgi complex to facilitate non-vesicular transport of ceramides from the ER to the Golgi complex where they are converted to complex sphingolipids, preventing toxic ceramide accumulation. {ECO:0000269|PubMed:28011845}. |
Q8IWU2 | LMTK2 | S886 | ochoa | Serine/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase) (hBREK) (CDK5/p35-regulated kinase) (CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-protein kinase KPI-2) | Phosphorylates PPP1C, phosphorylase b and CFTR. |
Q8IXS8 | HYCC2 | S491 | ochoa | Hyccin 2 | Component of a complex required to localize phosphatidylinositol 4-kinase (PI4K) to the plasma membrane. {ECO:0000305|PubMed:26571211}. |
Q8IXW5 | RPAP2 | S178 | ochoa | Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 (EC 3.1.3.16) (RNA polymerase II-associated protein 2) | Protein phosphatase that displays CTD phosphatase activity and regulates transcription of snRNA genes. Recognizes and binds phosphorylated 'Ser-7' of the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit POLR2A, and mediates dephosphorylation of 'Ser-5' of the CTD, thereby promoting transcription of snRNA genes (PubMed:17643375, PubMed:22137580, PubMed:24997600). Downstream of EIF2AK3/PERK, dephosphorylates ERN1, a sensor for the endoplasmic reticulum unfolded protein response (UPR), to abort failed ER-stress adaptation and trigger apoptosis (PubMed:30118681). {ECO:0000269|PubMed:17643375, ECO:0000269|PubMed:22137580, ECO:0000269|PubMed:24997600, ECO:0000269|PubMed:30118681}. |
Q8IYL3 | C1orf174 | S148 | ochoa | UPF0688 protein C1orf174 | None |
Q8N163 | CCAR2 | S681 | ochoa | Cell cycle and apoptosis regulator protein 2 (Cell division cycle and apoptosis regulator protein 2) (DBIRD complex subunit KIAA1967) (Deleted in breast cancer gene 1 protein) (DBC-1) (DBC.1) (NET35) (p30 DBC) | Core component of the DBIRD complex, a multiprotein complex that acts at the interface between core mRNP particles and RNA polymerase II (RNAPII) and integrates transcript elongation with the regulation of alternative splicing: the DBIRD complex affects local transcript elongation rates and alternative splicing of a large set of exons embedded in (A + T)-rich DNA regions (PubMed:22446626). Inhibits SIRT1 deacetylase activity leading to increasing levels of p53/TP53 acetylation and p53-mediated apoptosis (PubMed:18235501, PubMed:18235502, PubMed:23352644). Inhibits SUV39H1 methyltransferase activity (PubMed:19218236). Mediates ligand-dependent transcriptional activation by nuclear hormone receptors (PubMed:19131338). Plays a critical role in maintaining genomic stability and cellular integrity following UV-induced genotoxic stress (PubMed:23398316). Regulates the circadian expression of the core clock components NR1D1 and BMAL1 (PubMed:23398316). Enhances the transcriptional repressor activity of NR1D1 through stabilization of NR1D1 protein levels by preventing its ubiquitination and subsequent degradation (PubMed:23398316). Represses the ligand-dependent transcriptional activation function of ESR2 (PubMed:20074560). Acts as a regulator of PCK1 expression and gluconeogenesis by a mechanism that involves, at least in part, both NR1D1 and SIRT1 (PubMed:24415752). Negatively regulates the deacetylase activity of HDAC3 and can alter its subcellular localization (PubMed:21030595). Positively regulates the beta-catenin pathway (canonical Wnt signaling pathway) and is required for MCC-mediated repression of the beta-catenin pathway (PubMed:24824780). Represses ligand-dependent transcriptional activation function of NR1H2 and NR1H3 and inhibits the interaction of SIRT1 with NR1H3 (PubMed:25661920). Plays an important role in tumor suppression through p53/TP53 regulation; stabilizes p53/TP53 by affecting its interaction with ubiquitin ligase MDM2 (PubMed:25732823). Represses the transcriptional activator activity of BRCA1 (PubMed:20160719). Inhibits SIRT1 in a CHEK2 and PSEM3-dependent manner and inhibits the activity of CHEK2 in vitro (PubMed:25361978). {ECO:0000269|PubMed:18235501, ECO:0000269|PubMed:18235502, ECO:0000269|PubMed:19131338, ECO:0000269|PubMed:19218236, ECO:0000269|PubMed:20074560, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:21030595, ECO:0000269|PubMed:22446626, ECO:0000269|PubMed:23352644, ECO:0000269|PubMed:23398316, ECO:0000269|PubMed:24415752, ECO:0000269|PubMed:24824780, ECO:0000269|PubMed:25361978, ECO:0000269|PubMed:25661920, ECO:0000269|PubMed:25732823}. |
Q8N392 | ARHGAP18 | S69 | ochoa | Rho GTPase-activating protein 18 (MacGAP) (Rho-type GTPase-activating protein 18) | Rho GTPase activating protein that suppresses F-actin polymerization by inhibiting Rho. Rho GTPase activating proteins act by converting Rho-type GTPases to an inactive GDP-bound state (PubMed:21865595). Plays a key role in tissue tension and 3D tissue shape by regulating cortical actomyosin network formation. Acts downstream of YAP1 and inhibits actin polymerization, which in turn reduces nuclear localization of YAP1 (PubMed:25778702). Regulates cell shape, spreading, and migration (PubMed:21865595). {ECO:0000269|PubMed:21865595, ECO:0000269|PubMed:25778702}. |
Q8N3F8 | MICALL1 | S562 | ochoa | MICAL-like protein 1 (Molecule interacting with Rab13) (MIRab13) | Lipid-binding protein with higher affinity for phosphatidic acid, a lipid enriched in recycling endosome membranes. On endosome membranes, acts as a downstream effector of Rab proteins recruiting cytosolic proteins to regulate membrane tubulation (PubMed:19864458, PubMed:20801876, PubMed:23596323, PubMed:34100897). Involved in a late step of receptor-mediated endocytosis regulating for instance endocytosed-EGF receptor trafficking (PubMed:21795389). Alternatively, regulates slow endocytic recycling of endocytosed proteins back to the plasma membrane (PubMed:19864458). Also involved in cargo protein delivery to the plasma membrane (PubMed:34100897). Plays a role in ciliogenesis coordination, recruits EHD1 to primary cilium where it is anchored to the centriole through interaction with tubulins (PubMed:31615969). May indirectly play a role in neurite outgrowth (By similarity). {ECO:0000250|UniProtKB:Q8BGT6, ECO:0000269|PubMed:19864458, ECO:0000269|PubMed:20801876, ECO:0000269|PubMed:21795389, ECO:0000269|PubMed:23596323, ECO:0000269|PubMed:31615969, ECO:0000269|PubMed:34100897}. |
Q8N4N8 | KIF2B | S204 | psp | Kinesin-like protein KIF2B | Plus end-directed microtubule-dependent motor required for spindle assembly and chromosome movement. Has microtubule depolymerization activity (PubMed:17538014). Plays a role in chromosome congression (PubMed:23891108). {ECO:0000269|PubMed:17538014, ECO:0000269|PubMed:23891108}. |
Q8N6F7 | GCSAM | S102 | ochoa | Germinal center-associated signaling and motility protein (Germinal center B-cell-expressed transcript 2 protein) (Germinal center-associated lymphoma protein) (hGAL) | Involved in the negative regulation of lymphocyte motility. It mediates the migration-inhibitory effects of IL6. Serves as a positive regulator of the RhoA signaling pathway. Enhancement of RhoA activation results in inhibition of lymphocyte and lymphoma cell motility by activation of its downstream effector ROCK. Is a regulator of B-cell receptor signaling, that acts through SYK kinase activation. {ECO:0000269|PubMed:17823310, ECO:0000269|PubMed:20844236, ECO:0000269|PubMed:23299888}. |
Q8N6H7 | ARFGAP2 | S240 | ochoa | ADP-ribosylation factor GTPase-activating protein 2 (ARF GAP 2) (GTPase-activating protein ZNF289) (Zinc finger protein 289) | GTPase-activating protein (GAP) for ADP ribosylation factor 1 (ARF1). Implicated in coatomer-mediated protein transport between the Golgi complex and the endoplasmic reticulum. Hydrolysis of ARF1-bound GTP may lead to dissociation of coatomer from Golgi-derived membranes to allow fusion with target membranes. {ECO:0000269|PubMed:17760859}. |
Q8N6N3 | C1orf52 | S23 | ochoa | UPF0690 protein C1orf52 (BCL10-associated gene protein) | None |
Q8N8S7 | ENAH | S488 | ochoa | Protein enabled homolog | Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance and lamellipodial and filopodial dynamics in migrating cells. ENAH induces the formation of F-actin rich outgrowths in fibroblasts. Acts synergistically with BAIAP2-alpha and downstream of NTN1 to promote filipodia formation (By similarity). {ECO:0000250, ECO:0000269|PubMed:11696321, ECO:0000269|PubMed:18158903}. |
Q8N9T8 | KRI1 | S152 | ochoa | Protein KRI1 homolog | None |
Q8NBF6 | AVL9 | S329 | ochoa | Late secretory pathway protein AVL9 homolog | Functions in cell migration. {ECO:0000269|PubMed:22595670}. |
Q8NBU5 | ATAD1 | S322 | ochoa | Outer mitochondrial transmembrane helix translocase (EC 7.4.2.-) (ATPase family AAA domain-containing protein 1) (hATAD1) (Thorase) | Outer mitochondrial translocase required to remove mislocalized tail-anchored transmembrane proteins on mitochondria (PubMed:24843043). Specifically recognizes and binds tail-anchored transmembrane proteins: acts as a dislocase that mediates the ATP-dependent extraction of mistargeted tail-anchored transmembrane proteins from the mitochondrion outer membrane (By similarity). Also plays a critical role in regulating the surface expression of AMPA receptors (AMPAR), thereby regulating synaptic plasticity and learning and memory (By similarity). Required for NMDA-stimulated AMPAR internalization and inhibition of GRIA1 and GRIA2 recycling back to the plasma membrane; these activities are ATPase-dependent (By similarity). {ECO:0000250|UniProtKB:P28737, ECO:0000250|UniProtKB:Q9D5T0, ECO:0000269|PubMed:24843043}. |
Q8NC44 | RETREG2 | S347 | ochoa | Reticulophagy regulator 2 | Endoplasmic reticulum (ER)-anchored autophagy regulator which exists in an inactive state under basal conditions but is activated following cellular stress (PubMed:34338405). When activated, induces ER fragmentation and mediates ER delivery into lysosomes through sequestration into autophagosomes via interaction with ATG8 family proteins (PubMed:34338405). Required for collagen quality control in a LIR motif-independent manner (By similarity). {ECO:0000250|UniProtKB:Q6NS82, ECO:0000269|PubMed:34338405}. |
Q8NCP5 | ZBTB44 | S168 | ochoa | Zinc finger and BTB domain-containing protein 44 (BTB/POZ domain-containing protein 15) (Zinc finger protein 851) | May be involved in transcriptional regulation. {ECO:0000250}. |
Q8NDV7 | TNRC6A | S1217 | ochoa | Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa) | Plays a role in RNA-mediated gene silencing by both micro-RNAs (miRNAs) and short interfering RNAs (siRNAs). Required for miRNA-dependent repression of translation and for siRNA-dependent endonucleolytic cleavage of complementary mRNAs by argonaute family proteins. As a scaffolding protein, associates with argonaute proteins bound to partially complementary mRNAs, and can simultaneously recruit CCR4-NOT and PAN deadenylase complexes. {ECO:0000269|PubMed:16284622, ECO:0000269|PubMed:16284623, ECO:0000269|PubMed:17596515, ECO:0000269|PubMed:17671087, ECO:0000269|PubMed:19056672, ECO:0000269|PubMed:19304925}. |
Q8NDX1 | PSD4 | S491 | ochoa | PH and SEC7 domain-containing protein 4 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 B) (Exchange factor for ARF6 B) (Pleckstrin homology and SEC7 domain-containing protein 4) (Telomeric of interleukin-1 cluster protein) | Guanine nucleotide exchange factor for ARF6 and ARL14/ARF7. Through ARL14 activation, controls the movement of MHC class II-containing vesicles along the actin cytoskeleton in dendritic cells. Involved in membrane recycling. Interacts with several phosphatidylinositol phosphate species, including phosphatidylinositol 3,4-bisphosphate, phosphatidylinositol 3,5-bisphosphate and phosphatidylinositol 4,5-bisphosphate. {ECO:0000269|PubMed:12082148, ECO:0000269|PubMed:21458045}. |
Q8NEZ4 | KMT2C | S1310 | ochoa | Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:22266653, PubMed:24081332, PubMed:25561738). Likely plays a redundant role with KMT2D in enriching H3K4me1 mark on primed and active enhancer elements (PubMed:24081332). {ECO:0000269|PubMed:22266653, ECO:0000269|PubMed:24081332, ECO:0000269|PubMed:25561738}. |
Q8NFP9 | NBEA | S1262 | ochoa | Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B) | Binds to type II regulatory subunits of protein kinase A and anchors/targets them to the membrane. May anchor the kinase to cytoskeletal and/or organelle-associated proteins (By similarity). {ECO:0000250}. |
Q8NFP9 | NBEA | S1717 | ochoa | Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B) | Binds to type II regulatory subunits of protein kinase A and anchors/targets them to the membrane. May anchor the kinase to cytoskeletal and/or organelle-associated proteins (By similarity). {ECO:0000250}. |
Q8NFT2 | STEAP2 | S197 | ochoa | Metalloreductase STEAP2 (EC 1.16.1.-) (Prostate cancer-associated protein 1) (Protein up-regulated in metastatic prostate cancer) (PUMPCn) (Six-transmembrane epithelial antigen of prostate 2) (SixTransMembrane protein of prostate 1) | Integral membrane protein that functions as a NADPH-dependent ferric-chelate reductase, using NADPH from one side of the membrane to reduce a Fe(3+) chelate that is bound on the other side of the membrane (By similarity). Mediates sequential transmembrane electron transfer from NADPH to FAD and onto heme, and finally to the Fe(3+) chelate (By similarity). Can also reduce Cu(2+) to Cu(1+) (By similarity). {ECO:0000250|UniProtKB:Q687X5, ECO:0000250|UniProtKB:Q8BWB6}. |
Q8NHH9 | ATL2 | S38 | ochoa | Atlastin-2 (ATL-2) (EC 3.6.5.-) (ADP-ribosylation factor-like protein 6-interacting protein 2) | Atlastin-2 (ATL2) is a membrane-anchored GTPase that mediates the GTP-dependent fusion of endoplasmic reticulum (ER) membranes, maintaining the continuous ER network. It facilitates the formation of three-way junctions where ER tubules intersect (PubMed:18270207, PubMed:19665976, PubMed:22065636, PubMed:27619977, PubMed:34817557). Two atlastin-2 on neighboring ER tubules bind GTP and form loose homodimers through the GB1/RHD3-type G domains and 3HB regions. Upon GTP hydrolysis, the 3HB regions tighten, pulling the membranes together to drive their fusion. After fusion, the homodimer disassembles upon release of inorganic phosphate (Pi). Subsequently, GDP dissociates, resetting the monomers to a conformation ready for a new fusion cycle (By similarity). {ECO:0000250|UniProtKB:Q8WXF7, ECO:0000269|PubMed:18270207, ECO:0000269|PubMed:19665976, ECO:0000269|PubMed:22065636, ECO:0000269|PubMed:27619977, ECO:0000269|PubMed:34817557}. |
Q8NI08 | NCOA7 | S505 | ochoa | Nuclear receptor coactivator 7 (140 kDa estrogen receptor-associated protein) (Estrogen nuclear receptor coactivator 1) | Enhances the transcriptional activities of several nuclear receptors. Involved in the coactivation of different nuclear receptors, such as ESR1, THRB, PPARG and RARA. {ECO:0000269|PubMed:11971969}. |
Q8TEQ6 | GEMIN5 | S1322 | ochoa | Gem-associated protein 5 (Gemin5) | The SMN complex catalyzes the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome, and thereby plays an important role in the splicing of cellular pre-mRNAs (PubMed:16857593, PubMed:18984161, PubMed:20513430, PubMed:33963192). Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP (Sm core). In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP (PubMed:18984161). To assemble core snRNPs, the SMN complex accepts the trapped 5Sm proteins from CLNS1A forming an intermediate (PubMed:18984161). Binding of snRNA inside 5Sm ultimately triggers eviction of the SMN complex, thereby allowing binding of SNRPD3 and SNRPB to complete assembly of the core snRNP. Within the SMN complex, GEMIN5 recognizes and delivers the small nuclear RNAs (snRNAs) to the SMN complex (PubMed:11714716, PubMed:16314521, PubMed:16857593, PubMed:19377484, PubMed:19750007, PubMed:20513430, PubMed:27834343, PubMed:27881600, PubMed:27881601). Binds to the 7-methylguanosine cap of RNA molecules (PubMed:19750007, PubMed:27834343, PubMed:27881600, PubMed:27881601, Ref.27). Binds to the 3'-UTR of SMN1 mRNA and regulates its translation; does not affect mRNA stability (PubMed:25911097). May play a role in the regulation of protein synthesis via its interaction with ribosomes (PubMed:27507887). {ECO:0000269|PubMed:11714716, ECO:0000269|PubMed:16314521, ECO:0000269|PubMed:16857593, ECO:0000269|PubMed:18984161, ECO:0000269|PubMed:19377484, ECO:0000269|PubMed:19750007, ECO:0000269|PubMed:20513430, ECO:0000269|PubMed:25911097, ECO:0000269|PubMed:27507887, ECO:0000269|PubMed:27834343, ECO:0000269|PubMed:27881600, ECO:0000269|PubMed:27881601, ECO:0000269|PubMed:33963192, ECO:0000269|Ref.27}. |
Q8TEW0 | PARD3 | S720 | ochoa | Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha) | Adapter protein involved in asymmetrical cell division and cell polarization processes (PubMed:10954424, PubMed:27925688). Seems to play a central role in the formation of epithelial tight junctions (PubMed:27925688). Targets the phosphatase PTEN to cell junctions (By similarity). Involved in Schwann cell peripheral myelination (By similarity). Association with PARD6B may prevent the interaction of PARD3 with F11R/JAM1, thereby preventing tight junction assembly (By similarity). The PARD6-PARD3 complex links GTP-bound Rho small GTPases to atypical protein kinase C proteins (PubMed:10934474). Required for establishment of neuronal polarity and normal axon formation in cultured hippocampal neurons (PubMed:19812038, PubMed:27925688). {ECO:0000250|UniProtKB:Q99NH2, ECO:0000250|UniProtKB:Q9Z340, ECO:0000269|PubMed:10934474, ECO:0000269|PubMed:10954424, ECO:0000269|PubMed:19812038, ECO:0000269|PubMed:27925688}. |
Q8WU79 | SMAP2 | S240 | ochoa | Stromal membrane-associated protein 2 (Stromal membrane-associated protein 1-like) | GTPase activating protein that acts on ARF1. Can also activate ARF6 (in vitro). May play a role in clathrin-dependent retrograde transport from early endosomes to the trans-Golgi network (By similarity). {ECO:0000250}. |
Q8WUF8 | ARB2A | S219 | ochoa | Cotranscriptional regulator ARB2A (ARB2 cotranscriptional regulator A) (Cotranscriptional regulator FAM172A) (Protein FAM172A) | Plays a role in the regulation of alternative splicing, by interacting with AGO2 and CHD7. Seems to be required for stabilizing protein-protein interactions at the chromatin-spliceosome interface. May have hydrolase activity. {ECO:0000250|UniProtKB:Q3TNH5}. |
Q8WXD2 | SCG3 | S362 | ochoa | Secretogranin-3 (Secretogranin III) (SgIII) | Member of the granin protein family that regulates the biogenesis of secretory granules (PubMed:19357184). Acts as a sorting receptor for intragranular proteins including chromogranin A/CHGA (By similarity). May also play a role in angiogenesis. Promotes endothelial proliferation, migration and tube formation through MEK/ERK signaling pathway (PubMed:29154827). {ECO:0000250|UniProtKB:P47868, ECO:0000269|PubMed:19357184, ECO:0000269|PubMed:29154827}. |
Q92797 | SYMPK | S510 | ochoa | Symplekin | Scaffold protein that functions as a component of a multimolecular complex involved in histone mRNA 3'-end processing. Specific component of the tight junction (TJ) plaque, but might not be an exclusively junctional component. May have a house-keeping rule. Is involved in pre-mRNA polyadenylation. Enhances SSU72 phosphatase activity. {ECO:0000269|PubMed:16230528, ECO:0000269|PubMed:20861839}. |
Q93100 | PHKB | S704 | ochoa | Phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta) | Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. The beta chain acts as a regulatory unit and modulates the activity of the holoenzyme in response to phosphorylation. |
Q96CV9 | OPTN | S177 | ochoa|psp | Optineurin (E3-14.7K-interacting protein) (FIP-2) (Huntingtin yeast partner L) (Huntingtin-interacting protein 7) (HIP-7) (Huntingtin-interacting protein L) (NEMO-related protein) (Optic neuropathy-inducing protein) (Transcription factor IIIA-interacting protein) (TFIIIA-IntP) | Plays an important role in the maintenance of the Golgi complex, in membrane trafficking, in exocytosis, through its interaction with myosin VI and Rab8 (PubMed:27534431). Links myosin VI to the Golgi complex and plays an important role in Golgi ribbon formation (PubMed:27534431). Plays a role in the activation of innate immune response during viral infection. Mechanistically, recruits TBK1 at the Golgi apparatus, promoting its trans-phosphorylation after RLR or TLR3 stimulation (PubMed:27538435). In turn, activated TBK1 phosphorylates its downstream partner IRF3 to produce IFN-beta/IFNB1. Plays a neuroprotective role in the eye and optic nerve. May act by regulating membrane trafficking and cellular morphogenesis via a complex that contains Rab8 and huntingtin (HD). Mediates the interaction of Rab8 with the probable GTPase-activating protein TBC1D17 during Rab8-mediated endocytic trafficking, such as that of transferrin receptor (TFRC/TfR); regulates Rab8 recruitment to tubules emanating from the endocytic recycling compartment (PubMed:22854040). Autophagy receptor that interacts directly with both the cargo to become degraded and an autophagy modifier of the MAP1 LC3 family; targets ubiquitin-coated bacteria (xenophagy), such as cytoplasmic Salmonella enterica, and appears to function in the same pathway as SQSTM1 and CALCOCO2/NDP52. {ECO:0000269|PubMed:11834836, ECO:0000269|PubMed:15837803, ECO:0000269|PubMed:20085643, ECO:0000269|PubMed:20174559, ECO:0000269|PubMed:21617041, ECO:0000269|PubMed:22854040, ECO:0000269|PubMed:27534431, ECO:0000269|PubMed:27538435}.; FUNCTION: (Microbial infection) May constitute a cellular target for various viruses, such as adenovirus E3 14.7 or Bluetongue virus, to inhibit innate immune response (PubMed:27538435, PubMed:9488477). During RNA virus infection, such as that of Sendai virus, negatively regulates the induction of IFNB1 (PubMed:20174559). {ECO:0000269|PubMed:20174559, ECO:0000269|PubMed:27538435, ECO:0000269|PubMed:9488477}. |
Q96L73 | NSD1 | S486 | ochoa | Histone-lysine N-methyltransferase, H3 lysine-36 specific (EC 2.1.1.357) (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1) (NR-binding SET domain-containing protein) | Histone methyltransferase that dimethylates Lys-36 of histone H3 (H3K36me2). Transcriptional intermediary factor capable of both negatively or positively influencing transcription, depending on the cellular context. {ECO:0000269|PubMed:21196496}. |
Q96P16 | RPRD1A | S156 | ochoa | Regulation of nuclear pre-mRNA domain-containing protein 1A (Cyclin-dependent kinase inhibitor 2B-related protein) (p15INK4B-related protein) | Interacts with phosphorylated C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit POLR2A, and participates in dephosphorylation of the CTD by RPAP2. May act as a negative regulator of cyclin-D1 (CCND1) and cyclin-E (CCNE1) in the cell cycle. {ECO:0000269|PubMed:22231121, ECO:0000269|PubMed:24399136, ECO:0000269|PubMed:24997600}. |
Q96Q42 | ALS2 | S356 | ochoa | Alsin (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein) (Amyotrophic lateral sclerosis 2 protein) | May act as a GTPase regulator. Controls survival and growth of spinal motoneurons (By similarity). {ECO:0000250}. |
Q96QT4 | TRPM7 | S1361 | ochoa | Transient receptor potential cation channel subfamily M member 7 (EC 2.7.11.1) (Channel-kinase 1) (Long transient receptor potential channel 7) (LTrpC-7) (LTrpC7) [Cleaved into: TRPM7 kinase, cleaved form (M7CK); TRPM7 channel, cleaved form] | Bifunctional protein that combines an ion channel with an intrinsic kinase domain, enabling it to modulate cellular functions either by conducting ions through the pore or by phosphorylating downstream proteins via its kinase domain. The channel is highly permeable to divalent cations, specifically calcium (Ca2+), magnesium (Mg2+) and zinc (Zn2+) and mediates their influx (PubMed:11385574, PubMed:12887921, PubMed:15485879, PubMed:24316671, PubMed:35561741, PubMed:36027648). Controls a wide range of biological processes such as Ca2(+), Mg(2+) and Zn(2+) homeostasis, vesicular Zn(2+) release channel and intracellular Ca(2+) signaling, embryonic development, immune responses, cell motility, proliferation and differentiation (By similarity). The C-terminal alpha-kinase domain autophosphorylates cytoplasmic residues of TRPM7 (PubMed:18365021). In vivo, TRPM7 phosphorylates SMAD2, suggesting that TRPM7 kinase may play a role in activating SMAD signaling pathways. In vitro, TRPM7 kinase phosphorylates ANXA1 (annexin A1), myosin II isoforms and a variety of proteins with diverse cellular functions (PubMed:15485879, PubMed:18394644). {ECO:0000250|UniProtKB:Q923J1, ECO:0000269|PubMed:11385574, ECO:0000269|PubMed:12887921, ECO:0000269|PubMed:15485879, ECO:0000269|PubMed:18365021, ECO:0000269|PubMed:18394644, ECO:0000269|PubMed:24316671, ECO:0000269|PubMed:35561741, ECO:0000269|PubMed:36027648}.; FUNCTION: [TRPM7 channel, cleaved form]: The cleaved channel exhibits substantially higher current and potentiates Fas receptor signaling. {ECO:0000250|UniProtKB:Q923J1}.; FUNCTION: [TRPM7 kinase, cleaved form]: The C-terminal kinase domain can be cleaved from the channel segment in a cell-type-specific fashion. In immune cells, the TRPM7 kinase domain is clipped from the channel domain by caspases in response to Fas-receptor stimulation. The cleaved kinase fragments can translocate to the nucleus, and bind chromatin-remodeling complex proteins in a Zn(2+)-dependent manner to ultimately phosphorylate specific Ser/Thr residues of histones known to be functionally important for cell differentiation and embryonic development. {ECO:0000250|UniProtKB:Q923J1}. |
Q96RL1 | UIMC1 | S142 | ochoa | BRCA1-A complex subunit RAP80 (Receptor-associated protein 80) (Retinoid X receptor-interacting protein 110) (Ubiquitin interaction motif-containing protein 1) | Ubiquitin-binding protein (PubMed:24627472). Specifically recognizes and binds 'Lys-63'-linked ubiquitin (PubMed:19328070, Ref.38). Plays a central role in the BRCA1-A complex by specifically binding 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs). The BRCA1-A complex also possesses deubiquitinase activity that specifically removes 'Lys-63'-linked ubiquitin on histones H2A and H2AX. Also weakly binds monoubiquitin but with much less affinity than 'Lys-63'-linked ubiquitin. May interact with monoubiquitinated histones H2A and H2B; the relevance of such results is however unclear in vivo. Does not bind Lys-48'-linked ubiquitin. May indirectly act as a transcriptional repressor by inhibiting the interaction of NR6A1 with the corepressor NCOR1. {ECO:0000269|PubMed:12080054, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:17525341, ECO:0000269|PubMed:17525342, ECO:0000269|PubMed:17621610, ECO:0000269|PubMed:17643121, ECO:0000269|PubMed:19015238, ECO:0000269|PubMed:19202061, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19328070, ECO:0000269|PubMed:24627472, ECO:0000269|Ref.38}. |
Q96RL1 | UIMC1 | S684 | ochoa | BRCA1-A complex subunit RAP80 (Receptor-associated protein 80) (Retinoid X receptor-interacting protein 110) (Ubiquitin interaction motif-containing protein 1) | Ubiquitin-binding protein (PubMed:24627472). Specifically recognizes and binds 'Lys-63'-linked ubiquitin (PubMed:19328070, Ref.38). Plays a central role in the BRCA1-A complex by specifically binding 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs). The BRCA1-A complex also possesses deubiquitinase activity that specifically removes 'Lys-63'-linked ubiquitin on histones H2A and H2AX. Also weakly binds monoubiquitin but with much less affinity than 'Lys-63'-linked ubiquitin. May interact with monoubiquitinated histones H2A and H2B; the relevance of such results is however unclear in vivo. Does not bind Lys-48'-linked ubiquitin. May indirectly act as a transcriptional repressor by inhibiting the interaction of NR6A1 with the corepressor NCOR1. {ECO:0000269|PubMed:12080054, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:17525341, ECO:0000269|PubMed:17525342, ECO:0000269|PubMed:17621610, ECO:0000269|PubMed:17643121, ECO:0000269|PubMed:19015238, ECO:0000269|PubMed:19202061, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19328070, ECO:0000269|PubMed:24627472, ECO:0000269|Ref.38}. |
Q96RT1 | ERBIN | S800 | ochoa | Erbin (Densin-180-like protein) (Erbb2-interacting protein) (Protein LAP2) | Acts as an adapter for the receptor ERBB2, in epithelia. By binding the unphosphorylated 'Tyr-1248' of receptor ERBB2, it may contribute to stabilize this unphosphorylated state (PubMed:16203728). Inhibits NOD2-dependent NF-kappa-B signaling and pro-inflammatory cytokine secretion (PubMed:16203728). {ECO:0000269|PubMed:10878805, ECO:0000269|PubMed:16203728}. |
Q96RU2 | USP28 | S520 | ochoa | Ubiquitin carboxyl-terminal hydrolase 28 (EC 3.4.19.12) (Deubiquitinating enzyme 28) (Ubiquitin thioesterase 28) (Ubiquitin-specific-processing protease 28) | Deubiquitinase involved in DNA damage response checkpoint and MYC proto-oncogene stability. Involved in DNA damage induced apoptosis by specifically deubiquitinating proteins of the DNA damage pathway such as CLSPN. Also involved in G2 DNA damage checkpoint, by deubiquitinating CLSPN, and preventing its degradation by the anaphase promoting complex/cyclosome (APC/C). In contrast, it does not deubiquitinate PLK1. Specifically deubiquitinates MYC in the nucleoplasm, leading to prevent MYC degradation by the proteasome: acts by specifically interacting with isoform 1 of FBXW7 (FBW7alpha) in the nucleoplasm and counteracting ubiquitination of MYC by the SCF(FBW7) complex. In contrast, it does not interact with isoform 4 of FBXW7 (FBW7gamma) in the nucleolus, allowing MYC degradation and explaining the selective MYC degradation in the nucleolus. Deubiquitinates ZNF304, hence preventing ZNF304 degradation by the proteasome and leading to the activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) in a subset of colorectal cancers (CRC) cells (PubMed:24623306). {ECO:0000269|PubMed:16901786, ECO:0000269|PubMed:17558397, ECO:0000269|PubMed:17873522, ECO:0000269|PubMed:18662541, ECO:0000269|PubMed:24623306}. |
Q96T17 | MAP7D2 | S653 | ochoa | MAP7 domain-containing protein 2 | Microtubule-stabilizing protein that plays a role in the control of cell motility and neurite outgrowth via direct binding to the microtubule (By similarity). Acts as a critical cofactor for kinesin transport. In the proximal axon, regulates kinesin-1 family members, KIF5A, KIF5B and KIF5C recruitment to microtubules and contributes to kinesin-1-mediated transport in the axons (By similarity). {ECO:0000250|UniProtKB:A2AG50, ECO:0000250|UniProtKB:D4A4L4}. |
Q99496 | RNF2 | S203 | ochoa | E3 ubiquitin-protein ligase RING2 (EC 2.3.2.27) (Huntingtin-interacting protein 2-interacting protein 3) (HIP2-interacting protein 3) (Protein DinG) (RING finger protein 1B) (RING1b) (RING finger protein 2) (RING finger protein BAP-1) (RING-type E3 ubiquitin transferase RING2) | E3 ubiquitin-protein ligase that mediates monoubiquitination of 'Lys-119' of histone H2A (H2AK119Ub), thereby playing a central role in histone code and gene regulation (PubMed:15386022, PubMed:16359901, PubMed:21772249, PubMed:25355358, PubMed:25519132, PubMed:26151332, PubMed:33864376). H2AK119Ub gives a specific tag for epigenetic transcriptional repression and participates in X chromosome inactivation of female mammals. May be involved in the initiation of both imprinted and random X inactivation (By similarity). Essential component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development (PubMed:16359901, PubMed:26151332). PcG PRC1 complex acts via chromatin remodeling and modification of histones, rendering chromatin heritably changed in its expressibility (PubMed:26151332). E3 ubiquitin-protein ligase activity is enhanced by BMI1/PCGF4 (PubMed:21772249). Acts as the main E3 ubiquitin ligase on histone H2A of the PRC1 complex, while RING1 may rather act as a modulator of RNF2/RING2 activity (Probable). Association with the chromosomal DNA is cell-cycle dependent. In resting B- and T-lymphocytes, interaction with AURKB leads to block its activity, thereby maintaining transcription in resting lymphocytes (By similarity). Also acts as a negative regulator of autophagy by mediating ubiquitination of AMBRA1, leading to its subsequent degradation (By similarity). {ECO:0000250|UniProtKB:Q9CQJ4, ECO:0000269|PubMed:11513855, ECO:0000269|PubMed:15386022, ECO:0000269|PubMed:16359901, ECO:0000269|PubMed:16714294, ECO:0000269|PubMed:20696397, ECO:0000269|PubMed:21772249, ECO:0000269|PubMed:25355358, ECO:0000269|PubMed:25519132, ECO:0000269|PubMed:26151332, ECO:0000269|PubMed:33864376, ECO:0000305}. |
Q99549 | MPHOSPH8 | S319 | ochoa | M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) | Heterochromatin component that specifically recognizes and binds methylated 'Lys-9' of histone H3 (H3K9me) and promotes recruitment of proteins that mediate epigenetic repression (PubMed:20871592, PubMed:26022416). Mediates recruitment of the HUSH complex to H3K9me3 sites: the HUSH complex is recruited to genomic loci rich in H3K9me3 and is required to maintain transcriptional silencing by promoting recruitment of SETDB1, a histone methyltransferase that mediates further deposition of H3K9me3, as well as MORC2 (PubMed:26022416, PubMed:28581500). Binds H3K9me and promotes DNA methylation by recruiting DNMT3A to target CpG sites; these can be situated within the coding region of the gene (PubMed:20871592). Mediates down-regulation of CDH1 expression (PubMed:20871592). Also represses L1 retrotransposons in collaboration with MORC2 and, probably, SETDB1, the silencing is dependent of repressive epigenetic modifications, such as H3K9me3 mark. Silencing events often occur within introns of transcriptionally active genes, and lead to the down-regulation of host gene expression (PubMed:29211708). The HUSH complex is also involved in the silencing of unintegrated retroviral DNA by being recruited by ZNF638: some part of the retroviral DNA formed immediately after infection remains unintegrated in the host genome and is transcriptionally repressed (PubMed:30487602). {ECO:0000269|PubMed:20871592, ECO:0000269|PubMed:26022416, ECO:0000269|PubMed:28581500, ECO:0000269|PubMed:29211708, ECO:0000269|PubMed:30487602}. |
Q99549 | MPHOSPH8 | S403 | ochoa | M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) | Heterochromatin component that specifically recognizes and binds methylated 'Lys-9' of histone H3 (H3K9me) and promotes recruitment of proteins that mediate epigenetic repression (PubMed:20871592, PubMed:26022416). Mediates recruitment of the HUSH complex to H3K9me3 sites: the HUSH complex is recruited to genomic loci rich in H3K9me3 and is required to maintain transcriptional silencing by promoting recruitment of SETDB1, a histone methyltransferase that mediates further deposition of H3K9me3, as well as MORC2 (PubMed:26022416, PubMed:28581500). Binds H3K9me and promotes DNA methylation by recruiting DNMT3A to target CpG sites; these can be situated within the coding region of the gene (PubMed:20871592). Mediates down-regulation of CDH1 expression (PubMed:20871592). Also represses L1 retrotransposons in collaboration with MORC2 and, probably, SETDB1, the silencing is dependent of repressive epigenetic modifications, such as H3K9me3 mark. Silencing events often occur within introns of transcriptionally active genes, and lead to the down-regulation of host gene expression (PubMed:29211708). The HUSH complex is also involved in the silencing of unintegrated retroviral DNA by being recruited by ZNF638: some part of the retroviral DNA formed immediately after infection remains unintegrated in the host genome and is transcriptionally repressed (PubMed:30487602). {ECO:0000269|PubMed:20871592, ECO:0000269|PubMed:26022416, ECO:0000269|PubMed:28581500, ECO:0000269|PubMed:29211708, ECO:0000269|PubMed:30487602}. |
Q99590 | SCAF11 | S477 | ochoa | Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129) | Plays a role in pre-mRNA alternative splicing by regulating spliceosome assembly. {ECO:0000269|PubMed:9447963}. |
Q99590 | SCAF11 | S533 | ochoa | Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129) | Plays a role in pre-mRNA alternative splicing by regulating spliceosome assembly. {ECO:0000269|PubMed:9447963}. |
Q99590 | SCAF11 | S1110 | ochoa | Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129) | Plays a role in pre-mRNA alternative splicing by regulating spliceosome assembly. {ECO:0000269|PubMed:9447963}. |
Q99755 | PIP5K1A | S71 | ochoa | Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha (PIP5K1-alpha) (PtdIns(4)P-5-kinase 1 alpha) (EC 2.7.1.68) (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alpha) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha) (PIP5KIalpha) | Catalyzes the phosphorylation of phosphatidylinositol 4-phosphate (PtdIns(4)P/PI4P) to form phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2/PIP2), a lipid second messenger that regulates several cellular processes such as signal transduction, vesicle trafficking, actin cytoskeleton dynamics, cell adhesion, and cell motility (PubMed:21477596, PubMed:22942276, PubMed:8955136). PtdIns(4,5)P2 can directly act as a second messenger or can be utilized as a precursor to generate other second messengers: inositol 1,4,5-trisphosphate (IP3), diacylglycerol (DAG) or phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3/PIP3) (PubMed:19158393, PubMed:20660631). PIP5K1A-mediated phosphorylation of PtdIns(4)P is the predominant pathway for PtdIns(4,5)P2 synthesis (By similarity). Can also use phosphatidylinositol (PtdIns) as substrate in vitro (PubMed:22942276). Together with PIP5K1C, is required for phagocytosis, both enzymes regulating different types of actin remodeling at sequential steps (By similarity). Promotes particle ingestion by activating the WAS GTPase-binding protein that induces Arp2/3 dependent actin polymerization at the nascent phagocytic cup (By similarity). Together with PIP5K1B, is required, after stimulation by G-protein coupled receptors, for the synthesis of IP3 that will induce stable platelet adhesion (By similarity). Recruited to the plasma membrane by the E-cadherin/beta-catenin complex where it provides the substrate PtdIns(4,5)P2 for the production of PtdIns(3,4,5)P3, IP3 and DAG, that will mobilize internal calcium and drive keratinocyte differentiation (PubMed:19158393). Positively regulates insulin-induced translocation of SLC2A4 to the cell membrane in adipocytes (By similarity). Together with PIP5K1C has a role during embryogenesis (By similarity). Independently of its catalytic activity, is required for membrane ruffling formation, actin organization and focal adhesion formation during directional cell migration by controlling integrin-induced translocation of the small GTPase RAC1 to the plasma membrane (PubMed:20660631). Also functions in the nucleus where it acts as an activator of TUT1 adenylyltransferase activity in nuclear speckles, thereby regulating mRNA polyadenylation of a select set of mRNAs (PubMed:18288197). {ECO:0000250|UniProtKB:P70182, ECO:0000269|PubMed:18288197, ECO:0000269|PubMed:19158393, ECO:0000269|PubMed:20660631, ECO:0000269|PubMed:21477596, ECO:0000269|PubMed:22942276, ECO:0000269|PubMed:8955136}. |
Q99959 | PKP2 | S135 | ochoa | Plakophilin-2 | A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (PubMed:25208567). Regulates focal adhesion turnover resulting in changes in focal adhesion size, cell adhesion and cell spreading, potentially via transcriptional modulation of beta-integrins (PubMed:23884246). Required to maintain gingival epithelial barrier function (PubMed:34368962). Important component of the desmosome that is also required for localization of desmosome component proteins such as DSC2, DSG2 and JUP to the desmosome cell-cell junction (PubMed:22781308, PubMed:25208567). Required for the formation of desmosome cell junctions in cardiomyocytes, thereby required for the correct formation of the heart, specifically trabeculation and formation of the atria walls (By similarity). Loss of desmosome cell junctions leads to mis-localization of DSP and DSG2 resulting in disruption of cell-cell adhesion and disordered intermediate filaments (By similarity). Modulates profibrotic gene expression in cardiomyocytes via regulation of DSP expression and subsequent activation of downstream TGFB1 and MAPK14/p38 MAPK signaling (By similarity). Required for cardiac sodium current propagation and electrical synchrony in cardiac myocytes, via ANK3 stabilization and modulation of SCN5A/Nav1.5 localization to cell-cell junctions (By similarity). Required for mitochondrial function, nuclear envelope integrity and positive regulation of SIRT3 transcription via maintaining DES localization at its nuclear envelope and cell tip anchoring points, and thereby preserving regulation of the transcriptional program (PubMed:35959657). Maintenance of nuclear envelope integrity protects against DNA damage and transcriptional dysregulation of genes, especially those involved in the electron transport chain, thereby preserving mitochondrial function and protecting against superoxide radical anion generation (PubMed:35959657). Binds single-stranded DNA (ssDNA) (PubMed:20613778). May regulate the localization of GJA1 to gap junctions in intercalated disks of the heart (PubMed:18662195). Involved in the inhibition of viral infection by influenza A viruses (IAV) (PubMed:28169297). Acts as a host restriction factor for IAV viral propagation, potentially via disrupting the interaction of IAV polymerase complex proteins (PubMed:28169297). {ECO:0000250|UniProtKB:F1M7L9, ECO:0000250|UniProtKB:Q9CQ73, ECO:0000269|PubMed:18662195, ECO:0000269|PubMed:20613778, ECO:0000269|PubMed:22781308, ECO:0000269|PubMed:23884246, ECO:0000269|PubMed:25208567, ECO:0000269|PubMed:28169297, ECO:0000269|PubMed:34368962, ECO:0000269|PubMed:35959657}. |
Q9BSQ5 | CCM2 | S181 | ochoa | Cerebral cavernous malformations 2 protein (Malcavernin) | Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. May act through the stabilization of endothelial cell junctions (By similarity). May function as a scaffold protein for MAP2K3-MAP3K3 signaling. Seems to play a major role in the modulation of MAP3K3-dependent p38 activation induced by hyperosmotic shock (By similarity). {ECO:0000250}. |
Q9BXS6 | NUSAP1 | S63 | ochoa | Nucleolar and spindle-associated protein 1 (NuSAP) | Microtubule-associated protein with the capacity to bundle and stabilize microtubules (By similarity). May associate with chromosomes and promote the organization of mitotic spindle microtubules around them. {ECO:0000250, ECO:0000269|PubMed:12963707}. |
Q9BY84 | DUSP16 | S612 | ochoa | Dual specificity protein phosphatase 16 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 7) (MAP kinase phosphatase 7) (MKP-7) | Dual specificity protein phosphatase involved in the inactivation of MAP kinases. Dephosphorylates MAPK10 bound to ARRB2. {ECO:0000269|PubMed:11489891, ECO:0000269|PubMed:15888437}. |
Q9BYW2 | SETD2 | S1239 | ochoa | Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP) | Histone methyltransferase that specifically trimethylates 'Lys-36' of histone H3 (H3K36me3) using dimethylated 'Lys-36' (H3K36me2) as substrate (PubMed:16118227, PubMed:19141475, PubMed:21526191, PubMed:21792193, PubMed:23043551, PubMed:27474439). It is capable of trimethylating unmethylated H3K36 (H3K36me0) in vitro (PubMed:19332550). Represents the main enzyme generating H3K36me3, a specific tag for epigenetic transcriptional activation (By similarity). Plays a role in chromatin structure modulation during elongation by coordinating recruitment of the FACT complex and by interacting with hyperphosphorylated POLR2A (PubMed:23325844). Acts as a key regulator of DNA mismatch repair in G1 and early S phase by generating H3K36me3, a mark required to recruit MSH6 subunit of the MutS alpha complex: early recruitment of the MutS alpha complex to chromatin to be replicated allows a quick identification of mismatch DNA to initiate the mismatch repair reaction (PubMed:23622243). Required for DNA double-strand break repair in response to DNA damage: acts by mediating formation of H3K36me3, promoting recruitment of RAD51 and DNA repair via homologous recombination (HR) (PubMed:24843002). Acts as a tumor suppressor (PubMed:24509477). H3K36me3 also plays an essential role in the maintenance of a heterochromatic state, by recruiting DNA methyltransferase DNMT3A (PubMed:27317772). H3K36me3 is also enhanced in intron-containing genes, suggesting that SETD2 recruitment is enhanced by splicing and that splicing is coupled to recruitment of elongating RNA polymerase (PubMed:21792193). Required during angiogenesis (By similarity). Required for endoderm development by promoting embryonic stem cell differentiation toward endoderm: acts by mediating formation of H3K36me3 in distal promoter regions of FGFR3, leading to regulate transcription initiation of FGFR3 (By similarity). In addition to histones, also mediates methylation of other proteins, such as tubulins and STAT1 (PubMed:27518565, PubMed:28753426). Trimethylates 'Lys-40' of alpha-tubulins such as TUBA1B (alpha-TubK40me3); alpha-TubK40me3 is required for normal mitosis and cytokinesis and may be a specific tag in cytoskeletal remodeling (PubMed:27518565). Involved in interferon-alpha-induced antiviral defense by mediating both monomethylation of STAT1 at 'Lys-525' and catalyzing H3K36me3 on promoters of some interferon-stimulated genes (ISGs) to activate gene transcription (PubMed:28753426). {ECO:0000250|UniProtKB:E9Q5F9, ECO:0000269|PubMed:16118227, ECO:0000269|PubMed:19141475, ECO:0000269|PubMed:21526191, ECO:0000269|PubMed:21792193, ECO:0000269|PubMed:23043551, ECO:0000269|PubMed:23325844, ECO:0000269|PubMed:23622243, ECO:0000269|PubMed:24509477, ECO:0000269|PubMed:24843002, ECO:0000269|PubMed:27317772, ECO:0000269|PubMed:27474439, ECO:0000269|PubMed:27518565, ECO:0000269|PubMed:28753426}.; FUNCTION: (Microbial infection) Recruited to the promoters of adenovirus 12 E1A gene in case of infection, possibly leading to regulate its expression. {ECO:0000269|PubMed:11461154}. |
Q9C0C2 | TNKS1BP1 | S987 | ochoa | 182 kDa tankyrase-1-binding protein | None |
Q9C0C7 | AMBRA1 | S639 | ochoa | Activating molecule in BECN1-regulated autophagy protein 1 (DDB1- and CUL4-associated factor 3) | Substrate-recognition component of a DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex involved in cell cycle control and autophagy (PubMed:20921139, PubMed:23524951, PubMed:24587252, PubMed:32333458, PubMed:33854232, PubMed:33854235, PubMed:33854239). The DCX(AMBRA1) complex specifically mediates the polyubiquitination of target proteins such as BECN1, CCND1, CCND2, CCND3, ELOC and ULK1 (PubMed:23524951, PubMed:33854232, PubMed:33854235, PubMed:33854239). Acts as an upstream master regulator of the transition from G1 to S cell phase: AMBRA1 specifically recognizes and binds phosphorylated cyclin-D (CCND1, CCND2 and CCND3), leading to cyclin-D ubiquitination by the DCX(AMBRA1) complex and subsequent degradation (PubMed:33854232, PubMed:33854235, PubMed:33854239). By controlling the transition from G1 to S phase and cyclin-D degradation, AMBRA1 acts as a tumor suppressor that promotes genomic integrity during DNA replication and counteracts developmental abnormalities and tumor growth (PubMed:33854232, PubMed:33854235, PubMed:33854239). AMBRA1 also regulates the cell cycle by promoting MYC dephosphorylation and degradation independently of the DCX(AMBRA1) complex: acts via interaction with the catalytic subunit of protein phosphatase 2A (PPP2CA), which enhances interaction between PPP2CA and MYC, leading to MYC dephosphorylation and degradation (PubMed:25438055, PubMed:25803737). Acts as a regulator of Cul5-RING (CRL5) E3 ubiquitin-protein ligase complexes by mediating ubiquitination and degradation of Elongin-C (ELOC) component of CRL5 complexes (PubMed:25499913, PubMed:30166453). Acts as a key regulator of autophagy by modulating the BECN1-PIK3C3 complex: controls protein turnover during neuronal development, and regulates normal cell survival and proliferation (PubMed:21358617). In normal conditions, AMBRA1 is tethered to the cytoskeleton via interaction with dyneins DYNLL1 and DYNLL2 (PubMed:20921139). Upon autophagy induction, AMBRA1 is released from the cytoskeletal docking site to induce autophagosome nucleation by mediating ubiquitination of proteins involved in autophagy (PubMed:20921139). The DCX(AMBRA1) complex mediates 'Lys-63'-linked ubiquitination of BECN1, increasing the association between BECN1 and PIK3C3 to promote PIK3C3 activity (By similarity). In collaboration with TRAF6, AMBRA1 mediates 'Lys-63'-linked ubiquitination of ULK1 following autophagy induction, promoting ULK1 stability and kinase activity (PubMed:23524951). Also activates ULK1 via interaction with TRIM32: TRIM32 stimulates ULK1 through unanchored 'Lys-63'-linked polyubiquitin chains (PubMed:31123703). Also acts as an activator of mitophagy via interaction with PRKN and LC3 proteins (MAP1LC3A, MAP1LC3B or MAP1LC3C); possibly by bringing damaged mitochondria onto autophagosomes (PubMed:21753002, PubMed:25215947). Also activates mitophagy by acting as a cofactor for HUWE1; acts by promoting HUWE1-mediated ubiquitination of MFN2 (PubMed:30217973). AMBRA1 is also involved in regulatory T-cells (Treg) differentiation by promoting FOXO3 dephosphorylation independently of the DCX(AMBRA1) complex: acts via interaction with PPP2CA, which enhances interaction between PPP2CA and FOXO3, leading to FOXO3 dephosphorylation and stabilization (PubMed:30513302). May act as a regulator of intracellular trafficking, regulating the localization of active PTK2/FAK and SRC (By similarity). Also involved in transcription regulation by acting as a scaffold for protein complexes at chromatin (By similarity). {ECO:0000250|UniProtKB:A2AH22, ECO:0000269|PubMed:20921139, ECO:0000269|PubMed:21358617, ECO:0000269|PubMed:21753002, ECO:0000269|PubMed:23524951, ECO:0000269|PubMed:24587252, ECO:0000269|PubMed:25215947, ECO:0000269|PubMed:25438055, ECO:0000269|PubMed:25499913, ECO:0000269|PubMed:25803737, ECO:0000269|PubMed:30166453, ECO:0000269|PubMed:30217973, ECO:0000269|PubMed:30513302, ECO:0000269|PubMed:31123703, ECO:0000269|PubMed:32333458, ECO:0000269|PubMed:33854232, ECO:0000269|PubMed:33854235, ECO:0000269|PubMed:33854239}. |
Q9H1C4 | UNC93B1 | S550 | ochoa | Protein unc-93 homolog B1 (Unc-93B1) (hUNC93B1) | Plays an important role in innate and adaptive immunity by regulating nucleotide-sensing Toll-like receptor (TLR) signaling. Required for the transport of a subset of TLRs (including TLR3, TLR7 and TLR9) from the endoplasmic reticulum to endolysosomes where they can engage pathogen nucleotides and activate signaling cascades. May play a role in autoreactive B-cells removal. {ECO:0000269|PubMed:19006693}. |
Q9H2G2 | SLK | S347 | ochoa|psp | STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2) | Mediates apoptosis and actin stress fiber dissolution. {ECO:0000250}. |
Q9H410 | DSN1 | S30 | ochoa | Kinetochore-associated protein DSN1 homolog | Part of the MIS12 complex which is required for normal chromosome alignment and segregation and kinetochore formation during mitosis. {ECO:0000269|PubMed:15502821, ECO:0000269|PubMed:16585270}. |
Q9H6K5 | PRR36 | S1128 | ochoa | Proline-rich protein 36 | None |
Q9H6T3 | RPAP3 | S119 | ochoa|psp | RNA polymerase II-associated protein 3 | Forms an interface between the RNA polymerase II enzyme and chaperone/scaffolding protein, suggesting that it is required to connect RNA polymerase II to regulators of protein complex formation. {ECO:0000269|PubMed:17643375}. |
Q9H6U6 | BCAS3 | S715 | ochoa | BCAS3 microtubule associated cell migration factor (Breast carcinoma-amplified sequence 3) (GAOB1) | Plays a role in angiogenesis. Participates in the regulation of cell polarity and directional endothelial cell migration by mediating both the activation and recruitment of CDC42 and the reorganization of the actin cytoskeleton at the cell leading edge. Promotes filipodia formation (By similarity). Functions synergistically with PELP1 as a transcriptional coactivator of estrogen receptor-responsive genes. Stimulates histone acetyltransferase activity. Binds to chromatin. Plays a regulatory role in autophagic activity. In complex with PHAF1, associates with the preautophagosomal structure during both non-selective and selective autophagy (PubMed:33499712). Probably binds phosphatidylinositol 3-phosphate (PtdIns3P) which would mediate the recruitment preautophagosomal structures (PubMed:33499712). {ECO:0000250|UniProtKB:Q8CCN5, ECO:0000269|PubMed:17505058, ECO:0000269|PubMed:33499712}. |
Q9H6Z4 | RANBP3 | S244 | ochoa | Ran-binding protein 3 (RanBP3) | Acts as a cofactor for XPO1/CRM1-mediated nuclear export, perhaps as export complex scaffolding protein. Bound to XPO1/CRM1, stabilizes the XPO1/CRM1-cargo interaction. In the absence of Ran-bound GTP prevents binding of XPO1/CRM1 to the nuclear pore complex. Binds to CHC1/RCC1 and increases the guanine nucleotide exchange activity of CHC1/RCC1. Recruits XPO1/CRM1 to CHC1/RCC1 in a Ran-dependent manner. Negative regulator of TGF-beta signaling through interaction with the R-SMAD proteins, SMAD2 and SMAD3, and mediating their nuclear export. {ECO:0000269|PubMed:11425870, ECO:0000269|PubMed:11571268, ECO:0000269|PubMed:11932251, ECO:0000269|PubMed:19289081, ECO:0000269|PubMed:9637251}. |
Q9H8M2 | BRD9 | S571 | ochoa | Bromodomain-containing protein 9 (Rhabdomyosarcoma antigen MU-RMS-40.8) | Plays a role in chromatin remodeling and regulation of transcription (PubMed:22464331, PubMed:26365797). Acts as a chromatin reader that recognizes and binds acylated histones: binds histones that are acetylated and/or butyrylated (PubMed:26365797). Component of SWI/SNF chromatin remodeling subcomplex GBAF that carries out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner (PubMed:29374058). Also orchestrates the RAD51-RAD54 complex formation and thereby plays a role in homologous recombination (HR) (PubMed:32457312). {ECO:0000269|PubMed:22464331, ECO:0000269|PubMed:26365797, ECO:0000269|PubMed:29374058, ECO:0000269|PubMed:32457312}. |
Q9H8V3 | ECT2 | Y41 | ochoa | Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) | Guanine nucleotide exchange factor (GEF) that catalyzes the exchange of GDP for GTP. Promotes guanine nucleotide exchange on the Rho family members of small GTPases, like RHOA, RHOC, RAC1 and CDC42. Required for signal transduction pathways involved in the regulation of cytokinesis. Component of the centralspindlin complex that serves as a microtubule-dependent and Rho-mediated signaling required for the myosin contractile ring formation during the cell cycle cytokinesis. Regulates the translocation of RHOA from the central spindle to the equatorial region. Plays a role in the control of mitotic spindle assembly; regulates the activation of CDC42 in metaphase for the process of spindle fibers attachment to kinetochores before chromosome congression. Involved in the regulation of epithelial cell polarity; participates in the formation of epithelial tight junctions in a polarity complex PARD3-PARD6-protein kinase PRKCQ-dependent manner. Plays a role in the regulation of neurite outgrowth. Inhibits phenobarbital (PB)-induced NR1I3 nuclear translocation. Stimulates the activity of RAC1 through its association with the oncogenic PARD6A-PRKCI complex in cancer cells, thereby acting to coordinately drive tumor cell proliferation and invasion. Also stimulates genotoxic stress-induced RHOB activity in breast cancer cells leading to their cell death. {ECO:0000269|PubMed:10579713, ECO:0000269|PubMed:14645260, ECO:0000269|PubMed:15254234, ECO:0000269|PubMed:15545273, ECO:0000269|PubMed:15642749, ECO:0000269|PubMed:16103226, ECO:0000269|PubMed:16170345, ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:16495035, ECO:0000269|PubMed:19129481, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:19617897, ECO:0000269|PubMed:21189248, ECO:0000269|PubMed:21373644, ECO:0000269|PubMed:25068414, ECO:0000269|PubMed:31888991}. |
Q9HAW4 | CLSPN | S774 | ochoa | Claspin (hClaspin) | Required for checkpoint mediated cell cycle arrest in response to inhibition of DNA replication or to DNA damage induced by both ionizing and UV irradiation (PubMed:12766152, PubMed:15190204, PubMed:15707391, PubMed:16123041). Adapter protein which binds to BRCA1 and the checkpoint kinase CHEK1 and facilitates the ATR-dependent phosphorylation of both proteins (PubMed:12766152, PubMed:15096610, PubMed:15707391, PubMed:16123041). Also required to maintain normal rates of replication fork progression during unperturbed DNA replication. Binds directly to DNA, with particular affinity for branched or forked molecules and interacts with multiple protein components of the replisome such as the MCM2-7 complex and TIMELESS (PubMed:15226314, PubMed:34694004, PubMed:35585232). Important for initiation of DNA replication, recruits kinase CDC7 to phosphorylate MCM2-7 components (PubMed:27401717). {ECO:0000269|PubMed:12766152, ECO:0000269|PubMed:15096610, ECO:0000269|PubMed:15190204, ECO:0000269|PubMed:15226314, ECO:0000269|PubMed:15707391, ECO:0000269|PubMed:16123041, ECO:0000269|PubMed:27401717, ECO:0000269|PubMed:34694004, ECO:0000269|PubMed:35585232}. |
Q9HCG8 | CWC22 | S64 | ochoa | Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) (fSAPb) | Required for pre-mRNA splicing as component of the spliceosome (PubMed:11991638, PubMed:12226669, PubMed:22961380, PubMed:28076346, PubMed:28502770, PubMed:29301961, PubMed:29360106). As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Promotes exon-junction complex (EJC) assembly (PubMed:22959432, PubMed:22961380). Hinders EIF4A3 from non-specifically binding RNA and escorts it to the splicing machinery to promote EJC assembly on mature mRNAs. Through its role in EJC assembly, required for nonsense-mediated mRNA decay. {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:12226669, ECO:0000269|PubMed:22959432, ECO:0000269|PubMed:22961380, ECO:0000269|PubMed:23236153, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000305|PubMed:33509932}. |
Q9HCL2 | GPAM | S688 | ochoa | Glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAT-1) (EC 2.3.1.15) | Mitochondrial membrane protein that catalyzes the essential first step of biosynthesis of glycerolipids such as triglycerides, phosphatidic acids and lysophosphatidic acids (PubMed:18238778, PubMed:19075029, PubMed:36522428). Esterifies acyl-group from acyl-coenzyme A (acyl-CoA) to the sn-1 position of glycerol-3-phosphate, to produce lysophosphatidic acid (PubMed:18238778). Has a narrow hydrophobic binding cleft that selects for a linear acyl chain (PubMed:36522428). Catalytic activity is higher for substrates with a 16-carbon acyl chain (PubMed:36522428). {ECO:0000269|PubMed:18238778, ECO:0000269|PubMed:19075029, ECO:0000269|PubMed:36522428}. |
Q9HCS5 | EPB41L4A | S652 | ochoa | Band 4.1-like protein 4A (Erythrocyte membrane protein band 4.1-like 4A) (Protein NBL4) | None |
Q9HCS7 | XAB2 | S803 | ochoa | Pre-mRNA-splicing factor SYF1 (Protein HCNP) (XPA-binding protein 2) | Involved in pre-mRNA splicing as component of the spliceosome (PubMed:11991638, PubMed:28076346, PubMed:28502770). Involved in transcription-coupled repair (TCR), transcription and pre-mRNA splicing (PubMed:10944529, PubMed:17981804). {ECO:0000269|PubMed:10944529, ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:17981804, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770}. |
Q9NQC3 | RTN4 | S449 | ochoa | Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5) | Required to induce the formation and stabilization of endoplasmic reticulum (ER) tubules (PubMed:24262037, PubMed:25612671, PubMed:27619977). They regulate membrane morphogenesis in the ER by promoting tubular ER production (PubMed:24262037, PubMed:25612671, PubMed:27619977, PubMed:27786289). They influence nuclear envelope expansion, nuclear pore complex formation and proper localization of inner nuclear membrane proteins (PubMed:26906412). However each isoform have specific functions mainly depending on their tissue expression specificities (Probable). {ECO:0000269|PubMed:24262037, ECO:0000269|PubMed:25612671, ECO:0000269|PubMed:26906412, ECO:0000269|PubMed:27619977, ECO:0000269|PubMed:27786289, ECO:0000305}.; FUNCTION: [Isoform A]: Developmental neurite growth regulatory factor with a role as a negative regulator of axon-axon adhesion and growth, and as a facilitator of neurite branching. Regulates neurite fasciculation, branching and extension in the developing nervous system. Involved in down-regulation of growth, stabilization of wiring and restriction of plasticity in the adult CNS (PubMed:10667797, PubMed:11201742). Regulates the radial migration of cortical neurons via an RTN4R-LINGO1 containing receptor complex (By similarity). Acts as a negative regulator of central nervous system angiogenesis. Inhibits spreading, migration and sprouting of primary brain microvascular endothelial cells (MVECs). Also induces the retraction of MVECs lamellipodia and filopodia in a ROCK pathway-dependent manner (By similarity). {ECO:0000250|UniProtKB:Q99P72, ECO:0000269|PubMed:10667797, ECO:0000269|PubMed:11201742, ECO:0000269|PubMed:19699797}.; FUNCTION: [Isoform B]: Mainly function in endothelial cells and vascular smooth muscle cells, is also involved in immune system regulation (Probable). Modulator of vascular remodeling, promotes the migration of endothelial cells but inhibits the migration of vascular smooth muscle cells. Regulates endothelial sphingolipid biosynthesis with direct effects on vascular function and blood pressure. Inhibits serine palmitoyltransferase, SPTLC1, the rate-limiting enzyme of the novo sphingolipid biosynthetic pathway, thereby controlling production of endothelial sphingosine-1-phosphate (S1P). Required to promote macrophage homing and functions such as cytokine/chemokine gene expression involved in angiogenesis, arteriogenesis and tissue repair. Mediates ICAM1 induced transendothelial migration of leukocytes such as monocytes and neutrophils and acute inflammation. Necessary for immune responses triggered by nucleic acid sensing TLRs, such as TLR9, is required for proper TLR9 location to endolysosomes. Also involved in immune response to LPS. Plays a role in liver regeneration through the modulation of hepatocytes proliferation (By similarity). Reduces the anti-apoptotic activity of Bcl-xl and Bcl-2. This is likely consecutive to their change in subcellular location, from the mitochondria to the endoplasmic reticulum, after binding and sequestration (PubMed:11126360). With isoform C, inhibits BACE1 activity and amyloid precursor protein processing (PubMed:16965550). {ECO:0000250|UniProtKB:Q99P72, ECO:0000269|PubMed:11126360, ECO:0000269|PubMed:16965550, ECO:0000305}.; FUNCTION: [Isoform C]: Regulates cardiomyocyte apoptosis upon hypoxic conditions (By similarity). With isoform B, inhibits BACE1 activity and amyloid precursor protein processing (PubMed:16965550). {ECO:0000250|UniProtKB:Q99P72, ECO:0000269|PubMed:16965550}. |
Q9NQC7 | CYLD | S444 | psp | Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) | Deubiquitinase that specifically cleaves 'Lys-63'- and linear 'Met-1'-linked polyubiquitin chains and is involved in NF-kappa-B activation and TNF-alpha-induced necroptosis (PubMed:18313383, PubMed:18636086, PubMed:26670046, PubMed:26997266, PubMed:27458237, PubMed:27591049, PubMed:27746020, PubMed:29291351, PubMed:32185393). Negatively regulates NF-kappa-B activation by deubiquitinating upstream signaling factors (PubMed:12917689, PubMed:12917691, PubMed:32185393). Contributes to the regulation of cell survival, proliferation and differentiation via its effects on NF-kappa-B activation (PubMed:12917690). Negative regulator of Wnt signaling (PubMed:20227366). Inhibits HDAC6 and thereby promotes acetylation of alpha-tubulin and stabilization of microtubules (PubMed:19893491). Plays a role in the regulation of microtubule dynamics, and thereby contributes to the regulation of cell proliferation, cell polarization, cell migration, and angiogenesis (PubMed:18222923, PubMed:20194890). Required for normal cell cycle progress and normal cytokinesis (PubMed:17495026, PubMed:19893491). Inhibits nuclear translocation of NF-kappa-B (PubMed:18636086). Plays a role in the regulation of inflammation and the innate immune response, via its effects on NF-kappa-B activation (PubMed:18636086). Dispensable for the maturation of intrathymic natural killer cells, but required for the continued survival of immature natural killer cells (By similarity). Negatively regulates TNFRSF11A signaling and osteoclastogenesis (By similarity). Involved in the regulation of ciliogenesis, allowing ciliary basal bodies to migrate and dock to the plasma membrane; this process does not depend on NF-kappa-B activation (By similarity). Ability to remove linear ('Met-1'-linked) polyubiquitin chains regulates innate immunity and TNF-alpha-induced necroptosis: recruited to the LUBAC complex via interaction with SPATA2 and restricts linear polyubiquitin formation on target proteins (PubMed:26670046, PubMed:26997266, PubMed:27458237, PubMed:27591049). Regulates innate immunity by restricting linear polyubiquitin formation on RIPK2 in response to NOD2 stimulation (PubMed:26997266). Involved in TNF-alpha-induced necroptosis by removing linear ('Met-1'-linked) polyubiquitin chains from RIPK1, thereby regulating the kinase activity of RIPK1 (By similarity). Negatively regulates intestinal inflammation by removing 'Lys-63' linked polyubiquitin chain of NLRP6, thereby reducing the interaction between NLRP6 and PYCARD/ASC and formation of the NLRP6 inflammasome (By similarity). Does not catalyze deubiquitination of heterotypic 'Lys-63'-/'Lys-48'-linked branched ubiquitin chains (PubMed:27746020). Removes 'Lys-63' linked polyubiquitin chain of MAP3K7, which inhibits phosphorylation and blocks downstream activation of the JNK-p38 kinase cascades (PubMed:29291351). Also removes 'Lys-63'-linked polyubiquitin chains of MAP3K1 and MA3P3K3, which inhibit their interaction with MAP2K1 and MAP2K2 (PubMed:34497368). {ECO:0000250|UniProtKB:Q80TQ2, ECO:0000269|PubMed:12917689, ECO:0000269|PubMed:12917690, ECO:0000269|PubMed:12917691, ECO:0000269|PubMed:17495026, ECO:0000269|PubMed:18222923, ECO:0000269|PubMed:18313383, ECO:0000269|PubMed:18636086, ECO:0000269|PubMed:19893491, ECO:0000269|PubMed:20194890, ECO:0000269|PubMed:20227366, ECO:0000269|PubMed:26670046, ECO:0000269|PubMed:26997266, ECO:0000269|PubMed:27458237, ECO:0000269|PubMed:27591049, ECO:0000269|PubMed:27746020, ECO:0000269|PubMed:29291351, ECO:0000269|PubMed:32185393, ECO:0000269|PubMed:34497368}. |
Q9NRY4 | ARHGAP35 | S1179 | ochoa | Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1) (GRF-1) (Rho GAP p190A) (p190-A) | Rho GTPase-activating protein (GAP) (PubMed:19673492, PubMed:28894085). Binds several acidic phospholipids which inhibits the Rho GAP activity to promote the Rac GAP activity (PubMed:19673492). This binding is inhibited by phosphorylation by PRKCA (PubMed:19673492). Involved in cell differentiation as well as cell adhesion and migration, plays an important role in retinal tissue morphogenesis, neural tube fusion, midline fusion of the cerebral hemispheres and mammary gland branching morphogenesis (By similarity). Transduces signals from p21-ras to the nucleus, acting via the ras GTPase-activating protein (GAP) (By similarity). Transduces SRC-dependent signals from cell-surface adhesion molecules, such as laminin, to promote neurite outgrowth. Regulates axon outgrowth, guidance and fasciculation (By similarity). Modulates Rho GTPase-dependent F-actin polymerization, organization and assembly, is involved in polarized cell migration and in the positive regulation of ciliogenesis and cilia elongation (By similarity). During mammary gland development, is required in both the epithelial and stromal compartments for ductal outgrowth (By similarity). Represses transcription of the glucocorticoid receptor by binding to the cis-acting regulatory sequence 5'-GAGAAAAGAAACTGGAGAAACTC-3'; this function is however unclear and would need additional experimental evidences (PubMed:1894621). {ECO:0000250|UniProtKB:P81128, ECO:0000250|UniProtKB:Q91YM2, ECO:0000269|PubMed:1894621, ECO:0000269|PubMed:19673492, ECO:0000269|PubMed:28894085}. |
Q9NSI6 | BRWD1 | S2051 | ochoa | Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9) | May be a transcriptional activator. May be involved in chromatin remodeling (By similarity). Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape. {ECO:0000250, ECO:0000269|PubMed:21834987}. |
Q9NUQ6 | SPATS2L | S455 | ochoa | SPATS2-like protein (DNA polymerase-transactivated protein 6) (Stress granule and nucleolar protein) (SGNP) | None |
Q9NUU7 | DDX19A | S92 | ochoa | ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) | ATP-dependent RNA helicase involved in mRNA export from the nucleus. Rather than unwinding RNA duplexes, DDX19 functions as a remodeler of ribonucleoprotein particles, whereby proteins bound to nuclear mRNA are dissociated and replaced by cytoplasmic mRNA binding proteins. {ECO:0000250|UniProtKB:Q9UMR2}. |
Q9NWH9 | SLTM | S217 | ochoa | SAFB-like transcription modulator (Modulator of estrogen-induced transcription) | When overexpressed, acts as a general inhibitor of transcription that eventually leads to apoptosis. {ECO:0000250}. |
Q9NWQ8 | PAG1 | S301 | ochoa | Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (Csk-binding protein) (Transmembrane adapter protein PAG) (Transmembrane phosphoprotein Cbp) | Negatively regulates TCR (T-cell antigen receptor)-mediated signaling in T-cells and FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. Promotes CSK activation and recruitment to lipid rafts, which results in LCK inhibition. Inhibits immunological synapse formation by preventing dynamic arrangement of lipid raft proteins. May be involved in cell adhesion signaling. {ECO:0000269|PubMed:10790433}. |
Q9NYF8 | BCLAF1 | S762 | ochoa | Bcl-2-associated transcription factor 1 (Btf) (BCLAF1 and THRAP3 family member 1) | Death-promoting transcriptional repressor. May be involved in cyclin-D1/CCND1 mRNA stability through the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. {ECO:0000269|PubMed:18794151}. |
Q9NYF8 | BCLAF1 | S763 | ochoa | Bcl-2-associated transcription factor 1 (Btf) (BCLAF1 and THRAP3 family member 1) | Death-promoting transcriptional repressor. May be involved in cyclin-D1/CCND1 mRNA stability through the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. {ECO:0000269|PubMed:18794151}. |
Q9NZB2 | FAM120A | S1048 | ochoa | Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated SRC activator) (Protein FAM120A) | Component of the oxidative stress-induced survival signaling. May regulate the activation of SRC family protein kinases (PubMed:19015244). May act as a scaffolding protein enabling SRC family protein kinases to phosphorylate and activate PI3-kinase (PubMed:19015244). Binds IGF2 RNA and promotes the production of IGF2 protein (PubMed:19015244). {ECO:0000269|PubMed:19015244}. |
Q9P2D0 | IBTK | S1021 | ochoa | Inhibitor of Bruton tyrosine kinase (IBtk) | Acts as an inhibitor of BTK tyrosine kinase activity, thereby playing a role in B-cell development. Down-regulates BTK kinase activity, leading to interference with BTK-mediated calcium mobilization and NF-kappa-B-driven transcription. {ECO:0000269|PubMed:11577348}. |
Q9UGU0 | TCF20 | S810 | ochoa | Transcription factor 20 (TCF-20) (Nuclear factor SPBP) (Protein AR1) (Stromelysin-1 PDGF-responsive element-binding protein) (SPRE-binding protein) | Transcriptional activator that binds to the regulatory region of MMP3 and thereby controls stromelysin expression. It stimulates the activity of various transcriptional activators such as JUN, SP1, PAX6 and ETS1, suggesting a function as a coactivator. {ECO:0000269|PubMed:10995766}. |
Q9UHH9 | IP6K2 | S359 | psp | Inositol hexakisphosphate kinase 2 (InsP6 kinase 2) (InsP6K2) (EC 2.7.4.-) (P(i)-uptake stimulator) (PiUS) | Converts inositol hexakisphosphate (InsP6) to diphosphoinositol pentakisphosphate (InsP7/PP-InsP5). {ECO:0000269|PubMed:10574768, ECO:0000269|PubMed:30624931}. |
Q9UHY8 | FEZ2 | S208 | ochoa | Fasciculation and elongation protein zeta-2 (Zygin II) (Zygin-2) | Involved in axonal outgrowth and fasciculation. {ECO:0000250}. |
Q9UJA3 | MCM8 | S636 | ochoa | DNA helicase MCM8 (EC 3.6.4.12) (Minichromosome maintenance 8) | Component of the MCM8-MCM9 complex, a complex involved in the repair of double-stranded DNA breaks (DBSs) and DNA interstrand cross-links (ICLs) by homologous recombination (HR) (PubMed:23401855). Required for DNA resection by the MRE11-RAD50-NBN/NBS1 (MRN) complex by recruiting the MRN complex to the repair site and by promoting the complex nuclease activity (PubMed:26215093). Probably by regulating the localization of the MNR complex, indirectly regulates the recruitment of downstream effector RAD51 to DNA damage sites including DBSs and ICLs (PubMed:23401855). The MCM8-MCM9 complex is dispensable for DNA replication and S phase progression (PubMed:23401855). However, may play a non-essential for DNA replication: may be involved in the activation of the prereplicative complex (pre-RC) during G(1) phase by recruiting CDC6 to the origin recognition complex (ORC) (PubMed:15684404). Probably by regulating HR, plays a key role during gametogenesis (By similarity). Stabilizes MCM9 protein (PubMed:23401855, PubMed:26215093). {ECO:0000250|UniProtKB:Q9CWV1, ECO:0000269|PubMed:15684404, ECO:0000269|PubMed:23401855, ECO:0000269|PubMed:26215093}. |
Q9UJA5 | TRMT6 | S475 | ochoa | tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 (mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6) (tRNA(m1A58)-methyltransferase subunit TRM6) (tRNA(m1A58)MTase subunit TRM6) | Substrate-binding subunit of tRNA (adenine-N(1)-)-methyltransferase, which catalyzes the formation of N(1)-methyladenine at position 58 (m1A58) in initiator methionyl-tRNA (PubMed:16043508). Together with the TRMT61A catalytic subunit, part of a mRNA N(1)-methyltransferase complex that mediates methylation of adenosine residues at the N(1) position of a small subset of mRNAs: N(1) methylation takes place in tRNA T-loop-like structures of mRNAs and is only present at low stoichiometries (PubMed:29072297, PubMed:29107537). {ECO:0000269|PubMed:16043508, ECO:0000269|PubMed:29072297, ECO:0000269|PubMed:29107537}. |
Q9UK61 | TASOR | S636 | ochoa | Protein TASOR (CTCL tumor antigen se89-1) (Retinoblastoma-associated protein RAP140) (Transgene activation suppressor protein) | Component of the HUSH complex, a multiprotein complex that mediates epigenetic repression (PubMed:26022416, PubMed:28581500). The HUSH complex is recruited to genomic loci rich in H3K9me3 and is required to maintain transcriptional silencing by promoting recruitment of SETDB1, a histone methyltransferase that mediates further deposition of H3K9me3, as well as MORC2 (PubMed:26022416, PubMed:28581500). Also represses L1 retrotransposons in collaboration with MORC2 and, probably, SETDB1, the silencing is dependent of repressive epigenetic modifications, such as H3K9me3 mark. Silencing events often occur within introns of transcriptionally active genes, and lead to the down-regulation of host gene expression (PubMed:29211708). The HUSH complex is also involved in the silencing of unintegrated retroviral DNA by being recruited by ZNF638: some part of the retroviral DNA formed immediately after infection remains unintegrated in the host genome and is transcriptionally repressed (PubMed:30487602). Plays a crucial role in early embryonic development (By similarity). Involved in the organization of spindle poles and spindle apparatus assembly during zygotic division (By similarity). Plays an important role in maintaining epiblast fitness or potency (By similarity). {ECO:0000250|UniProtKB:Q69ZR9, ECO:0000269|PubMed:26022416, ECO:0000269|PubMed:28581500, ECO:0000269|PubMed:29211708, ECO:0000269|PubMed:30487602}. |
Q9ULD4 | BRPF3 | S965 | ochoa | Bromodomain and PHD finger-containing protein 3 | Scaffold subunit of various histone acetyltransferase (HAT) complexes, such as the MOZ/MORF and HBO1 complexes, which have a histone H3 acetyltransferase activity (PubMed:16387653, PubMed:26620551, PubMed:26677226). Plays a role in DNA replication initiation by directing KAT7/HBO1 specificity towards histone H3 'Lys-14' acetylation (H3K14ac), thereby facilitating the activation of replication origins (PubMed:26620551). Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity (PubMed:16387653). {ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:26620551, ECO:0000269|PubMed:26677226}. |
Q9ULH7 | MRTFB | S550 | ochoa | Myocardin-related transcription factor B (MRTF-B) (MKL/myocardin-like protein 2) (Megakaryoblastic leukemia 2) | Acts as a transcriptional coactivator of serum response factor (SRF). Required for skeletal myogenic differentiation. {ECO:0000269|PubMed:14565952}. |
Q9ULI0 | ATAD2B | S950 | ochoa | ATPase family AAA domain-containing protein 2B | None |
Q9UMR2 | DDX19B | S93 | ochoa|psp | ATP-dependent RNA helicase DDX19B (EC 3.6.4.13) (DEAD box RNA helicase DEAD5) (DEAD box protein 19B) | ATP-dependent RNA helicase involved in mRNA export from the nucleus (PubMed:10428971). Rather than unwinding RNA duplexes, DDX19B functions as a remodeler of ribonucleoprotein particles, whereby proteins bound to nuclear mRNA are dissociated and replaced by cytoplasmic mRNA binding proteins (PubMed:10428971). {ECO:0000269|PubMed:10428971}. |
Q9UQ35 | SRRM2 | S1329 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9Y250 | LZTS1 | S257 | ochoa | Leucine zipper putative tumor suppressor 1 (F37/esophageal cancer-related gene-coding leucine-zipper motif) (Fez1) | Involved in the regulation of cell growth. May stabilize the active CDC2-cyclin B1 complex and thereby contribute to the regulation of the cell cycle and the prevention of uncontrolled cell proliferation. May act as a tumor suppressor. {ECO:0000269|PubMed:10097140, ECO:0000269|PubMed:11464283, ECO:0000269|PubMed:11504921}. |
Q9Y2L9 | LRCH1 | S393 | ochoa | Leucine-rich repeat and calponin homology domain-containing protein 1 (Calponin homology domain-containing protein 1) (Neuronal protein 81) (NP81) | Acts as a negative regulator of GTPase CDC42 by sequestering CDC42-guanine exchange factor DOCK8. Probably by preventing CDC42 activation, negatively regulates CD4(+) T-cell migration. {ECO:0000269|PubMed:28028151}. |
Q9Y3P8 | SIT1 | S83 | ochoa | Signaling threshold-regulating transmembrane adapter 1 (SHP2-interacting transmembrane adapter protein) (Suppression-inducing transmembrane adapter 1) (gp30/40) | Negatively regulates TCR (T-cell antigen receptor)-mediated signaling in T-cells. Involved in positive selection of T-cells. {ECO:0000269|PubMed:10209036}. |
Q9Y3S1 | WNK2 | S1846 | ochoa | Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43) | Serine/threonine-protein kinase component of the WNK2-SPAK/OSR1 kinase cascade, which plays an important role in the regulation of electrolyte homeostasis, cell signaling, survival, and proliferation (PubMed:17667937, PubMed:18593598, PubMed:21733846). The WNK2-SPAK/OSR1 kinase cascade is composed of WNK2, which mediates phosphorylation and activation of downstream kinases OXSR1/OSR1 and STK39/SPAK (By similarity). Following activation, OXSR1/OSR1 and STK39/SPAK catalyze phosphorylation of ion cotransporters, regulating their activity (By similarity). Acts as an activator and inhibitor of sodium-coupled chloride cotransporters and potassium-coupled chloride cotransporters respectively (PubMed:21733846). Activates SLC12A2, SCNN1A, SCNN1B, SCNN1D and SGK1 and inhibits SLC12A5 (PubMed:21733846). Negatively regulates the EGF-induced activation of the ERK/MAPK-pathway and the downstream cell cycle progression (PubMed:17667937, PubMed:18593598). Affects MAPK3/MAPK1 activity by modulating the activity of MAP2K1 and this modulation depends on phosphorylation of MAP2K1 by PAK1 (PubMed:17667937, PubMed:18593598). WNK2 acts by interfering with the activity of PAK1 by controlling the balance of the activity of upstream regulators of PAK1 activity, RHOA and RAC1, which display reciprocal activity (PubMed:17667937, PubMed:18593598). {ECO:0000250|UniProtKB:Q9H4A3, ECO:0000269|PubMed:17667937, ECO:0000269|PubMed:18593598, ECO:0000269|PubMed:21733846}. |
Q9Y490 | TLN1 | S458 | ochoa | Talin-1 | High molecular weight cytoskeletal protein concentrated at regions of cell-matrix and cell-cell contacts. Involved in connections of major cytoskeletal structures to the plasma membrane. With KANK1 co-organize the assembly of cortical microtubule stabilizing complexes (CMSCs) positioned to control microtubule-actin crosstalk at focal adhesions (FAs) rims. {ECO:0000250|UniProtKB:P26039}. |
Q9Y4A5 | TRRAP | S2054 | ochoa | Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog) | Adapter protein, which is found in various multiprotein chromatin complexes with histone acetyltransferase activity (HAT), which gives a specific tag for epigenetic transcription activation. Component of the NuA4 histone acetyltransferase complex which is responsible for acetylation of nucleosomal histones H4 and H2A. Plays a central role in MYC transcription activation, and also participates in cell transformation by MYC. Required for p53/TP53-, E2F1- and E2F4-mediated transcription activation. Also involved in transcription activation mediated by the adenovirus E1A, a viral oncoprotein that deregulates transcription of key genes. Probably acts by linking transcription factors such as E1A, MYC or E2F1 to HAT complexes such as STAGA thereby allowing transcription activation. Probably not required in the steps following histone acetylation in processes of transcription activation. May be required for the mitotic checkpoint and normal cell cycle progression. Component of a SWR1-like complex that specifically mediates the removal of histone H2A.Z/H2AZ1 from the nucleosome. May play a role in the formation and maintenance of the auditory system (By similarity). {ECO:0000250|UniProtKB:A0A0R4ITC5, ECO:0000269|PubMed:11418595, ECO:0000269|PubMed:12138177, ECO:0000269|PubMed:12660246, ECO:0000269|PubMed:12743606, ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:17967892, ECO:0000269|PubMed:24463511, ECO:0000269|PubMed:9708738}. |
Q9Y4I1 | MYO5A | S1118 | ochoa | Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain 12) (Myosin-12) (Myoxin) | Processive actin-based motor that can move in large steps approximating the 36-nm pseudo-repeat of the actin filament. Can hydrolyze ATP in the presence of actin, which is essential for its function as a motor protein (PubMed:10448864). Involved in melanosome transport. Also mediates the transport of vesicles to the plasma membrane (By similarity). May also be required for some polarization process involved in dendrite formation (By similarity). {ECO:0000250|UniProtKB:Q99104, ECO:0000250|UniProtKB:Q9QYF3, ECO:0000269|PubMed:10448864}. |
Q9Y520 | PRRC2C | S636 | ochoa | Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C) | Required for efficient formation of stress granules. {ECO:0000269|PubMed:29395067}. |
Q9Y6A5 | TACC3 | S76 | ochoa | Transforming acidic coiled-coil-containing protein 3 (ERIC-1) | Plays a role in the microtubule-dependent coupling of the nucleus and the centrosome. Involved in the processes that regulate centrosome-mediated interkinetic nuclear migration (INM) of neural progenitors (By similarity). Acts as a component of the TACC3/ch-TOG/clathrin complex proposed to contribute to stabilization of kinetochore fibers of the mitotic spindle by acting as inter-microtubule bridge. The TACC3/ch-TOG/clathrin complex is required for the maintenance of kinetochore fiber tension (PubMed:21297582, PubMed:23532825). May be involved in the control of cell growth and differentiation. May contribute to cancer (PubMed:14767476). {ECO:0000250|UniProtKB:Q9JJ11, ECO:0000269|PubMed:14767476, ECO:0000269|PubMed:21297582, ECO:0000269|PubMed:23532825}. |
Q9Y6I3 | EPN1 | S420 | ochoa | Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1) | Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). Modifies membrane curvature and facilitates the formation of clathrin-coated invaginations (By similarity). Regulates receptor-mediated endocytosis (PubMed:10393179, PubMed:10557078). {ECO:0000250|UniProtKB:O88339, ECO:0000269|PubMed:10393179, ECO:0000269|PubMed:10557078}. |
Q9Y6I9 | TEX264 | S272 | ochoa | Testis-expressed protein 264 (Putative secreted protein Zsig11) | Major reticulophagy (also called ER-phagy) receptor that acts independently of other candidate reticulophagy receptors to remodel subdomains of the endoplasmic reticulum into autophagosomes upon nutrient stress, which then fuse with lysosomes for endoplasmic reticulum turnover (PubMed:31006537, PubMed:31006538). The ATG8-containing isolation membrane (IM) cradles a tubular segment of TEX264-positive ER near a three-way junction, allowing the formation of a synapse of 2 juxtaposed membranes with trans interaction between the TEX264 and ATG8 proteins (PubMed:31006537). Expansion of the IM would extend the capture of ER, possibly through a 'zipper-like' process involving continued trans TEX264-ATG8 interactions, until poorly understood mechanisms lead to the fission of relevant membranes and, ultimately, autophagosomal membrane closure (PubMed:31006537). Also involved in the repair of covalent DNA-protein cross-links (DPCs) during DNA synthesis: acts by bridging VCP/p97 to covalent DNA-protein cross-links (DPCs) and initiating resolution of DPCs by SPRTN (PubMed:32152270). {ECO:0000269|PubMed:31006537, ECO:0000269|PubMed:31006538, ECO:0000269|PubMed:32152270}. |
P19338 | NCL | Y463 | Sugiyama | Nucleolin (Protein C23) | Nucleolin is the major nucleolar protein of growing eukaryotic cells. It is found associated with intranucleolar chromatin and pre-ribosomal particles. It induces chromatin decondensation by binding to histone H1. It is thought to play a role in pre-rRNA transcription and ribosome assembly. May play a role in the process of transcriptional elongation. Binds RNA oligonucleotides with 5'-UUAGGG-3' repeats more tightly than the telomeric single-stranded DNA 5'-TTAGGG-3' repeats. {ECO:0000269|PubMed:10393184}. |
P21333 | FLNA | Y1525 | Sugiyama | Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) | Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNB may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in ciliogenesis. Plays a role in cell-cell contacts and adherens junctions during the development of blood vessels, heart and brain organs. Plays a role in platelets morphology through interaction with SYK that regulates ITAM- and ITAM-like-containing receptor signaling, resulting in by platelet cytoskeleton organization maintenance (By similarity). During the axon guidance process, required for growth cone collapse induced by SEMA3A-mediated stimulation of neurons (PubMed:25358863). {ECO:0000250, ECO:0000250|UniProtKB:Q8BTM8, ECO:0000269|PubMed:22121117, ECO:0000269|PubMed:25358863}. |
P08684 | CYP3A4 | S119 | EPSD|PSP | Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55) | A cytochrome P450 monooxygenase involved in the metabolism of sterols, steroid hormones, retinoids and fatty acids (PubMed:10681376, PubMed:11093772, PubMed:11555828, PubMed:12865317, PubMed:14559847, PubMed:15373842, PubMed:15764715, PubMed:19965576, PubMed:20702771, PubMed:21490593, PubMed:21576599). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds (PubMed:12865317, PubMed:14559847, PubMed:15373842, PubMed:15764715, PubMed:21490593, PubMed:21576599, PubMed:2732228). Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2, as well as D-ring hydroxylated E1 and E2 at the C-16 position (PubMed:11555828, PubMed:12865317, PubMed:14559847). Plays a role in the metabolism of androgens, particularly in oxidative deactivation of testosterone (PubMed:15373842, PubMed:15764715, PubMed:22773874, PubMed:2732228). Metabolizes testosterone to less biologically active 2beta- and 6beta-hydroxytestosterones (PubMed:15373842, PubMed:15764715, PubMed:2732228). Contributes to the formation of hydroxycholesterols (oxysterols), particularly A-ring hydroxylated cholesterol at the C-4beta position, and side chain hydroxylated cholesterol at the C-25 position, likely contributing to cholesterol degradation and bile acid biosynthesis (PubMed:21576599). Catalyzes bisallylic hydroxylation of polyunsaturated fatty acids (PUFA) (PubMed:9435160). Catalyzes the epoxidation of double bonds of PUFA with a preference for the last double bond (PubMed:19965576). Metabolizes endocannabinoid arachidonoylethanolamide (anandamide) to 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling (PubMed:20702771). Plays a role in the metabolism of retinoids. Displays high catalytic activity for oxidation of all-trans-retinol to all-trans-retinal, a rate-limiting step for the biosynthesis of all-trans-retinoic acid (atRA) (PubMed:10681376). Further metabolizes atRA toward 4-hydroxyretinoate and may play a role in hepatic atRA clearance (PubMed:11093772). Responsible for oxidative metabolism of xenobiotics. Acts as a 2-exo-monooxygenase for plant lipid 1,8-cineole (eucalyptol) (PubMed:11159812). Metabolizes the majority of the administered drugs. Catalyzes sulfoxidation of the anthelmintics albendazole and fenbendazole (PubMed:10759686). Hydroxylates antimalarial drug quinine (PubMed:8968357). Acts as a 1,4-cineole 2-exo-monooxygenase (PubMed:11695850). Also involved in vitamin D catabolism and calcium homeostasis. Catalyzes the inactivation of the active hormone calcitriol (1-alpha,25-dihydroxyvitamin D(3)) (PubMed:29461981). {ECO:0000269|PubMed:10681376, ECO:0000269|PubMed:10759686, ECO:0000269|PubMed:11093772, ECO:0000269|PubMed:11159812, ECO:0000269|PubMed:11555828, ECO:0000269|PubMed:11695850, ECO:0000269|PubMed:12865317, ECO:0000269|PubMed:14559847, ECO:0000269|PubMed:15373842, ECO:0000269|PubMed:15764715, ECO:0000269|PubMed:19965576, ECO:0000269|PubMed:20702771, ECO:0000269|PubMed:21490593, ECO:0000269|PubMed:21576599, ECO:0000269|PubMed:22773874, ECO:0000269|PubMed:2732228, ECO:0000269|PubMed:29461981, ECO:0000269|PubMed:8968357, ECO:0000269|PubMed:9435160}. |
Q9UNN4 | GTF2A1L | S357 | SIGNOR|ELM|iPTMNet | TFIIA-alpha and beta-like factor (General transcription factor II A, 1-like factor) | May function as a testis specific transcription factor. Binds DNA in conjunction with GTF2A2 and TBP (the TATA-binding protein) and together with GTF2A2, allows mRNA transcription. {ECO:0000269|PubMed:10364255}. |
Q9UQ80 | PA2G4 | S47 | Sugiyama | Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog) (hG4-1) (ErbB3-binding protein 1) | May play a role in a ERBB3-regulated signal transduction pathway. Seems be involved in growth regulation. Acts a corepressor of the androgen receptor (AR) and is regulated by the ERBB3 ligand neuregulin-1/heregulin (HRG). Inhibits transcription of some E2F1-regulated promoters, probably by recruiting histone acetylase (HAT) activity. Binds RNA. Associates with 28S, 18S and 5.8S mature rRNAs, several rRNA precursors and probably U3 small nucleolar RNA. May be involved in regulation of intermediate and late steps of rRNA processing. May be involved in ribosome assembly. Mediates cap-independent translation of specific viral IRESs (internal ribosomal entry site) (By similarity). Regulates cell proliferation, differentiation, and survival. Isoform 1 suppresses apoptosis whereas isoform 2 promotes cell differentiation (By similarity). {ECO:0000250|UniProtKB:P50580, ECO:0000250|UniProtKB:Q6AYD3, ECO:0000269|PubMed:11268000, ECO:0000269|PubMed:12682367, ECO:0000269|PubMed:15064750, ECO:0000269|PubMed:15583694, ECO:0000269|PubMed:16832058}. |
Q7Z4S6 | KIF21A | S708 | Sugiyama | Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62) | Processive microtubule plus-end directed motor protein involved in neuronal axon guidance. Is recruited by KANK1 to cortical microtubule stabilizing complexes (CMSCs) at focal adhesions (FAs) rims where it promotes microtubule capture and stability. Controls microtubule polymerization rate at axonal growth cones and suppresses microtubule growth without inducing microtubule disassembly once it reaches the cell cortex. {ECO:0000250|UniProtKB:Q9QXL2, ECO:0000269|PubMed:24120883}. |
Q8TBC4 | UBA3 | S420 | Sugiyama | NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3) | Catalytic subunit of the dimeric UBA3-NAE1 E1 enzyme. E1 activates NEDD8 by first adenylating its C-terminal glycine residue with ATP, thereafter linking this residue to the side chain of the catalytic cysteine, yielding a NEDD8-UBA3 thioester and free AMP. E1 finally transfers NEDD8 to the catalytic cysteine of UBE2M. Down-regulates steroid receptor activity. Necessary for cell cycle progression. {ECO:0000269|PubMed:10207026, ECO:0000269|PubMed:12740388, ECO:0000269|PubMed:9694792}. |
Q16740 | CLPP | S222 | Sugiyama | ATP-dependent Clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92) (Caseinolytic mitochondrial matrix peptidase proteolytic subunit) (Endopeptidase Clp) | Protease component of the ClpXP complex that cleaves peptides and various proteins in an ATP-dependent process. Has low peptidase activity in the absence of CLPX. The ClpXP complex can degrade CSN1S1, CSN2 and CSN3, as well as synthetic peptides (in vitro) and may be responsible for a fairly general and central housekeeping function rather than for the degradation of specific substrates (PubMed:11923310, PubMed:15522782). Cleaves PINK1 in the mitochondrion (PubMed:22354088). {ECO:0000269|PubMed:11923310, ECO:0000269|PubMed:15522782, ECO:0000269|PubMed:22354088}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-428359 | Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RN... | 2.350592e-07 | 6.629 |
R-HSA-5674400 | Constitutive Signaling by AKT1 E17K in Cancer | 2.250869e-05 | 4.648 |
R-HSA-9764561 | Regulation of CDH1 Function | 4.039877e-05 | 4.394 |
R-HSA-9913351 | Formation of the dystrophin-glycoprotein complex (DGC) | 8.562431e-05 | 4.067 |
R-HSA-198323 | AKT phosphorylates targets in the cytosol | 2.681936e-04 | 3.572 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 2.485312e-04 | 3.605 |
R-HSA-389356 | Co-stimulation by CD28 | 7.646578e-04 | 3.117 |
R-HSA-69620 | Cell Cycle Checkpoints | 9.730737e-04 | 3.012 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 1.233803e-03 | 2.909 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 1.233803e-03 | 2.909 |
R-HSA-3000171 | Non-integrin membrane-ECM interactions | 1.138535e-03 | 2.944 |
R-HSA-389513 | Co-inhibition by CTLA4 | 1.400170e-03 | 2.854 |
R-HSA-6804757 | Regulation of TP53 Degradation | 1.469709e-03 | 2.833 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 1.496389e-03 | 2.825 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 2.286799e-03 | 2.641 |
R-HSA-141424 | Amplification of signal from the kinetochores | 2.286799e-03 | 2.641 |
R-HSA-5218920 | VEGFR2 mediated vascular permeability | 2.361261e-03 | 2.627 |
R-HSA-6806003 | Regulation of TP53 Expression and Degradation | 1.967425e-03 | 2.706 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 1.977872e-03 | 2.704 |
R-HSA-421270 | Cell-cell junction organization | 2.223416e-03 | 2.653 |
R-HSA-162582 | Signal Transduction | 2.389525e-03 | 2.622 |
R-HSA-418990 | Adherens junctions interactions | 2.176185e-03 | 2.662 |
R-HSA-446728 | Cell junction organization | 1.847155e-03 | 2.733 |
R-HSA-1257604 | PIP3 activates AKT signaling | 3.031020e-03 | 2.518 |
R-HSA-9932451 | SWI/SNF chromatin remodelers | 3.031680e-03 | 2.518 |
R-HSA-9932444 | ATP-dependent chromatin remodelers | 3.031680e-03 | 2.518 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 2.940151e-03 | 2.532 |
R-HSA-445095 | Interaction between L1 and Ankyrins | 3.780917e-03 | 2.422 |
R-HSA-389357 | CD28 dependent PI3K/Akt signaling | 3.780917e-03 | 2.422 |
R-HSA-9824585 | Regulation of MITF-M-dependent genes involved in pigmentation | 3.592890e-03 | 2.445 |
R-HSA-1839120 | Signaling by FGFR1 amplification mutants | 4.172213e-03 | 2.380 |
R-HSA-9933947 | Formation of the non-canonical BAF (ncBAF) complex | 4.306151e-03 | 2.366 |
R-HSA-9006925 | Intracellular signaling by second messengers | 4.162386e-03 | 2.381 |
R-HSA-6804759 | Regulation of TP53 Activity through Association with Co-factors | 4.306151e-03 | 2.366 |
R-HSA-9927432 | Developmental Lineage of Mammary Gland Myoepithelial Cells | 4.646598e-03 | 2.333 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 4.521878e-03 | 2.345 |
R-HSA-6803211 | TP53 Regulates Transcription of Death Receptors and Ligands | 5.041604e-03 | 2.297 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 4.750625e-03 | 2.323 |
R-HSA-8863795 | Downregulation of ERBB2 signaling | 5.125543e-03 | 2.290 |
R-HSA-9933939 | Formation of the polybromo-BAF (pBAF) complex | 5.041604e-03 | 2.297 |
R-HSA-1500931 | Cell-Cell communication | 5.287760e-03 | 2.277 |
R-HSA-165181 | Inhibition of TSC complex formation by PKB | 5.933961e-03 | 2.227 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 5.603304e-03 | 2.252 |
R-HSA-211163 | AKT-mediated inactivation of FOXO1A | 5.933961e-03 | 2.227 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 5.637749e-03 | 2.249 |
R-HSA-4839726 | Chromatin organization | 5.688492e-03 | 2.245 |
R-HSA-446353 | Cell-extracellular matrix interactions | 5.848259e-03 | 2.233 |
R-HSA-73887 | Death Receptor Signaling | 5.956436e-03 | 2.225 |
R-HSA-397795 | G-protein beta:gamma signalling | 6.757945e-03 | 2.170 |
R-HSA-68877 | Mitotic Prometaphase | 7.729053e-03 | 2.112 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 7.971725e-03 | 2.098 |
R-HSA-447038 | NrCAM interactions | 7.977417e-03 | 2.098 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 8.762795e-03 | 2.057 |
R-HSA-3247509 | Chromatin modifying enzymes | 9.748995e-03 | 2.011 |
R-HSA-72172 | mRNA Splicing | 1.104591e-02 | 1.957 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 1.239481e-02 | 1.907 |
R-HSA-8953854 | Metabolism of RNA | 1.234807e-02 | 1.908 |
R-HSA-373755 | Semaphorin interactions | 1.182175e-02 | 1.927 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 1.210601e-02 | 1.917 |
R-HSA-373760 | L1CAM interactions | 1.258063e-02 | 1.900 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 1.515655e-02 | 1.819 |
R-HSA-9856651 | MITF-M-dependent gene expression | 1.551820e-02 | 1.809 |
R-HSA-8931987 | RUNX1 regulates estrogen receptor mediated transcription | 1.568877e-02 | 1.804 |
R-HSA-9674415 | Drug resistance of PDGFR mutants | 1.870196e-02 | 1.728 |
R-HSA-9674428 | PDGFR mutants bind TKIs | 1.870196e-02 | 1.728 |
R-HSA-9674403 | Regorafenib-resistant PDGFR mutants | 1.870196e-02 | 1.728 |
R-HSA-9674396 | Imatinib-resistant PDGFR mutants | 1.870196e-02 | 1.728 |
R-HSA-5467333 | APC truncation mutants are not K63 polyubiquitinated | 1.870196e-02 | 1.728 |
R-HSA-9674404 | Sorafenib-resistant PDGFR mutants | 1.870196e-02 | 1.728 |
R-HSA-9674401 | Sunitinib-resistant PDGFR mutants | 1.870196e-02 | 1.728 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 1.628508e-02 | 1.788 |
R-HSA-392451 | G beta:gamma signalling through PI3Kgamma | 1.813112e-02 | 1.742 |
R-HSA-194138 | Signaling by VEGF | 1.808768e-02 | 1.743 |
R-HSA-196025 | Formation of annular gap junctions | 1.875133e-02 | 1.727 |
R-HSA-9825895 | Regulation of MITF-M-dependent genes involved in DNA replication, damage repair ... | 1.875133e-02 | 1.727 |
R-HSA-5357905 | Regulation of TNFR1 signaling | 1.999146e-02 | 1.699 |
R-HSA-5633007 | Regulation of TP53 Activity | 2.105415e-02 | 1.677 |
R-HSA-5633008 | TP53 Regulates Transcription of Cell Death Genes | 2.157433e-02 | 1.666 |
R-HSA-1266695 | Interleukin-7 signaling | 2.155159e-02 | 1.667 |
R-HSA-9675108 | Nervous system development | 2.170911e-02 | 1.663 |
R-HSA-1640170 | Cell Cycle | 2.183042e-02 | 1.661 |
R-HSA-198693 | AKT phosphorylates targets in the nucleus | 2.204324e-02 | 1.657 |
R-HSA-190873 | Gap junction degradation | 2.204324e-02 | 1.657 |
R-HSA-428543 | Inactivation of CDC42 and RAC1 | 2.204324e-02 | 1.657 |
R-HSA-109581 | Apoptosis | 2.231023e-02 | 1.651 |
R-HSA-5357956 | TNFR1-induced NF-kappa-B signaling pathway | 2.530019e-02 | 1.597 |
R-HSA-6803204 | TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 2.530019e-02 | 1.597 |
R-HSA-422475 | Axon guidance | 2.314675e-02 | 1.636 |
R-HSA-451308 | Activation of Ca-permeable Kainate Receptor | 2.555492e-02 | 1.593 |
R-HSA-4839744 | Signaling by APC mutants | 2.927704e-02 | 1.533 |
R-HSA-5467337 | APC truncation mutants have impaired AXIN binding | 2.927704e-02 | 1.533 |
R-HSA-5467340 | AXIN missense mutants destabilize the destruction complex | 2.927704e-02 | 1.533 |
R-HSA-5467348 | Truncations of AMER1 destabilize the destruction complex | 2.927704e-02 | 1.533 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 2.943945e-02 | 1.531 |
R-HSA-451306 | Ionotropic activity of kainate receptors | 2.927704e-02 | 1.533 |
R-HSA-445355 | Smooth Muscle Contraction | 2.943945e-02 | 1.531 |
R-HSA-199991 | Membrane Trafficking | 3.043745e-02 | 1.517 |
R-HSA-9614399 | Regulation of localization of FOXO transcription factors | 2.927704e-02 | 1.533 |
R-HSA-8941332 | RUNX2 regulates genes involved in cell migration | 2.927704e-02 | 1.533 |
R-HSA-9008059 | Interleukin-37 signaling | 3.153669e-02 | 1.501 |
R-HSA-114452 | Activation of BH3-only proteins | 3.153669e-02 | 1.501 |
R-HSA-211728 | Regulation of PAK-2p34 activity by PS-GAP/RHG10 | 3.705529e-02 | 1.431 |
R-HSA-5602415 | UNC93B1 deficiency - HSE | 3.705529e-02 | 1.431 |
R-HSA-9645722 | Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | 3.705529e-02 | 1.431 |
R-HSA-9663199 | Defective DNA double strand break response due to BRCA1 loss of function | 3.705529e-02 | 1.431 |
R-HSA-9699150 | Defective DNA double strand break response due to BARD1 loss of function | 3.705529e-02 | 1.431 |
R-HSA-1839122 | Signaling by activated point mutants of FGFR1 | 3.320056e-02 | 1.479 |
R-HSA-2514853 | Condensation of Prometaphase Chromosomes | 3.320056e-02 | 1.479 |
R-HSA-5339716 | Signaling by GSK3beta mutants | 3.320056e-02 | 1.479 |
R-HSA-4839735 | Signaling by AXIN mutants | 3.320056e-02 | 1.479 |
R-HSA-4839748 | Signaling by AMER1 mutants | 3.320056e-02 | 1.479 |
R-HSA-75893 | TNF signaling | 3.417336e-02 | 1.466 |
R-HSA-109606 | Intrinsic Pathway for Apoptosis | 3.417336e-02 | 1.466 |
R-HSA-4839743 | Signaling by CTNNB1 phospho-site mutants | 3.731670e-02 | 1.428 |
R-HSA-5358752 | CTNNB1 T41 mutants aren't phosphorylated | 3.731670e-02 | 1.428 |
R-HSA-5358751 | CTNNB1 S45 mutants aren't phosphorylated | 3.731670e-02 | 1.428 |
R-HSA-5358749 | CTNNB1 S37 mutants aren't phosphorylated | 3.731670e-02 | 1.428 |
R-HSA-5358747 | CTNNB1 S33 mutants aren't phosphorylated | 3.731670e-02 | 1.428 |
R-HSA-1358803 | Downregulation of ERBB2:ERBB3 signaling | 3.731670e-02 | 1.428 |
R-HSA-1839124 | FGFR1 mutant receptor activation | 3.850204e-02 | 1.415 |
R-HSA-8939243 | RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not kno... | 3.850204e-02 | 1.415 |
R-HSA-6804758 | Regulation of TP53 Activity through Acetylation | 3.850204e-02 | 1.415 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 4.543562e-02 | 1.343 |
R-HSA-5205647 | Mitophagy | 4.354381e-02 | 1.361 |
R-HSA-983189 | Kinesins | 4.113500e-02 | 1.386 |
R-HSA-1227986 | Signaling by ERBB2 | 4.113500e-02 | 1.386 |
R-HSA-9933937 | Formation of the canonical BAF (cBAF) complex | 4.609300e-02 | 1.336 |
R-HSA-9007101 | Rab regulation of trafficking | 3.957696e-02 | 1.403 |
R-HSA-5683057 | MAPK family signaling cascades | 4.815850e-02 | 1.317 |
R-HSA-196299 | Beta-catenin phosphorylation cascade | 5.073683e-02 | 1.295 |
R-HSA-399954 | Sema3A PAK dependent Axon repulsion | 5.073683e-02 | 1.295 |
R-HSA-111447 | Activation of BAD and translocation to mitochondria | 5.073683e-02 | 1.295 |
R-HSA-9933946 | Formation of the embryonic stem cell BAF (esBAF) complex | 5.073683e-02 | 1.295 |
R-HSA-9755779 | SARS-CoV-2 targets host intracellular signalling and regulatory pathways | 5.073683e-02 | 1.295 |
R-HSA-8950505 | Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulati... | 5.088420e-02 | 1.293 |
R-HSA-5619101 | Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG... | 5.506646e-02 | 1.259 |
R-HSA-5660686 | Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG... | 5.506646e-02 | 1.259 |
R-HSA-9665230 | Drug resistance in ERBB2 KD mutants | 7.274184e-02 | 1.138 |
R-HSA-211736 | Stimulation of the cell death response by PAK-2p34 | 7.274184e-02 | 1.138 |
R-HSA-9652282 | Drug-mediated inhibition of ERBB2 signaling | 7.274184e-02 | 1.138 |
R-HSA-9665250 | Resistance of ERBB2 KD mutants to AEE788 | 7.274184e-02 | 1.138 |
R-HSA-9665246 | Resistance of ERBB2 KD mutants to neratinib | 7.274184e-02 | 1.138 |
R-HSA-9665247 | Resistance of ERBB2 KD mutants to osimertinib | 7.274184e-02 | 1.138 |
R-HSA-9665245 | Resistance of ERBB2 KD mutants to tesevatinib | 7.274184e-02 | 1.138 |
R-HSA-9665249 | Resistance of ERBB2 KD mutants to afatinib | 7.274184e-02 | 1.138 |
R-HSA-9665737 | Drug resistance in ERBB2 TMD/JMD mutants | 7.274184e-02 | 1.138 |
R-HSA-9665244 | Resistance of ERBB2 KD mutants to sapitinib | 7.274184e-02 | 1.138 |
R-HSA-9665233 | Resistance of ERBB2 KD mutants to trastuzumab | 7.274184e-02 | 1.138 |
R-HSA-9665251 | Resistance of ERBB2 KD mutants to lapatinib | 7.274184e-02 | 1.138 |
R-HSA-9603798 | Class I peroxisomal membrane protein import | 5.554066e-02 | 1.255 |
R-HSA-5654219 | Phospholipase C-mediated cascade: FGFR1 | 6.559825e-02 | 1.183 |
R-HSA-190242 | FGFR1 ligand binding and activation | 7.083755e-02 | 1.150 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 6.410561e-02 | 1.193 |
R-HSA-6802948 | Signaling by high-kinase activity BRAF mutants | 5.169001e-02 | 1.287 |
R-HSA-5674135 | MAP2K and MAPK activation | 6.676536e-02 | 1.175 |
R-HSA-9924644 | Developmental Lineages of the Mammary Gland | 6.646820e-02 | 1.177 |
R-HSA-5655302 | Signaling by FGFR1 in disease | 6.676536e-02 | 1.175 |
R-HSA-9656223 | Signaling by RAF1 mutants | 6.676536e-02 | 1.175 |
R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic | 5.386774e-02 | 1.269 |
R-HSA-376172 | DSCAM interactions | 7.274184e-02 | 1.138 |
R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors | 6.676536e-02 | 1.175 |
R-HSA-8953750 | Transcriptional Regulation by E2F6 | 5.750015e-02 | 1.240 |
R-HSA-3214841 | PKMTs methylate histone lysines | 6.360499e-02 | 1.197 |
R-HSA-114608 | Platelet degranulation | 5.438531e-02 | 1.265 |
R-HSA-3214847 | HATs acetylate histones | 5.919131e-02 | 1.228 |
R-HSA-2467813 | Separation of Sister Chromatids | 5.938631e-02 | 1.226 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 5.919131e-02 | 1.228 |
R-HSA-1226099 | Signaling by FGFR in disease | 7.132743e-02 | 1.147 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 5.169001e-02 | 1.287 |
R-HSA-8854214 | TBC/RABGAPs | 7.329653e-02 | 1.135 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 6.534461e-02 | 1.185 |
R-HSA-5673001 | RAF/MAP kinase cascade | 7.100178e-02 | 1.149 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 6.887557e-02 | 1.162 |
R-HSA-165159 | MTOR signalling | 6.999625e-02 | 1.155 |
R-HSA-9013694 | Signaling by NOTCH4 | 7.132743e-02 | 1.147 |
R-HSA-8849932 | Synaptic adhesion-like molecules | 7.083755e-02 | 1.150 |
R-HSA-5357801 | Programmed Cell Death | 6.589451e-02 | 1.181 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 7.700347e-02 | 1.113 |
R-HSA-9607240 | FLT3 Signaling | 6.360499e-02 | 1.197 |
R-HSA-9020591 | Interleukin-12 signaling | 7.636339e-02 | 1.117 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 7.954236e-02 | 1.099 |
R-HSA-5688426 | Deubiquitination | 7.955926e-02 | 1.099 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 8.092815e-02 | 1.092 |
R-HSA-416482 | G alpha (12/13) signalling events | 8.157337e-02 | 1.088 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 8.157337e-02 | 1.088 |
R-HSA-9934037 | Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | 8.170264e-02 | 1.088 |
R-HSA-72165 | mRNA Splicing - Minor Pathway | 8.360202e-02 | 1.078 |
R-HSA-6802946 | Signaling by moderate kinase activity BRAF mutants | 8.360202e-02 | 1.078 |
R-HSA-6802955 | Paradoxical activation of RAF signaling by kinase inactive BRAF | 8.360202e-02 | 1.078 |
R-HSA-9649948 | Signaling downstream of RAS mutants | 8.360202e-02 | 1.078 |
R-HSA-6802949 | Signaling by RAS mutants | 8.360202e-02 | 1.078 |
R-HSA-75153 | Apoptotic execution phase | 8.360202e-02 | 1.078 |
R-HSA-179409 | APC-Cdc20 mediated degradation of Nek2A | 8.731523e-02 | 1.059 |
R-HSA-5357786 | TNFR1-induced proapoptotic signaling | 8.731523e-02 | 1.059 |
R-HSA-140837 | Intrinsic Pathway of Fibrin Clot Formation | 8.731523e-02 | 1.059 |
R-HSA-9013695 | NOTCH4 Intracellular Domain Regulates Transcription | 8.731523e-02 | 1.059 |
R-HSA-8853336 | Signaling by plasma membrane FGFR1 fusions | 9.008765e-02 | 1.045 |
R-HSA-438066 | Unblocking of NMDA receptors, glutamate binding and activation | 9.303940e-02 | 1.031 |
R-HSA-442982 | Ras activation upon Ca2+ influx through NMDA receptor | 9.303940e-02 | 1.031 |
R-HSA-9938206 | Developmental Lineage of Mammary Stem Cells | 9.886903e-02 | 1.005 |
R-HSA-5654688 | SHC-mediated cascade:FGFR1 | 1.108212e-01 | 0.955 |
R-HSA-5654693 | FRS-mediated FGFR1 signaling | 1.169325e-01 | 0.932 |
R-HSA-72187 | mRNA 3'-end processing | 1.059225e-01 | 0.975 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 9.250337e-02 | 1.034 |
R-HSA-5654689 | PI-3K cascade:FGFR1 | 9.886903e-02 | 1.005 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 1.070869e-01 | 0.970 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 8.970813e-02 | 1.047 |
R-HSA-5626978 | TNFR1-mediated ceramide production | 1.071100e-01 | 0.970 |
R-HSA-109704 | PI3K Cascade | 9.824104e-02 | 1.008 |
R-HSA-432722 | Golgi Associated Vesicle Biogenesis | 1.098492e-01 | 0.959 |
R-HSA-5693538 | Homology Directed Repair | 1.069233e-01 | 0.971 |
R-HSA-6802957 | Oncogenic MAPK signaling | 1.011339e-01 | 0.995 |
R-HSA-9620244 | Long-term potentiation | 1.169325e-01 | 0.932 |
R-HSA-212165 | Epigenetic regulation of gene expression | 1.181915e-01 | 0.927 |
R-HSA-6794362 | Protein-protein interactions at synapses | 1.011339e-01 | 0.995 |
R-HSA-9612973 | Autophagy | 1.141939e-01 | 0.942 |
R-HSA-400685 | Sema4D in semaphorin signaling | 1.169325e-01 | 0.932 |
R-HSA-9617324 | Negative regulation of NMDA receptor-mediated neuronal transmission | 9.303940e-02 | 1.031 |
R-HSA-8939211 | ESR-mediated signaling | 1.166549e-01 | 0.933 |
R-HSA-9634638 | Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 1.047982e-01 | 0.980 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 1.032396e-01 | 0.986 |
R-HSA-69278 | Cell Cycle, Mitotic | 9.303086e-02 | 1.031 |
R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs | 1.040908e-01 | 0.983 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 9.526595e-02 | 1.021 |
R-HSA-9634815 | Transcriptional Regulation by NPAS4 | 1.059225e-01 | 0.975 |
R-HSA-447115 | Interleukin-12 family signaling | 1.101217e-01 | 0.958 |
R-HSA-6782210 | Gap-filling DNA repair synthesis and ligation in TC-NER | 1.219563e-01 | 0.914 |
R-HSA-193648 | NRAGE signals death through JNK | 1.219563e-01 | 0.914 |
R-HSA-5689901 | Metalloprotease DUBs | 1.231267e-01 | 0.910 |
R-HSA-190374 | FGFR1c and Klotho ligand binding and activation | 1.238150e-01 | 0.907 |
R-HSA-110381 | Resolution of AP sites via the single-nucleotide replacement pathway | 1.238150e-01 | 0.907 |
R-HSA-165158 | Activation of AKT2 | 1.238150e-01 | 0.907 |
R-HSA-426496 | Post-transcriptional silencing by small RNAs | 1.238150e-01 | 0.907 |
R-HSA-9636569 | Suppression of autophagy | 1.238150e-01 | 0.907 |
R-HSA-68689 | CDC6 association with the ORC:origin complex | 1.402084e-01 | 0.853 |
R-HSA-9652817 | Signaling by MAPK mutants | 1.402084e-01 | 0.853 |
R-HSA-113507 | E2F-enabled inhibition of pre-replication complex formation | 1.562961e-01 | 0.806 |
R-HSA-428890 | Role of ABL in ROBO-SLIT signaling | 1.720838e-01 | 0.764 |
R-HSA-190370 | FGFR1b ligand binding and activation | 1.875770e-01 | 0.727 |
R-HSA-9768778 | Regulation of NPAS4 mRNA translation | 1.875770e-01 | 0.727 |
R-HSA-164843 | 2-LTR circle formation | 2.177018e-01 | 0.662 |
R-HSA-390450 | Folding of actin by CCT/TriC | 2.177018e-01 | 0.662 |
R-HSA-9759811 | Regulation of CDH11 mRNA translation by microRNAs | 2.323440e-01 | 0.634 |
R-HSA-418885 | DCC mediated attractive signaling | 3.015577e-01 | 0.521 |
R-HSA-8948700 | Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 3.015577e-01 | 0.521 |
R-HSA-9673767 | Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 3.015577e-01 | 0.521 |
R-HSA-9673770 | Signaling by PDGFRA extracellular domain mutants | 3.015577e-01 | 0.521 |
R-HSA-2173791 | TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 3.015577e-01 | 0.521 |
R-HSA-8964315 | G beta:gamma signalling through BTK | 3.015577e-01 | 0.521 |
R-HSA-390522 | Striated Muscle Contraction | 1.750723e-01 | 0.757 |
R-HSA-354194 | GRB2:SOS provides linkage to MAPK signaling for Integrins | 3.146352e-01 | 0.502 |
R-HSA-77595 | Processing of Intronless Pre-mRNAs | 3.274687e-01 | 0.485 |
R-HSA-141430 | Inactivation of APC/C via direct inhibition of the APC/C complex | 3.274687e-01 | 0.485 |
R-HSA-372708 | p130Cas linkage to MAPK signaling for integrins | 3.400626e-01 | 0.468 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 2.159121e-01 | 0.666 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 2.228091e-01 | 0.652 |
R-HSA-167242 | Abortive elongation of HIV-1 transcript in the absence of Tat | 3.645496e-01 | 0.438 |
R-HSA-9709603 | Impaired BRCA2 binding to PALB2 | 3.645496e-01 | 0.438 |
R-HSA-9909620 | Regulation of PD-L1(CD274) translation | 3.764513e-01 | 0.424 |
R-HSA-9701193 | Defective homologous recombination repair (HRR) due to PALB2 loss of function | 3.764513e-01 | 0.424 |
R-HSA-9701192 | Defective homologous recombination repair (HRR) due to BRCA1 loss of function | 3.764513e-01 | 0.424 |
R-HSA-9704331 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 3.764513e-01 | 0.424 |
R-HSA-9704646 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 3.764513e-01 | 0.424 |
R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere | 2.644467e-01 | 0.578 |
R-HSA-774815 | Nucleosome assembly | 2.644467e-01 | 0.578 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 1.982049e-01 | 0.703 |
R-HSA-8957275 | Post-translational protein phosphorylation | 1.528501e-01 | 0.816 |
R-HSA-112382 | Formation of RNA Pol II elongation complex | 3.130177e-01 | 0.504 |
R-HSA-75955 | RNA Polymerase II Transcription Elongation | 3.199131e-01 | 0.495 |
R-HSA-179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of th... | 3.199131e-01 | 0.495 |
R-HSA-6782135 | Dual incision in TC-NER | 3.541044e-01 | 0.451 |
R-HSA-191859 | snRNP Assembly | 3.608740e-01 | 0.443 |
R-HSA-194441 | Metabolism of non-coding RNA | 3.608740e-01 | 0.443 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 3.676173e-01 | 0.435 |
R-HSA-5654687 | Downstream signaling of activated FGFR1 | 1.885591e-01 | 0.725 |
R-HSA-5620916 | VxPx cargo-targeting to cilium | 3.764513e-01 | 0.424 |
R-HSA-6781827 | Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 2.078396e-01 | 0.682 |
R-HSA-354192 | Integrin signaling | 1.683893e-01 | 0.774 |
R-HSA-9843970 | Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | 1.817968e-01 | 0.740 |
R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | 1.609027e-01 | 0.793 |
R-HSA-76009 | Platelet Aggregation (Plug Formation) | 2.644467e-01 | 0.578 |
R-HSA-418886 | Netrin mediated repulsion signals | 1.720838e-01 | 0.764 |
R-HSA-6781823 | Formation of TC-NER Pre-Incision Complex | 2.714030e-01 | 0.566 |
R-HSA-5654736 | Signaling by FGFR1 | 3.404918e-01 | 0.468 |
R-HSA-190373 | FGFR1c ligand binding and activation | 2.746518e-01 | 0.561 |
R-HSA-9764562 | Regulation of CDH1 mRNA translation by microRNAs | 2.882315e-01 | 0.540 |
R-HSA-141405 | Inhibition of the proteolytic activity of APC/C required for the onset of anapha... | 3.274687e-01 | 0.485 |
R-HSA-73762 | RNA Polymerase I Transcription Initiation | 2.435905e-01 | 0.613 |
R-HSA-9927418 | Developmental Lineage of Mammary Gland Luminal Epithelial Cells | 2.435905e-01 | 0.613 |
R-HSA-9613829 | Chaperone Mediated Autophagy | 3.524215e-01 | 0.453 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 2.163249e-01 | 0.665 |
R-HSA-8937144 | Aryl hydrocarbon receptor signalling | 1.402084e-01 | 0.853 |
R-HSA-428542 | Regulation of commissural axon pathfinding by SLIT and ROBO | 2.027812e-01 | 0.693 |
R-HSA-6794361 | Neurexins and neuroligins | 3.130177e-01 | 0.504 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 1.905809e-01 | 0.720 |
R-HSA-4791275 | Signaling by WNT in cancer | 1.617518e-01 | 0.791 |
R-HSA-5649702 | APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement P... | 2.027812e-01 | 0.693 |
R-HSA-176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | 3.336519e-01 | 0.477 |
R-HSA-9842860 | Regulation of endogenous retroelements | 1.671025e-01 | 0.777 |
R-HSA-165160 | PDE3B signalling | 1.402084e-01 | 0.853 |
R-HSA-109703 | PKB-mediated events | 1.402084e-01 | 0.853 |
R-HSA-193634 | Axonal growth inhibition (RHOA activation) | 1.875770e-01 | 0.727 |
R-HSA-418889 | Caspase activation via Dependence Receptors in the absence of ligand | 2.027812e-01 | 0.693 |
R-HSA-209560 | NF-kB is activated and signals survival | 2.467130e-01 | 0.608 |
R-HSA-9634285 | Constitutive Signaling by Overexpressed ERBB2 | 2.608140e-01 | 0.584 |
R-HSA-418890 | Role of second messengers in netrin-1 signaling | 2.608140e-01 | 0.584 |
R-HSA-5205685 | PINK1-PRKN Mediated Mitophagy | 1.357430e-01 | 0.867 |
R-HSA-1855191 | Synthesis of IPs in the nucleus | 2.882315e-01 | 0.540 |
R-HSA-73856 | RNA Polymerase II Transcription Termination | 1.431439e-01 | 0.844 |
R-HSA-181429 | Serotonin Neurotransmitter Release Cycle | 3.524215e-01 | 0.453 |
R-HSA-8851708 | Signaling by FGFR2 IIIa TM | 3.645496e-01 | 0.438 |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | 1.357302e-01 | 0.867 |
R-HSA-9766229 | Degradation of CDH1 | 2.922499e-01 | 0.534 |
R-HSA-381426 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-l... | 2.202679e-01 | 0.657 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 3.743327e-01 | 0.427 |
R-HSA-6807070 | PTEN Regulation | 3.403953e-01 | 0.468 |
R-HSA-176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 3.404918e-01 | 0.468 |
R-HSA-193639 | p75NTR signals via NF-kB | 3.015577e-01 | 0.521 |
R-HSA-5696398 | Nucleotide Excision Repair | 1.818059e-01 | 0.740 |
R-HSA-209543 | p75NTR recruits signalling complexes | 2.608140e-01 | 0.584 |
R-HSA-112399 | IRS-mediated signalling | 1.260966e-01 | 0.899 |
R-HSA-1679131 | Trafficking and processing of endosomal TLR | 2.608140e-01 | 0.584 |
R-HSA-9734779 | Developmental Cell Lineages of the Integumentary System | 1.931048e-01 | 0.714 |
R-HSA-139915 | Activation of PUMA and translocation to mitochondria | 1.720838e-01 | 0.764 |
R-HSA-193697 | p75NTR regulates axonogenesis | 2.027812e-01 | 0.693 |
R-HSA-2029482 | Regulation of actin dynamics for phagocytic cup formation | 1.810135e-01 | 0.742 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 1.345258e-01 | 0.871 |
R-HSA-9828211 | Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | 1.875770e-01 | 0.727 |
R-HSA-416550 | Sema4D mediated inhibition of cell attachment and migration | 2.467130e-01 | 0.608 |
R-HSA-9824878 | Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | 2.467130e-01 | 0.608 |
R-HSA-451326 | Activation of kainate receptors upon glutamate binding | 1.357430e-01 | 0.867 |
R-HSA-9754706 | Atorvastatin ADME | 3.146352e-01 | 0.502 |
R-HSA-2428928 | IRS-related events triggered by IGF1R | 1.431439e-01 | 0.844 |
R-HSA-9604323 | Negative regulation of NOTCH4 signaling | 2.228091e-01 | 0.652 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 3.696707e-01 | 0.432 |
R-HSA-2559585 | Oncogene Induced Senescence | 1.885591e-01 | 0.725 |
R-HSA-1632852 | Macroautophagy | 1.810135e-01 | 0.742 |
R-HSA-9664873 | Pexophagy | 2.177018e-01 | 0.662 |
R-HSA-5693606 | DNA Double Strand Break Response | 1.700214e-01 | 0.769 |
R-HSA-8934903 | Receptor Mediated Mitophagy | 2.177018e-01 | 0.662 |
R-HSA-4641262 | Disassembly of the destruction complex and recruitment of AXIN to the membrane | 1.293985e-01 | 0.888 |
R-HSA-205043 | NRIF signals cell death from the nucleus | 2.882315e-01 | 0.540 |
R-HSA-442742 | CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 1.683893e-01 | 0.774 |
R-HSA-5602358 | Diseases associated with the TLR signaling cascade | 2.228091e-01 | 0.652 |
R-HSA-5260271 | Diseases of Immune System | 2.228091e-01 | 0.652 |
R-HSA-416572 | Sema4D induced cell migration and growth-cone collapse | 3.764513e-01 | 0.424 |
R-HSA-3928664 | Ephrin signaling | 3.524215e-01 | 0.453 |
R-HSA-9856532 | Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | 3.645496e-01 | 0.438 |
R-HSA-5654726 | Negative regulation of FGFR1 signaling | 1.683893e-01 | 0.774 |
R-HSA-9665348 | Signaling by ERBB2 ECD mutants | 3.524215e-01 | 0.453 |
R-HSA-190236 | Signaling by FGFR | 3.390035e-01 | 0.470 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 3.446437e-01 | 0.463 |
R-HSA-9664407 | Parasite infection | 3.446437e-01 | 0.463 |
R-HSA-9664417 | Leishmania phagocytosis | 3.446437e-01 | 0.463 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 3.594691e-01 | 0.444 |
R-HSA-8849469 | PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | 1.875770e-01 | 0.727 |
R-HSA-176974 | Unwinding of DNA | 2.027812e-01 | 0.693 |
R-HSA-9820962 | Assembly and release of respiratory syncytial virus (RSV) virions | 2.177018e-01 | 0.662 |
R-HSA-428540 | Activation of RAC1 | 2.467130e-01 | 0.608 |
R-HSA-5685939 | HDR through MMEJ (alt-NHEJ) | 2.746518e-01 | 0.561 |
R-HSA-399719 | Trafficking of AMPA receptors | 1.551642e-01 | 0.809 |
R-HSA-163615 | PKA activation | 3.524215e-01 | 0.453 |
R-HSA-113510 | E2F mediated regulation of DNA replication | 3.645496e-01 | 0.438 |
R-HSA-69473 | G2/M DNA damage checkpoint | 2.030088e-01 | 0.692 |
R-HSA-9663891 | Selective autophagy | 2.776125e-01 | 0.557 |
R-HSA-73894 | DNA Repair | 1.852261e-01 | 0.732 |
R-HSA-2428924 | IGF1R signaling cascade | 1.564011e-01 | 0.806 |
R-HSA-376176 | Signaling by ROBO receptors | 1.300771e-01 | 0.886 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 3.541044e-01 | 0.451 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 3.594691e-01 | 0.444 |
R-HSA-176187 | Activation of ATR in response to replication stress | 1.683893e-01 | 0.774 |
R-HSA-5635838 | Activation of SMO | 3.146352e-01 | 0.502 |
R-HSA-844456 | The NLRP3 inflammasome | 3.645496e-01 | 0.438 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 1.505251e-01 | 0.822 |
R-HSA-162592 | Integration of provirus | 2.467130e-01 | 0.608 |
R-HSA-437239 | Recycling pathway of L1 | 2.783571e-01 | 0.555 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 3.014910e-01 | 0.521 |
R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 1.609027e-01 | 0.793 |
R-HSA-199992 | trans-Golgi Network Vesicle Budding | 1.934292e-01 | 0.713 |
R-HSA-5653656 | Vesicle-mediated transport | 1.583115e-01 | 0.800 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 3.212181e-01 | 0.493 |
R-HSA-69481 | G2/M Checkpoints | 1.333759e-01 | 0.875 |
R-HSA-5628897 | TP53 Regulates Metabolic Genes | 2.242302e-01 | 0.649 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 1.864374e-01 | 0.729 |
R-HSA-9758919 | Epithelial-Mesenchymal Transition (EMT) during gastrulation | 1.402084e-01 | 0.853 |
R-HSA-164944 | Nef and signal transduction | 1.562961e-01 | 0.806 |
R-HSA-5336415 | Uptake and function of diphtheria toxin | 1.720838e-01 | 0.764 |
R-HSA-9834752 | Respiratory syncytial virus genome replication | 2.027812e-01 | 0.693 |
R-HSA-3270619 | IRF3-mediated induction of type I IFN | 3.015577e-01 | 0.521 |
R-HSA-450604 | KSRP (KHSRP) binds and destabilizes mRNA | 3.146352e-01 | 0.502 |
R-HSA-190828 | Gap junction trafficking | 2.574909e-01 | 0.589 |
R-HSA-397014 | Muscle contraction | 1.524156e-01 | 0.817 |
R-HSA-9768759 | Regulation of NPAS4 gene expression | 3.400626e-01 | 0.468 |
R-HSA-9018519 | Estrogen-dependent gene expression | 1.654873e-01 | 0.781 |
R-HSA-5675221 | Negative regulation of MAPK pathway | 2.366513e-01 | 0.626 |
R-HSA-389359 | CD28 dependent Vav1 pathway | 2.746518e-01 | 0.561 |
R-HSA-450385 | Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 3.015577e-01 | 0.521 |
R-HSA-388844 | Receptor-type tyrosine-protein phosphatases | 3.146352e-01 | 0.502 |
R-HSA-157858 | Gap junction trafficking and regulation | 2.922499e-01 | 0.534 |
R-HSA-68886 | M Phase | 2.340064e-01 | 0.631 |
R-HSA-9856530 | High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR... | 2.323545e-01 | 0.634 |
R-HSA-74751 | Insulin receptor signalling cascade | 1.564011e-01 | 0.806 |
R-HSA-913531 | Interferon Signaling | 2.362316e-01 | 0.627 |
R-HSA-5689880 | Ub-specific processing proteases | 2.978492e-01 | 0.526 |
R-HSA-9033500 | TYSND1 cleaves peroxisomal proteins | 1.402084e-01 | 0.853 |
R-HSA-9027307 | Biosynthesis of maresin-like SPMs | 3.274687e-01 | 0.485 |
R-HSA-177929 | Signaling by EGFR | 3.404918e-01 | 0.468 |
R-HSA-3214858 | RMTs methylate histone arginines | 2.574909e-01 | 0.589 |
R-HSA-9013973 | TICAM1-dependent activation of IRF3/IRF7 | 2.467130e-01 | 0.608 |
R-HSA-936964 | Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | 3.274687e-01 | 0.485 |
R-HSA-9009391 | Extra-nuclear estrogen signaling | 3.543593e-01 | 0.451 |
R-HSA-9734009 | Defective Intrinsic Pathway for Apoptosis | 1.293985e-01 | 0.888 |
R-HSA-399955 | SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 3.146352e-01 | 0.502 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 3.404918e-01 | 0.468 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 2.352487e-01 | 0.628 |
R-HSA-202433 | Generation of second messenger molecules | 2.228091e-01 | 0.652 |
R-HSA-74752 | Signaling by Insulin receptor | 3.031313e-01 | 0.518 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 3.051399e-01 | 0.516 |
R-HSA-157118 | Signaling by NOTCH | 3.678363e-01 | 0.434 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 1.853187e-01 | 0.732 |
R-HSA-430116 | GP1b-IX-V activation signalling | 2.027812e-01 | 0.693 |
R-HSA-399721 | Glutamate binding, activation of AMPA receptors and synaptic plasticity | 1.683893e-01 | 0.774 |
R-HSA-432142 | Platelet sensitization by LDL | 3.524215e-01 | 0.453 |
R-HSA-3928665 | EPH-ephrin mediated repulsion of cells | 2.783571e-01 | 0.555 |
R-HSA-1660661 | Sphingolipid de novo biosynthesis | 3.676173e-01 | 0.435 |
R-HSA-168898 | Toll-like Receptor Cascades | 3.641752e-01 | 0.439 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 3.573944e-01 | 0.447 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 1.915379e-01 | 0.718 |
R-HSA-9860931 | Response of endothelial cells to shear stress | 3.696707e-01 | 0.432 |
R-HSA-180292 | GAB1 signalosome | 3.524215e-01 | 0.453 |
R-HSA-445144 | Signal transduction by L1 | 3.764513e-01 | 0.424 |
R-HSA-2682334 | EPH-Ephrin signaling | 3.031313e-01 | 0.518 |
R-HSA-210745 | Regulation of gene expression in beta cells | 1.421552e-01 | 0.847 |
R-HSA-9706369 | Negative regulation of FLT3 | 3.146352e-01 | 0.502 |
R-HSA-6804760 | Regulation of TP53 Activity through Methylation | 3.524215e-01 | 0.453 |
R-HSA-140877 | Formation of Fibrin Clot (Clotting Cascade) | 1.953553e-01 | 0.709 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 3.319043e-01 | 0.479 |
R-HSA-8948751 | Regulation of PTEN stability and activity | 3.199131e-01 | 0.495 |
R-HSA-111471 | Apoptotic factor-mediated response | 3.524215e-01 | 0.453 |
R-HSA-9764725 | Negative Regulation of CDH1 Gene Transcription | 3.676173e-01 | 0.435 |
R-HSA-8983711 | OAS antiviral response | 2.608140e-01 | 0.584 |
R-HSA-68882 | Mitotic Anaphase | 1.618228e-01 | 0.791 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 1.642149e-01 | 0.785 |
R-HSA-1251985 | Nuclear signaling by ERBB4 | 2.228091e-01 | 0.652 |
R-HSA-9768919 | NPAS4 regulates expression of target genes | 1.817968e-01 | 0.740 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 1.617518e-01 | 0.791 |
R-HSA-1834941 | STING mediated induction of host immune responses | 3.645496e-01 | 0.438 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 1.366782e-01 | 0.864 |
R-HSA-3928662 | EPHB-mediated forward signaling | 2.574909e-01 | 0.589 |
R-HSA-186712 | Regulation of beta-cell development | 3.608740e-01 | 0.443 |
R-HSA-1474244 | Extracellular matrix organization | 2.217889e-01 | 0.654 |
R-HSA-69615 | G1/S DNA Damage Checkpoints | 3.876751e-01 | 0.412 |
R-HSA-8848021 | Signaling by PTK6 | 3.876751e-01 | 0.412 |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | 3.876751e-01 | 0.412 |
R-HSA-2426168 | Activation of gene expression by SREBF (SREBP) | 3.876751e-01 | 0.412 |
R-HSA-5602498 | MyD88 deficiency (TLR2/4) | 3.881309e-01 | 0.411 |
R-HSA-264642 | Acetylcholine Neurotransmitter Release Cycle | 3.881309e-01 | 0.411 |
R-HSA-9824594 | Regulation of MITF-M-dependent genes involved in apoptosis | 3.881309e-01 | 0.411 |
R-HSA-111931 | PKA-mediated phosphorylation of CREB | 3.881309e-01 | 0.411 |
R-HSA-162594 | Early Phase of HIV Life Cycle | 3.881309e-01 | 0.411 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 3.899803e-01 | 0.409 |
R-HSA-9700206 | Signaling by ALK in cancer | 3.899803e-01 | 0.409 |
R-HSA-195721 | Signaling by WNT | 3.942359e-01 | 0.404 |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signali... | 3.942995e-01 | 0.404 |
R-HSA-5603041 | IRAK4 deficiency (TLR2/4) | 3.995924e-01 | 0.398 |
R-HSA-9671555 | Signaling by PDGFR in disease | 3.995924e-01 | 0.398 |
R-HSA-76066 | RNA Polymerase III Transcription Initiation From Type 2 Promoter | 3.995924e-01 | 0.398 |
R-HSA-5696397 | Gap-filling DNA repair synthesis and ligation in GG-NER | 3.995924e-01 | 0.398 |
R-HSA-977347 | Serine metabolism | 3.995924e-01 | 0.398 |
R-HSA-446652 | Interleukin-1 family signaling | 3.998047e-01 | 0.398 |
R-HSA-202403 | TCR signaling | 4.051075e-01 | 0.392 |
R-HSA-6803529 | FGFR2 alternative splicing | 4.108399e-01 | 0.386 |
R-HSA-912694 | Regulation of IFNA/IFNB signaling | 4.108399e-01 | 0.386 |
R-HSA-76071 | RNA Polymerase III Transcription Initiation From Type 3 Promoter | 4.108399e-01 | 0.386 |
R-HSA-76061 | RNA Polymerase III Transcription Initiation From Type 1 Promoter | 4.108399e-01 | 0.386 |
R-HSA-212676 | Dopamine Neurotransmitter Release Cycle | 4.108399e-01 | 0.386 |
R-HSA-112409 | RAF-independent MAPK1/3 activation | 4.108399e-01 | 0.386 |
R-HSA-6803205 | TP53 regulates transcription of several additional cell death genes whose specif... | 4.108399e-01 | 0.386 |
R-HSA-6804115 | TP53 regulates transcription of additional cell cycle genes whose exact role in ... | 4.108399e-01 | 0.386 |
R-HSA-9013507 | NOTCH3 Activation and Transmission of Signal to the Nucleus | 4.108399e-01 | 0.386 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 4.204596e-01 | 0.376 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 4.204596e-01 | 0.376 |
R-HSA-8943723 | Regulation of PTEN mRNA translation | 4.218773e-01 | 0.375 |
R-HSA-77075 | RNA Pol II CTD phosphorylation and interaction with CE | 4.218773e-01 | 0.375 |
R-HSA-167160 | RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 4.218773e-01 | 0.375 |
R-HSA-389957 | Prefoldin mediated transfer of substrate to CCT/TriC | 4.218773e-01 | 0.375 |
R-HSA-9937008 | Mitochondrial mRNA modification | 4.218773e-01 | 0.375 |
R-HSA-1369062 | ABC transporters in lipid homeostasis | 4.218773e-01 | 0.375 |
R-HSA-9018682 | Biosynthesis of maresins | 4.218773e-01 | 0.375 |
R-HSA-3000170 | Syndecan interactions | 4.218773e-01 | 0.375 |
R-HSA-164952 | The role of Nef in HIV-1 replication and disease pathogenesis | 4.218773e-01 | 0.375 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 4.251027e-01 | 0.372 |
R-HSA-74160 | Gene expression (Transcription) | 4.271455e-01 | 0.369 |
R-HSA-877300 | Interferon gamma signaling | 4.292236e-01 | 0.367 |
R-HSA-75067 | Processing of Capped Intronless Pre-mRNA | 4.327087e-01 | 0.364 |
R-HSA-181430 | Norepinephrine Neurotransmitter Release Cycle | 4.327087e-01 | 0.364 |
R-HSA-9665686 | Signaling by ERBB2 TMD/JMD mutants | 4.327087e-01 | 0.364 |
R-HSA-429947 | Deadenylation of mRNA | 4.327087e-01 | 0.364 |
R-HSA-9836573 | Mitochondrial RNA degradation | 4.327087e-01 | 0.364 |
R-HSA-8863678 | Neurodegenerative Diseases | 4.327087e-01 | 0.364 |
R-HSA-8862803 | Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's dis... | 4.327087e-01 | 0.364 |
R-HSA-5621575 | CD209 (DC-SIGN) signaling | 4.327087e-01 | 0.364 |
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | 4.333230e-01 | 0.363 |
R-HSA-9764560 | Regulation of CDH1 Gene Transcription | 4.333230e-01 | 0.363 |
R-HSA-69202 | Cyclin E associated events during G1/S transition | 4.333230e-01 | 0.363 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 4.359890e-01 | 0.361 |
R-HSA-453276 | Regulation of mitotic cell cycle | 4.396973e-01 | 0.357 |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | 4.396973e-01 | 0.357 |
R-HSA-909733 | Interferon alpha/beta signaling | 4.399464e-01 | 0.357 |
R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SD... | 4.433378e-01 | 0.353 |
R-HSA-9839394 | TGFBR3 expression | 4.433378e-01 | 0.353 |
R-HSA-420029 | Tight junction interactions | 4.433378e-01 | 0.353 |
R-HSA-1482801 | Acyl chain remodelling of PS | 4.433378e-01 | 0.353 |
R-HSA-70221 | Glycogen breakdown (glycogenolysis) | 4.433378e-01 | 0.353 |
R-HSA-389887 | Beta-oxidation of pristanoyl-CoA | 4.433378e-01 | 0.353 |
R-HSA-2160916 | Hyaluronan degradation | 4.433378e-01 | 0.353 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 4.460323e-01 | 0.351 |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | 4.460323e-01 | 0.351 |
R-HSA-449147 | Signaling by Interleukins | 4.468269e-01 | 0.350 |
R-HSA-8934593 | Regulation of RUNX1 Expression and Activity | 4.537683e-01 | 0.343 |
R-HSA-210500 | Glutamate Neurotransmitter Release Cycle | 4.537683e-01 | 0.343 |
R-HSA-5357769 | Caspase activation via extrinsic apoptotic signalling pathway | 4.537683e-01 | 0.343 |
R-HSA-3295583 | TRP channels | 4.537683e-01 | 0.343 |
R-HSA-674695 | RNA Polymerase II Pre-transcription Events | 4.585813e-01 | 0.339 |
R-HSA-1236394 | Signaling by ERBB4 | 4.585813e-01 | 0.339 |
R-HSA-9711123 | Cellular response to chemical stress | 4.609313e-01 | 0.336 |
R-HSA-167243 | Tat-mediated HIV elongation arrest and recovery | 4.640041e-01 | 0.333 |
R-HSA-167238 | Pausing and recovery of Tat-mediated HIV elongation | 4.640041e-01 | 0.333 |
R-HSA-73863 | RNA Polymerase I Transcription Termination | 4.640041e-01 | 0.333 |
R-HSA-8949613 | Cristae formation | 4.640041e-01 | 0.333 |
R-HSA-202427 | Phosphorylation of CD3 and TCR zeta chains | 4.640041e-01 | 0.333 |
R-HSA-75109 | Triglyceride biosynthesis | 4.640041e-01 | 0.333 |
R-HSA-9841251 | Mitochondrial unfolded protein response (UPRmt) | 4.640041e-01 | 0.333 |
R-HSA-264876 | Insulin processing | 4.640041e-01 | 0.333 |
R-HSA-3371556 | Cellular response to heat stress | 4.691762e-01 | 0.329 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 4.709645e-01 | 0.327 |
R-HSA-167158 | Formation of the HIV-1 Early Elongation Complex | 4.740486e-01 | 0.324 |
R-HSA-167287 | HIV elongation arrest and recovery | 4.740486e-01 | 0.324 |
R-HSA-113418 | Formation of the Early Elongation Complex | 4.740486e-01 | 0.324 |
R-HSA-167290 | Pausing and recovery of HIV elongation | 4.740486e-01 | 0.324 |
R-HSA-5576892 | Phase 0 - rapid depolarisation | 4.740486e-01 | 0.324 |
R-HSA-622312 | Inflammasomes | 4.740486e-01 | 0.324 |
R-HSA-9757110 | Prednisone ADME | 4.740486e-01 | 0.324 |
R-HSA-8951664 | Neddylation | 4.780869e-01 | 0.320 |
R-HSA-73864 | RNA Polymerase I Transcription | 4.831767e-01 | 0.316 |
R-HSA-216083 | Integrin cell surface interactions | 4.831767e-01 | 0.316 |
R-HSA-9709570 | Impaired BRCA2 binding to RAD51 | 4.839056e-01 | 0.315 |
R-HSA-72086 | mRNA Capping | 4.839056e-01 | 0.315 |
R-HSA-9664565 | Signaling by ERBB2 KD Mutants | 4.839056e-01 | 0.315 |
R-HSA-9759475 | Regulation of CDH11 Expression and Function | 4.839056e-01 | 0.315 |
R-HSA-9659379 | Sensory processing of sound | 4.892174e-01 | 0.310 |
R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) | 4.892174e-01 | 0.310 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 4.930050e-01 | 0.307 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 4.930050e-01 | 0.307 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 4.930050e-01 | 0.307 |
R-HSA-69206 | G1/S Transition | 4.930050e-01 | 0.307 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 4.935784e-01 | 0.307 |
R-HSA-68962 | Activation of the pre-replicative complex | 4.935784e-01 | 0.307 |
R-HSA-76046 | RNA Polymerase III Transcription Initiation | 4.935784e-01 | 0.307 |
R-HSA-1227990 | Signaling by ERBB2 in Cancer | 4.935784e-01 | 0.307 |
R-HSA-2424491 | DAP12 signaling | 4.935784e-01 | 0.307 |
R-HSA-380972 | Energy dependent regulation of mTOR by LKB1-AMPK | 4.935784e-01 | 0.307 |
R-HSA-1474151 | Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | 4.935784e-01 | 0.307 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 5.030705e-01 | 0.298 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 5.030705e-01 | 0.298 |
R-HSA-211733 | Regulation of activated PAK-2p34 by proteasome mediated degradation | 5.030705e-01 | 0.298 |
R-HSA-186763 | Downstream signal transduction | 5.030705e-01 | 0.298 |
R-HSA-389958 | Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 5.030705e-01 | 0.298 |
R-HSA-9820960 | Respiratory syncytial virus (RSV) attachment and entry | 5.030705e-01 | 0.298 |
R-HSA-182971 | EGFR downregulation | 5.030705e-01 | 0.298 |
R-HSA-2129379 | Molecules associated with elastic fibres | 5.030705e-01 | 0.298 |
R-HSA-9833109 | Evasion by RSV of host interferon responses | 5.030705e-01 | 0.298 |
R-HSA-936440 | Negative regulators of DDX58/IFIH1 signaling | 5.030705e-01 | 0.298 |
R-HSA-69190 | DNA strand elongation | 5.123852e-01 | 0.290 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 5.187476e-01 | 0.285 |
R-HSA-5696399 | Global Genome Nucleotide Excision Repair (GG-NER) | 5.187476e-01 | 0.285 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 5.215260e-01 | 0.283 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 5.215260e-01 | 0.283 |
R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | 5.215260e-01 | 0.283 |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | 5.215260e-01 | 0.283 |
R-HSA-9022692 | Regulation of MECP2 expression and activity | 5.215260e-01 | 0.283 |
R-HSA-9764260 | Regulation of Expression and Function of Type II Classical Cadherins | 5.215260e-01 | 0.283 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 5.215260e-01 | 0.283 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 5.245162e-01 | 0.280 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 5.304959e-01 | 0.275 |
R-HSA-5693537 | Resolution of D-Loop Structures | 5.304959e-01 | 0.275 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 5.304959e-01 | 0.275 |
R-HSA-1482788 | Acyl chain remodelling of PC | 5.304959e-01 | 0.275 |
R-HSA-5696394 | DNA Damage Recognition in GG-NER | 5.304959e-01 | 0.275 |
R-HSA-9619665 | EGR2 and SOX10-mediated initiation of Schwann cell myelination | 5.304959e-01 | 0.275 |
R-HSA-5223345 | Miscellaneous transport and binding events | 5.304959e-01 | 0.275 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 5.359133e-01 | 0.271 |
R-HSA-381038 | XBP1(S) activates chaperone genes | 5.359133e-01 | 0.271 |
R-HSA-9675136 | Diseases of DNA Double-Strand Break Repair | 5.392982e-01 | 0.268 |
R-HSA-9701190 | Defective homologous recombination repair (HRR) due to BRCA2 loss of function | 5.392982e-01 | 0.268 |
R-HSA-203615 | eNOS activation | 5.392982e-01 | 0.268 |
R-HSA-180746 | Nuclear import of Rev protein | 5.392982e-01 | 0.268 |
R-HSA-2142845 | Hyaluronan metabolism | 5.392982e-01 | 0.268 |
R-HSA-5673000 | RAF activation | 5.392982e-01 | 0.268 |
R-HSA-168638 | NOD1/2 Signaling Pathway | 5.392982e-01 | 0.268 |
R-HSA-438064 | Post NMDA receptor activation events | 5.415413e-01 | 0.266 |
R-HSA-69275 | G2/M Transition | 5.418699e-01 | 0.266 |
R-HSA-9694516 | SARS-CoV-2 Infection | 5.469127e-01 | 0.262 |
R-HSA-9645723 | Diseases of programmed cell death | 5.471219e-01 | 0.262 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 5.479360e-01 | 0.261 |
R-HSA-169911 | Regulation of Apoptosis | 5.479360e-01 | 0.261 |
R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange | 5.479360e-01 | 0.261 |
R-HSA-1482839 | Acyl chain remodelling of PE | 5.479360e-01 | 0.261 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 5.479360e-01 | 0.261 |
R-HSA-453274 | Mitotic G2-G2/M phases | 5.494951e-01 | 0.260 |
R-HSA-749476 | RNA Polymerase III Abortive And Retractive Initiation | 5.564124e-01 | 0.255 |
R-HSA-74158 | RNA Polymerase III Transcription | 5.564124e-01 | 0.255 |
R-HSA-3371511 | HSF1 activation | 5.564124e-01 | 0.255 |
R-HSA-1839126 | FGFR2 mutant receptor activation | 5.564124e-01 | 0.255 |
R-HSA-111933 | Calmodulin induced events | 5.564124e-01 | 0.255 |
R-HSA-111997 | CaM pathway | 5.564124e-01 | 0.255 |
R-HSA-109582 | Hemostasis | 5.575178e-01 | 0.254 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 5.647304e-01 | 0.248 |
R-HSA-390247 | Beta-oxidation of very long chain fatty acids | 5.647304e-01 | 0.248 |
R-HSA-5689896 | Ovarian tumor domain proteases | 5.647304e-01 | 0.248 |
R-HSA-381070 | IRE1alpha activates chaperones | 5.689673e-01 | 0.245 |
R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | 5.728929e-01 | 0.242 |
R-HSA-202131 | Metabolism of nitric oxide: NOS3 activation and regulation | 5.728929e-01 | 0.242 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 5.728929e-01 | 0.242 |
R-HSA-2046106 | alpha-linolenic acid (ALA) metabolism | 5.728929e-01 | 0.242 |
R-HSA-1566948 | Elastic fibre formation | 5.728929e-01 | 0.242 |
R-HSA-983695 | Antigen activates B Cell Receptor (BCR) leading to generation of second messenge... | 5.796017e-01 | 0.237 |
R-HSA-167200 | Formation of HIV-1 elongation complex containing HIV-1 Tat | 5.809028e-01 | 0.236 |
R-HSA-69541 | Stabilization of p53 | 5.809028e-01 | 0.236 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 5.809028e-01 | 0.236 |
R-HSA-9929356 | GSK3B-mediated proteasomal degradation of PD-L1(CD274) | 5.809028e-01 | 0.236 |
R-HSA-9820965 | Respiratory syncytial virus (RSV) genome replication, transcription and translat... | 5.809028e-01 | 0.236 |
R-HSA-167152 | Formation of HIV elongation complex in the absence of HIV Tat | 5.887630e-01 | 0.230 |
R-HSA-167169 | HIV Transcription Elongation | 5.887630e-01 | 0.230 |
R-HSA-167246 | Tat-mediated elongation of the HIV-1 transcript | 5.887630e-01 | 0.230 |
R-HSA-9843743 | Transcriptional regulation of brown and beige adipocyte differentiation | 5.887630e-01 | 0.230 |
R-HSA-9844594 | Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | 5.887630e-01 | 0.230 |
R-HSA-73779 | RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 5.887630e-01 | 0.230 |
R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 5.887630e-01 | 0.230 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 5.887630e-01 | 0.230 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 5.887630e-01 | 0.230 |
R-HSA-8941858 | Regulation of RUNX3 expression and activity | 5.887630e-01 | 0.230 |
R-HSA-3371568 | Attenuation phase | 5.887630e-01 | 0.230 |
R-HSA-8982491 | Glycogen metabolism | 5.887630e-01 | 0.230 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 5.900429e-01 | 0.229 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 5.964762e-01 | 0.224 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 5.964762e-01 | 0.224 |
R-HSA-73933 | Resolution of Abasic Sites (AP sites) | 5.964762e-01 | 0.224 |
R-HSA-5423646 | Aflatoxin activation and detoxification | 5.964762e-01 | 0.224 |
R-HSA-8853884 | Transcriptional Regulation by VENTX | 5.964762e-01 | 0.224 |
R-HSA-5676590 | NIK-->noncanonical NF-kB signaling | 5.964762e-01 | 0.224 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 5.992017e-01 | 0.222 |
R-HSA-6807878 | COPI-mediated anterograde transport | 6.002906e-01 | 0.222 |
R-HSA-167162 | RNA Polymerase II HIV Promoter Escape | 6.040452e-01 | 0.219 |
R-HSA-167161 | HIV Transcription Initiation | 6.040452e-01 | 0.219 |
R-HSA-75953 | RNA Polymerase II Transcription Initiation | 6.040452e-01 | 0.219 |
R-HSA-442660 | SLC-mediated transport of neurotransmitters | 6.040452e-01 | 0.219 |
R-HSA-1266738 | Developmental Biology | 6.060166e-01 | 0.218 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 6.073714e-01 | 0.217 |
R-HSA-69242 | S Phase | 6.073714e-01 | 0.217 |
R-HSA-111996 | Ca-dependent events | 6.114728e-01 | 0.214 |
R-HSA-192105 | Synthesis of bile acids and bile salts | 6.152994e-01 | 0.211 |
R-HSA-9614085 | FOXO-mediated transcription | 6.152994e-01 | 0.211 |
R-HSA-9679191 | Potential therapeutics for SARS | 6.154301e-01 | 0.211 |
R-HSA-73776 | RNA Polymerase II Promoter Escape | 6.187614e-01 | 0.208 |
R-HSA-9637690 | Response of Mtb to phagocytosis | 6.187614e-01 | 0.208 |
R-HSA-9734767 | Developmental Cell Lineages | 6.193718e-01 | 0.208 |
R-HSA-373752 | Netrin-1 signaling | 6.259137e-01 | 0.203 |
R-HSA-2172127 | DAP12 interactions | 6.259137e-01 | 0.203 |
R-HSA-168256 | Immune System | 6.265074e-01 | 0.203 |
R-HSA-9609507 | Protein localization | 6.273083e-01 | 0.203 |
R-HSA-73857 | RNA Polymerase II Transcription | 6.282209e-01 | 0.202 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 6.298737e-01 | 0.201 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 6.312115e-01 | 0.200 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 6.312115e-01 | 0.200 |
R-HSA-76042 | RNA Polymerase II Transcription Initiation And Promoter Clearance | 6.329323e-01 | 0.199 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 6.329323e-01 | 0.199 |
R-HSA-69613 | p53-Independent G1/S DNA Damage Checkpoint | 6.329323e-01 | 0.199 |
R-HSA-69601 | Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | 6.329323e-01 | 0.199 |
R-HSA-5607761 | Dectin-1 mediated noncanonical NF-kB signaling | 6.329323e-01 | 0.199 |
R-HSA-1489509 | DAG and IP3 signaling | 6.329323e-01 | 0.199 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 6.350863e-01 | 0.197 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 6.387780e-01 | 0.195 |
R-HSA-9675135 | Diseases of DNA repair | 6.398197e-01 | 0.194 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 6.398197e-01 | 0.194 |
R-HSA-9839373 | Signaling by TGFBR3 | 6.398197e-01 | 0.194 |
R-HSA-9660826 | Purinergic signaling in leishmaniasis infection | 6.398197e-01 | 0.194 |
R-HSA-9664424 | Cell recruitment (pro-inflammatory response) | 6.398197e-01 | 0.194 |
R-HSA-162587 | HIV Life Cycle | 6.427511e-01 | 0.192 |
R-HSA-9833110 | RSV-host interactions | 6.440158e-01 | 0.191 |
R-HSA-6811440 | Retrograde transport at the Trans-Golgi-Network | 6.465782e-01 | 0.189 |
R-HSA-2046104 | alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 6.465782e-01 | 0.189 |
R-HSA-211000 | Gene Silencing by RNA | 6.577289e-01 | 0.182 |
R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | 6.597184e-01 | 0.181 |
R-HSA-69563 | p53-Dependent G1 DNA Damage Response | 6.597184e-01 | 0.181 |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | 6.597184e-01 | 0.181 |
R-HSA-2672351 | Stimuli-sensing channels | 6.622053e-01 | 0.179 |
R-HSA-5655253 | Signaling by FGFR2 in disease | 6.661047e-01 | 0.176 |
R-HSA-194068 | Bile acid and bile salt metabolism | 6.710172e-01 | 0.173 |
R-HSA-3371571 | HSF1-dependent transactivation | 6.723716e-01 | 0.172 |
R-HSA-912446 | Meiotic recombination | 6.723716e-01 | 0.172 |
R-HSA-9658195 | Leishmania infection | 6.725407e-01 | 0.172 |
R-HSA-9824443 | Parasitic Infection Pathways | 6.725407e-01 | 0.172 |
R-HSA-174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 6.785212e-01 | 0.168 |
R-HSA-73772 | RNA Polymerase I Promoter Escape | 6.785212e-01 | 0.168 |
R-HSA-68949 | Orc1 removal from chromatin | 6.785212e-01 | 0.168 |
R-HSA-5339562 | Uptake and actions of bacterial toxins | 6.785212e-01 | 0.168 |
R-HSA-1483249 | Inositol phosphate metabolism | 6.796426e-01 | 0.168 |
R-HSA-1221632 | Meiotic synapsis | 6.845558e-01 | 0.165 |
R-HSA-162906 | HIV Infection | 6.865016e-01 | 0.163 |
R-HSA-9754678 | SARS-CoV-2 modulates host translation machinery | 6.904774e-01 | 0.161 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 6.932144e-01 | 0.159 |
R-HSA-9012852 | Signaling by NOTCH3 | 6.962883e-01 | 0.157 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 6.999680e-01 | 0.155 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 7.075858e-01 | 0.150 |
R-HSA-1483166 | Synthesis of PA | 7.075858e-01 | 0.150 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 7.075858e-01 | 0.150 |
R-HSA-9029569 | NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflu... | 7.130764e-01 | 0.147 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 7.161957e-01 | 0.145 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 7.161957e-01 | 0.145 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 7.161957e-01 | 0.145 |
R-HSA-9033241 | Peroxisomal protein import | 7.184643e-01 | 0.144 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 7.184643e-01 | 0.144 |
R-HSA-8979227 | Triglyceride metabolism | 7.184643e-01 | 0.144 |
R-HSA-352230 | Amino acid transport across the plasma membrane | 7.184643e-01 | 0.144 |
R-HSA-168255 | Influenza Infection | 7.227181e-01 | 0.141 |
R-HSA-8943724 | Regulation of PTEN gene transcription | 7.237514e-01 | 0.140 |
R-HSA-73886 | Chromosome Maintenance | 7.238281e-01 | 0.140 |
R-HSA-9759194 | Nuclear events mediated by NFE2L2 | 7.238281e-01 | 0.140 |
R-HSA-2559583 | Cellular Senescence | 7.258562e-01 | 0.139 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 7.275791e-01 | 0.138 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 7.275791e-01 | 0.138 |
R-HSA-9793380 | Formation of paraxial mesoderm | 7.289395e-01 | 0.137 |
R-HSA-112043 | PLC beta mediated events | 7.289395e-01 | 0.137 |
R-HSA-2132295 | MHC class II antigen presentation | 7.312869e-01 | 0.136 |
R-HSA-186797 | Signaling by PDGF | 7.340305e-01 | 0.134 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 7.340305e-01 | 0.134 |
R-HSA-176408 | Regulation of APC/C activators between G1/S and early anaphase | 7.340305e-01 | 0.134 |
R-HSA-6784531 | tRNA processing in the nucleus | 7.340305e-01 | 0.134 |
R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | 7.340305e-01 | 0.134 |
R-HSA-375165 | NCAM signaling for neurite out-growth | 7.340305e-01 | 0.134 |
R-HSA-162909 | Host Interactions of HIV factors | 7.349519e-01 | 0.134 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 7.390261e-01 | 0.131 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 7.390261e-01 | 0.131 |
R-HSA-6790901 | rRNA modification in the nucleus and cytosol | 7.390261e-01 | 0.131 |
R-HSA-211981 | Xenobiotics | 7.439283e-01 | 0.128 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 7.499710e-01 | 0.125 |
R-HSA-8854518 | AURKA Activation by TPX2 | 7.534589e-01 | 0.123 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 7.534589e-01 | 0.123 |
R-HSA-6782315 | tRNA modification in the nucleus and cytosol | 7.534589e-01 | 0.123 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 7.580908e-01 | 0.120 |
R-HSA-193368 | Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 7.580908e-01 | 0.120 |
R-HSA-9958863 | SLC-mediated transport of amino acids | 7.580908e-01 | 0.120 |
R-HSA-112040 | G-protein mediated events | 7.580908e-01 | 0.120 |
R-HSA-167172 | Transcription of the HIV genome | 7.626359e-01 | 0.118 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 7.626359e-01 | 0.118 |
R-HSA-9925563 | Developmental Lineage of Pancreatic Ductal Cells | 7.670960e-01 | 0.115 |
R-HSA-1474228 | Degradation of the extracellular matrix | 7.693145e-01 | 0.114 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 7.714725e-01 | 0.113 |
R-HSA-5620920 | Cargo trafficking to the periciliary membrane | 7.757670e-01 | 0.110 |
R-HSA-3000178 | ECM proteoglycans | 7.757670e-01 | 0.110 |
R-HSA-427413 | NoRC negatively regulates rRNA expression | 7.757670e-01 | 0.110 |
R-HSA-5632684 | Hedgehog 'on' state | 7.757670e-01 | 0.110 |
R-HSA-8978934 | Metabolism of cofactors | 7.757670e-01 | 0.110 |
R-HSA-112315 | Transmission across Chemical Synapses | 7.765589e-01 | 0.110 |
R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | 7.799811e-01 | 0.108 |
R-HSA-499943 | Interconversion of nucleotide di- and triphosphates | 7.799811e-01 | 0.108 |
R-HSA-389948 | Co-inhibition by PD-1 | 7.829305e-01 | 0.106 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 7.841162e-01 | 0.106 |
R-HSA-69052 | Switching of origins to a post-replicative state | 7.841162e-01 | 0.106 |
R-HSA-9749641 | Aspirin ADME | 7.841162e-01 | 0.106 |
R-HSA-4086398 | Ca2+ pathway | 7.841162e-01 | 0.106 |
R-HSA-380287 | Centrosome maturation | 7.921555e-01 | 0.101 |
R-HSA-1169408 | ISG15 antiviral mechanism | 7.921555e-01 | 0.101 |
R-HSA-381119 | Unfolded Protein Response (UPR) | 7.939556e-01 | 0.100 |
R-HSA-5689603 | UCH proteinases | 7.960626e-01 | 0.099 |
R-HSA-1980143 | Signaling by NOTCH1 | 7.960626e-01 | 0.099 |
R-HSA-1280218 | Adaptive Immune System | 7.969437e-01 | 0.099 |
R-HSA-9024446 | NR1H2 and NR1H3-mediated signaling | 7.998964e-01 | 0.097 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 8.053846e-01 | 0.094 |
R-HSA-5654738 | Signaling by FGFR2 | 8.109722e-01 | 0.091 |
R-HSA-5250941 | Negative epigenetic regulation of rRNA expression | 8.109722e-01 | 0.091 |
R-HSA-9833482 | PKR-mediated signaling | 8.109722e-01 | 0.091 |
R-HSA-9018677 | Biosynthesis of DHA-derived SPMs | 8.145267e-01 | 0.089 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 8.188779e-01 | 0.087 |
R-HSA-5668541 | TNFR2 non-canonical NF-kB pathway | 8.214369e-01 | 0.085 |
R-HSA-390918 | Peroxisomal lipid metabolism | 8.247952e-01 | 0.084 |
R-HSA-1500620 | Meiosis | 8.280905e-01 | 0.082 |
R-HSA-9909615 | Regulation of PD-L1(CD274) Post-translational modification | 8.313241e-01 | 0.080 |
R-HSA-390466 | Chaperonin-mediated protein folding | 8.376104e-01 | 0.077 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 8.406654e-01 | 0.075 |
R-HSA-156902 | Peptide chain elongation | 8.406654e-01 | 0.075 |
R-HSA-1236974 | ER-Phagosome pathway | 8.436632e-01 | 0.074 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 8.456579e-01 | 0.073 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 8.466047e-01 | 0.072 |
R-HSA-112310 | Neurotransmitter release cycle | 8.466047e-01 | 0.072 |
R-HSA-73884 | Base Excision Repair | 8.466047e-01 | 0.072 |
R-HSA-9954714 | PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 8.494911e-01 | 0.071 |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | 8.494911e-01 | 0.071 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 8.494911e-01 | 0.071 |
R-HSA-9006936 | Signaling by TGFB family members | 8.501236e-01 | 0.071 |
R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 8.523233e-01 | 0.069 |
R-HSA-9679506 | SARS-CoV Infections | 8.532244e-01 | 0.069 |
R-HSA-156842 | Eukaryotic Translation Elongation | 8.551025e-01 | 0.068 |
R-HSA-391251 | Protein folding | 8.551025e-01 | 0.068 |
R-HSA-72312 | rRNA processing | 8.554750e-01 | 0.068 |
R-HSA-68867 | Assembly of the pre-replicative complex | 8.578294e-01 | 0.067 |
R-HSA-9837999 | Mitochondrial protein degradation | 8.605053e-01 | 0.065 |
R-HSA-9954716 | ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ri... | 8.631309e-01 | 0.064 |
R-HSA-5619102 | SLC transporter disorders | 8.648441e-01 | 0.063 |
R-HSA-9954709 | Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | 8.657072e-01 | 0.063 |
R-HSA-72764 | Eukaryotic Translation Termination | 8.657072e-01 | 0.063 |
R-HSA-72689 | Formation of a pool of free 40S subunits | 8.657072e-01 | 0.063 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 8.682353e-01 | 0.061 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 8.707159e-01 | 0.060 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 8.707159e-01 | 0.060 |
R-HSA-72306 | tRNA processing | 8.726504e-01 | 0.059 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 8.745362e-01 | 0.058 |
R-HSA-70171 | Glycolysis | 8.778818e-01 | 0.057 |
R-HSA-382556 | ABC-family proteins mediated transport | 8.778818e-01 | 0.057 |
R-HSA-2408557 | Selenocysteine synthesis | 8.801813e-01 | 0.055 |
R-HSA-9020702 | Interleukin-1 signaling | 8.801813e-01 | 0.055 |
R-HSA-1483255 | PI Metabolism | 8.824377e-01 | 0.054 |
R-HSA-192823 | Viral mRNA Translation | 8.846518e-01 | 0.053 |
R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency | 8.868242e-01 | 0.052 |
R-HSA-111885 | Opioid Signalling | 8.868242e-01 | 0.052 |
R-HSA-212436 | Generic Transcription Pathway | 8.869658e-01 | 0.052 |
R-HSA-2262752 | Cellular responses to stress | 8.873403e-01 | 0.052 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 8.889559e-01 | 0.051 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 8.889559e-01 | 0.051 |
R-HSA-6798695 | Neutrophil degranulation | 8.893678e-01 | 0.051 |
R-HSA-8957322 | Metabolism of steroids | 8.903383e-01 | 0.050 |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | 8.910476e-01 | 0.050 |
R-HSA-418346 | Platelet homeostasis | 8.931000e-01 | 0.049 |
R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | 8.951139e-01 | 0.048 |
R-HSA-69239 | Synthesis of DNA | 8.951139e-01 | 0.048 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 8.970899e-01 | 0.047 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 8.970899e-01 | 0.047 |
R-HSA-1236975 | Antigen processing-Cross presentation | 8.970899e-01 | 0.047 |
R-HSA-69002 | DNA Replication Pre-Initiation | 8.990288e-01 | 0.046 |
R-HSA-937061 | TRIF (TICAM1)-mediated TLR4 signaling | 9.009314e-01 | 0.045 |
R-HSA-166166 | MyD88-independent TLR4 cascade | 9.009314e-01 | 0.045 |
R-HSA-112316 | Neuronal System | 9.012018e-01 | 0.045 |
R-HSA-983712 | Ion channel transport | 9.043685e-01 | 0.044 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 9.046299e-01 | 0.044 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 9.046299e-01 | 0.044 |
R-HSA-2871796 | FCERI mediated MAPK activation | 9.046299e-01 | 0.044 |
R-HSA-5617833 | Cilium Assembly | 9.058150e-01 | 0.043 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 9.064272e-01 | 0.043 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 9.086470e-01 | 0.042 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 9.116191e-01 | 0.040 |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | 9.132851e-01 | 0.039 |
R-HSA-72613 | Eukaryotic Translation Initiation | 9.149198e-01 | 0.039 |
R-HSA-72737 | Cap-dependent Translation Initiation | 9.149198e-01 | 0.039 |
R-HSA-70326 | Glucose metabolism | 9.165238e-01 | 0.038 |
R-HSA-1592230 | Mitochondrial biogenesis | 9.165238e-01 | 0.038 |
R-HSA-2980736 | Peptide hormone metabolism | 9.165238e-01 | 0.038 |
R-HSA-428157 | Sphingolipid metabolism | 9.204336e-01 | 0.036 |
R-HSA-68875 | Mitotic Prophase | 9.211572e-01 | 0.036 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 9.216514e-01 | 0.035 |
R-HSA-9635486 | Infection with Mycobacterium tuberculosis | 9.226440e-01 | 0.035 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 9.228516e-01 | 0.035 |
R-HSA-1483206 | Glycerophospholipid biosynthesis | 9.228516e-01 | 0.035 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 9.255342e-01 | 0.034 |
R-HSA-6809371 | Formation of the cornified envelope | 9.269387e-01 | 0.033 |
R-HSA-977606 | Regulation of Complement cascade | 9.283168e-01 | 0.032 |
R-HSA-8953897 | Cellular responses to stimuli | 9.309265e-01 | 0.031 |
R-HSA-388396 | GPCR downstream signalling | 9.352300e-01 | 0.029 |
R-HSA-1474165 | Reproduction | 9.372645e-01 | 0.028 |
R-HSA-1483257 | Phospholipid metabolism | 9.373965e-01 | 0.028 |
R-HSA-9843745 | Adipogenesis | 9.384484e-01 | 0.028 |
R-HSA-5576891 | Cardiac conduction | 9.384484e-01 | 0.028 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 9.450985e-01 | 0.025 |
R-HSA-9948299 | Ribosome-associated quality control | 9.471521e-01 | 0.024 |
R-HSA-5358351 | Signaling by Hedgehog | 9.471521e-01 | 0.024 |
R-HSA-9018678 | Biosynthesis of specialized proresolving mediators (SPMs) | 9.528646e-01 | 0.021 |
R-HSA-166658 | Complement cascade | 9.546285e-01 | 0.020 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 9.558717e-01 | 0.020 |
R-HSA-168249 | Innate Immune System | 9.566329e-01 | 0.019 |
R-HSA-9758941 | Gastrulation | 9.579614e-01 | 0.019 |
R-HSA-9820448 | Developmental Cell Lineages of the Exocrine Pancreas | 9.602999e-01 | 0.018 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 9.602999e-01 | 0.018 |
R-HSA-69306 | DNA Replication | 9.610502e-01 | 0.017 |
R-HSA-5619115 | Disorders of transmembrane transporters | 9.620065e-01 | 0.017 |
R-HSA-597592 | Post-translational protein modification | 9.630810e-01 | 0.016 |
R-HSA-9610379 | HCMV Late Events | 9.639127e-01 | 0.016 |
R-HSA-9711097 | Cellular response to starvation | 9.645950e-01 | 0.016 |
R-HSA-2408522 | Selenoamino acid metabolism | 9.684268e-01 | 0.014 |
R-HSA-211897 | Cytochrome P450 - arranged by substrate type | 9.701847e-01 | 0.013 |
R-HSA-372790 | Signaling by GPCR | 9.708905e-01 | 0.013 |
R-HSA-416476 | G alpha (q) signalling events | 9.711039e-01 | 0.013 |
R-HSA-9824446 | Viral Infection Pathways | 9.721909e-01 | 0.012 |
R-HSA-611105 | Respiratory electron transport | 9.762932e-01 | 0.010 |
R-HSA-211945 | Phase I - Functionalization of compounds | 9.769857e-01 | 0.010 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 9.784420e-01 | 0.009 |
R-HSA-375276 | Peptide ligand-binding receptors | 9.796552e-01 | 0.009 |
R-HSA-1630316 | Glycosaminoglycan metabolism | 9.822046e-01 | 0.008 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 9.826191e-01 | 0.008 |
R-HSA-9609690 | HCMV Early Events | 9.831972e-01 | 0.007 |
R-HSA-6805567 | Keratinization | 9.863874e-01 | 0.006 |
R-HSA-418594 | G alpha (i) signalling events | 9.878860e-01 | 0.005 |
R-HSA-9748784 | Drug ADME | 9.891827e-01 | 0.005 |
R-HSA-15869 | Metabolism of nucleotides | 9.923398e-01 | 0.003 |
R-HSA-202733 | Cell surface interactions at the vascular wall | 9.924853e-01 | 0.003 |
R-HSA-9609646 | HCMV Infection | 9.941447e-01 | 0.003 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 9.942094e-01 | 0.003 |
R-HSA-9824439 | Bacterial Infection Pathways | 9.965410e-01 | 0.002 |
R-HSA-1643685 | Disease | 9.967620e-01 | 0.001 |
R-HSA-446203 | Asparagine N-linked glycosylation | 9.980080e-01 | 0.001 |
R-HSA-5663205 | Infectious disease | 9.984915e-01 | 0.001 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 9.989848e-01 | 0.000 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 9.993491e-01 | 0.000 |
R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | 9.996428e-01 | 0.000 |
R-HSA-211859 | Biological oxidations | 9.996625e-01 | 0.000 |
R-HSA-425407 | SLC-mediated transmembrane transport | 9.996630e-01 | 0.000 |
R-HSA-8978868 | Fatty acid metabolism | 9.997224e-01 | 0.000 |
R-HSA-392499 | Metabolism of proteins | 9.997634e-01 | 0.000 |
R-HSA-72766 | Translation | 9.998189e-01 | 0.000 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 9.999388e-01 | 0.000 |
R-HSA-382551 | Transport of small molecules | 9.999725e-01 | 0.000 |
R-HSA-500792 | GPCR ligand binding | 9.999920e-01 | 0.000 |
R-HSA-556833 | Metabolism of lipids | 9.999993e-01 | 0.000 |
R-HSA-9709957 | Sensory Perception | 1.000000e+00 | 0.000 |
R-HSA-1430728 | Metabolism | 1.000000e+00 | -0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
CK1D |
0.774 | 0.427 | -3 | 0.656 |
CK1E |
0.770 | 0.410 | -3 | 0.641 |
CK1A2 |
0.768 | 0.410 | -3 | 0.655 |
CK2A2 |
0.760 | 0.452 | 1 | 0.729 |
CK1G1 |
0.759 | 0.366 | -3 | 0.626 |
GRK1 |
0.756 | 0.292 | -2 | 0.833 |
CK1A |
0.756 | 0.371 | -3 | 0.679 |
CK2A1 |
0.752 | 0.430 | 1 | 0.711 |
GRK6 |
0.749 | 0.403 | 1 | 0.832 |
FAM20C |
0.749 | 0.225 | 2 | 0.804 |
GRK7 |
0.747 | 0.348 | 1 | 0.763 |
COT |
0.746 | 0.112 | 2 | 0.832 |
CK1G3 |
0.744 | 0.373 | -3 | 0.682 |
KIS |
0.743 | 0.101 | 1 | 0.737 |
IKKB |
0.741 | 0.154 | -2 | 0.755 |
BMPR1B |
0.740 | 0.207 | 1 | 0.813 |
GRK4 |
0.738 | 0.229 | -2 | 0.852 |
GRK5 |
0.737 | 0.266 | -3 | 0.305 |
IKKA |
0.735 | 0.149 | -2 | 0.755 |
DSTYK |
0.734 | 0.054 | 2 | 0.851 |
CDC7 |
0.733 | 0.058 | 1 | 0.839 |
MOS |
0.732 | 0.079 | 1 | 0.861 |
CAMK2G |
0.732 | 0.127 | 2 | 0.826 |
CLK3 |
0.731 | 0.037 | 1 | 0.837 |
GRK3 |
0.729 | 0.204 | -2 | 0.706 |
BMPR1A |
0.726 | 0.174 | 1 | 0.789 |
PRPK |
0.725 | -0.020 | -1 | 0.862 |
TGFBR1 |
0.725 | 0.142 | -2 | 0.849 |
MTOR |
0.725 | 0.011 | 1 | 0.805 |
CK1G2 |
0.723 | 0.288 | -3 | 0.656 |
CAMK2B |
0.723 | 0.121 | 2 | 0.836 |
ALK2 |
0.723 | 0.174 | -2 | 0.858 |
PDHK4 |
0.722 | -0.050 | 1 | 0.850 |
RAF1 |
0.722 | -0.032 | 1 | 0.845 |
TBK1 |
0.722 | -0.001 | 1 | 0.756 |
ACVR2A |
0.722 | 0.162 | -2 | 0.827 |
IKKE |
0.722 | 0.007 | 1 | 0.757 |
PIM3 |
0.721 | -0.003 | -3 | 0.178 |
GRK2 |
0.720 | 0.139 | -2 | 0.738 |
BMPR2 |
0.720 | -0.004 | -2 | 0.883 |
ACVR2B |
0.720 | 0.132 | -2 | 0.836 |
SRPK1 |
0.719 | -0.035 | -3 | 0.143 |
MAPKAPK2 |
0.719 | 0.038 | -3 | 0.104 |
ATR |
0.718 | 0.008 | 1 | 0.799 |
ALK4 |
0.718 | 0.122 | -2 | 0.865 |
SRPK3 |
0.717 | -0.033 | -3 | 0.156 |
ATM |
0.717 | 0.051 | 1 | 0.731 |
CAMK1B |
0.716 | -0.045 | -3 | 0.172 |
ERK5 |
0.716 | 0.002 | 1 | 0.829 |
NDR2 |
0.716 | -0.037 | -3 | 0.169 |
CDKL1 |
0.715 | -0.053 | -3 | 0.153 |
NLK |
0.714 | -0.034 | 1 | 0.853 |
MLK1 |
0.714 | 0.008 | 2 | 0.738 |
PIM1 |
0.714 | 0.003 | -3 | 0.174 |
PLK3 |
0.713 | 0.117 | 2 | 0.773 |
PDHK1 |
0.713 | -0.079 | 1 | 0.845 |
RSK2 |
0.713 | -0.022 | -3 | 0.124 |
SKMLCK |
0.713 | -0.034 | -2 | 0.803 |
NEK7 |
0.712 | -0.083 | -3 | 0.191 |
PLK1 |
0.712 | 0.088 | -2 | 0.812 |
GCN2 |
0.712 | -0.125 | 2 | 0.750 |
SRPK2 |
0.712 | -0.045 | -3 | 0.120 |
CAMK2A |
0.711 | 0.059 | 2 | 0.817 |
NEK6 |
0.711 | -0.083 | -2 | 0.859 |
HUNK |
0.711 | -0.049 | 2 | 0.763 |
RIPK3 |
0.711 | -0.098 | 3 | 0.079 |
TTBK2 |
0.710 | 0.054 | 2 | 0.662 |
JNK3 |
0.710 | 0.073 | 1 | 0.703 |
BCKDK |
0.710 | -0.022 | -1 | 0.796 |
DLK |
0.710 | 0.046 | 1 | 0.826 |
CAMK2D |
0.708 | -0.008 | -3 | 0.133 |
MARK4 |
0.708 | -0.048 | 4 | 0.825 |
TGFBR2 |
0.708 | -0.056 | -2 | 0.830 |
PKN3 |
0.707 | -0.071 | -3 | 0.146 |
CLK2 |
0.707 | 0.003 | -3 | 0.147 |
CDK1 |
0.707 | 0.024 | 1 | 0.686 |
ULK2 |
0.706 | -0.135 | 2 | 0.730 |
NUAK2 |
0.706 | -0.072 | -3 | 0.172 |
CDKL5 |
0.705 | -0.061 | -3 | 0.137 |
HIPK4 |
0.705 | -0.052 | 1 | 0.799 |
CAMLCK |
0.705 | -0.079 | -2 | 0.790 |
LATS2 |
0.705 | -0.028 | -5 | 0.721 |
JNK2 |
0.704 | 0.060 | 1 | 0.677 |
CDK8 |
0.704 | 0.002 | 1 | 0.715 |
NIK |
0.704 | -0.121 | -3 | 0.181 |
MASTL |
0.704 | -0.117 | -2 | 0.802 |
P90RSK |
0.704 | -0.058 | -3 | 0.123 |
PLK2 |
0.704 | 0.080 | -3 | 0.207 |
PRKD1 |
0.704 | -0.070 | -3 | 0.111 |
MEKK3 |
0.703 | 0.104 | 1 | 0.801 |
WNK1 |
0.703 | -0.084 | -2 | 0.831 |
MST4 |
0.702 | -0.061 | 2 | 0.785 |
LATS1 |
0.702 | 0.007 | -3 | 0.157 |
AMPKA1 |
0.702 | -0.059 | -3 | 0.159 |
ICK |
0.702 | -0.053 | -3 | 0.159 |
ULK1 |
0.702 | -0.108 | -3 | 0.166 |
CHAK2 |
0.702 | -0.084 | -1 | 0.821 |
MAPKAPK3 |
0.702 | -0.045 | -3 | 0.100 |
MEK1 |
0.702 | 0.044 | 2 | 0.803 |
DYRK2 |
0.701 | -0.002 | 1 | 0.736 |
DNAPK |
0.701 | 0.041 | 1 | 0.693 |
DAPK2 |
0.701 | -0.099 | -3 | 0.167 |
TLK2 |
0.701 | 0.036 | 1 | 0.763 |
NDR1 |
0.701 | -0.099 | -3 | 0.154 |
RSK4 |
0.700 | -0.016 | -3 | 0.130 |
ANKRD3 |
0.700 | -0.107 | 1 | 0.841 |
CLK4 |
0.699 | -0.034 | -3 | 0.156 |
MSK2 |
0.699 | -0.051 | -3 | 0.140 |
PRKX |
0.699 | -0.012 | -3 | 0.128 |
JNK1 |
0.698 | 0.060 | 1 | 0.663 |
TSSK2 |
0.698 | -0.032 | -5 | 0.819 |
P38B |
0.698 | 0.042 | 1 | 0.689 |
PRKD2 |
0.697 | -0.081 | -3 | 0.097 |
MLK4 |
0.697 | -0.008 | 2 | 0.651 |
PKN2 |
0.697 | -0.099 | -3 | 0.167 |
P70S6KB |
0.697 | -0.078 | -3 | 0.136 |
CDK19 |
0.697 | -0.006 | 1 | 0.681 |
PKACG |
0.697 | -0.049 | -2 | 0.660 |
WNK3 |
0.697 | -0.155 | 1 | 0.797 |
PRP4 |
0.697 | -0.029 | -3 | 0.162 |
RIPK1 |
0.697 | -0.127 | 1 | 0.786 |
NIM1 |
0.696 | -0.097 | 3 | 0.120 |
MSK1 |
0.696 | -0.034 | -3 | 0.126 |
NEK9 |
0.696 | -0.144 | 2 | 0.767 |
AMPKA2 |
0.696 | -0.077 | -3 | 0.140 |
SMG1 |
0.696 | -0.017 | 1 | 0.745 |
P38G |
0.695 | 0.043 | 1 | 0.607 |
PASK |
0.695 | 0.016 | -3 | 0.201 |
ERK1 |
0.695 | 0.025 | 1 | 0.681 |
MLK3 |
0.694 | -0.064 | 2 | 0.661 |
QSK |
0.694 | -0.065 | 4 | 0.803 |
TLK1 |
0.694 | 0.041 | -2 | 0.856 |
PKACB |
0.694 | -0.034 | -2 | 0.585 |
P38A |
0.694 | 0.015 | 1 | 0.750 |
CDK3 |
0.694 | 0.001 | 1 | 0.629 |
YSK4 |
0.694 | -0.054 | 1 | 0.786 |
CDK5 |
0.693 | -0.020 | 1 | 0.734 |
RSK3 |
0.693 | -0.093 | -3 | 0.111 |
P38D |
0.693 | 0.051 | 1 | 0.619 |
TSSK1 |
0.693 | -0.071 | -3 | 0.155 |
MYLK4 |
0.693 | -0.050 | -2 | 0.697 |
MARK3 |
0.692 | -0.032 | 4 | 0.770 |
CDK2 |
0.692 | -0.036 | 1 | 0.754 |
CLK1 |
0.692 | -0.056 | -3 | 0.121 |
MARK2 |
0.692 | -0.035 | 4 | 0.732 |
HIPK2 |
0.692 | 0.003 | 1 | 0.660 |
PKCD |
0.691 | -0.094 | 2 | 0.712 |
PKR |
0.691 | -0.080 | 1 | 0.813 |
AURA |
0.691 | -0.023 | -2 | 0.552 |
BRAF |
0.690 | -0.040 | -4 | 0.825 |
CDK13 |
0.690 | -0.017 | 1 | 0.697 |
VRK2 |
0.690 | -0.185 | 1 | 0.855 |
BRSK1 |
0.690 | -0.075 | -3 | 0.126 |
CAMK4 |
0.689 | -0.103 | -3 | 0.161 |
MEKK2 |
0.689 | 0.006 | 2 | 0.741 |
ERK2 |
0.689 | 0.010 | 1 | 0.714 |
DRAK1 |
0.689 | -0.033 | 1 | 0.768 |
SIK |
0.689 | -0.089 | -3 | 0.131 |
DYRK4 |
0.688 | 0.013 | 1 | 0.675 |
MLK2 |
0.688 | -0.165 | 2 | 0.751 |
PAK1 |
0.688 | -0.065 | -2 | 0.700 |
HIPK1 |
0.688 | -0.017 | 1 | 0.755 |
MARK1 |
0.688 | -0.056 | 4 | 0.787 |
GAK |
0.688 | 0.096 | 1 | 0.853 |
IRE1 |
0.688 | -0.123 | 1 | 0.759 |
AKT2 |
0.687 | -0.070 | -3 | 0.117 |
AURC |
0.687 | -0.059 | -2 | 0.574 |
CDK18 |
0.686 | -0.007 | 1 | 0.659 |
GSK3A |
0.686 | 0.031 | 4 | 0.419 |
QIK |
0.686 | -0.121 | -3 | 0.153 |
PLK4 |
0.686 | -0.046 | 2 | 0.593 |
CDK7 |
0.686 | -0.033 | 1 | 0.723 |
MAPKAPK5 |
0.686 | -0.107 | -3 | 0.097 |
TTBK1 |
0.685 | -0.004 | 2 | 0.581 |
PINK1 |
0.685 | -0.129 | 1 | 0.823 |
PRKD3 |
0.685 | -0.098 | -3 | 0.105 |
NUAK1 |
0.684 | -0.121 | -3 | 0.123 |
DYRK1A |
0.684 | -0.042 | 1 | 0.765 |
MEK5 |
0.684 | -0.099 | 2 | 0.766 |
ZAK |
0.683 | -0.062 | 1 | 0.787 |
MEKK1 |
0.683 | -0.118 | 1 | 0.800 |
SGK3 |
0.683 | -0.063 | -3 | 0.120 |
PERK |
0.683 | -0.095 | -2 | 0.864 |
PIM2 |
0.683 | -0.068 | -3 | 0.119 |
MST3 |
0.682 | -0.021 | 2 | 0.754 |
PAK2 |
0.682 | -0.076 | -2 | 0.686 |
NEK2 |
0.682 | -0.118 | 2 | 0.736 |
PKCG |
0.681 | -0.088 | 2 | 0.650 |
PKCB |
0.681 | -0.096 | 2 | 0.652 |
CDK12 |
0.681 | -0.020 | 1 | 0.672 |
CDK17 |
0.681 | -0.007 | 1 | 0.609 |
YANK3 |
0.681 | 0.088 | 2 | 0.394 |
TAO3 |
0.681 | -0.050 | 1 | 0.797 |
IRE2 |
0.681 | -0.149 | 2 | 0.677 |
MELK |
0.680 | -0.149 | -3 | 0.116 |
DYRK1B |
0.680 | -0.006 | 1 | 0.694 |
CAMK1G |
0.680 | -0.091 | -3 | 0.131 |
PAK6 |
0.679 | -0.057 | -2 | 0.622 |
PAK3 |
0.679 | -0.119 | -2 | 0.698 |
PKCA |
0.678 | -0.097 | 2 | 0.643 |
CHK1 |
0.678 | -0.106 | -3 | 0.102 |
PKACA |
0.678 | -0.052 | -2 | 0.533 |
AURB |
0.678 | -0.069 | -2 | 0.570 |
DCAMKL1 |
0.678 | -0.098 | -3 | 0.130 |
PHKG1 |
0.678 | -0.139 | -3 | 0.155 |
BRSK2 |
0.678 | -0.125 | -3 | 0.126 |
NEK5 |
0.677 | -0.144 | 1 | 0.801 |
GSK3B |
0.677 | -0.013 | 4 | 0.405 |
CAMK1D |
0.677 | -0.061 | -3 | 0.094 |
MPSK1 |
0.677 | -0.043 | 1 | 0.787 |
CAMKK1 |
0.677 | -0.071 | -2 | 0.762 |
CDK9 |
0.676 | -0.043 | 1 | 0.704 |
DYRK3 |
0.676 | -0.037 | 1 | 0.752 |
HIPK3 |
0.676 | -0.057 | 1 | 0.747 |
CHAK1 |
0.675 | -0.171 | 2 | 0.695 |
HRI |
0.675 | -0.165 | -2 | 0.848 |
NEK11 |
0.675 | -0.072 | 1 | 0.799 |
CDK14 |
0.675 | -0.023 | 1 | 0.702 |
WNK4 |
0.675 | -0.122 | -2 | 0.824 |
PKCH |
0.675 | -0.117 | 2 | 0.637 |
MNK2 |
0.674 | -0.121 | -2 | 0.708 |
TAK1 |
0.674 | 0.025 | 1 | 0.816 |
PKG2 |
0.674 | -0.082 | -2 | 0.585 |
GCK |
0.673 | -0.044 | 1 | 0.815 |
SGK1 |
0.673 | -0.044 | -3 | 0.095 |
AKT1 |
0.673 | -0.076 | -3 | 0.112 |
PKCZ |
0.673 | -0.137 | 2 | 0.702 |
DAPK1 |
0.673 | -0.042 | -3 | 0.168 |
MST2 |
0.673 | -0.043 | 1 | 0.811 |
SNRK |
0.673 | -0.188 | 2 | 0.627 |
SMMLCK |
0.672 | -0.103 | -3 | 0.145 |
DAPK3 |
0.672 | -0.063 | -3 | 0.159 |
CDK16 |
0.672 | -0.008 | 1 | 0.624 |
MNK1 |
0.672 | -0.119 | -2 | 0.717 |
EEF2K |
0.672 | -0.044 | 3 | 0.131 |
ALPHAK3 |
0.671 | 0.104 | -1 | 0.797 |
NEK8 |
0.671 | -0.112 | 2 | 0.738 |
SSTK |
0.671 | -0.072 | 4 | 0.783 |
MAK |
0.671 | -0.016 | -2 | 0.678 |
LKB1 |
0.670 | -0.106 | -3 | 0.153 |
SBK |
0.670 | -0.037 | -3 | 0.067 |
CAMKK2 |
0.670 | -0.083 | -2 | 0.750 |
PDK1 |
0.670 | -0.086 | 1 | 0.781 |
IRAK1 |
0.669 | -0.163 | -1 | 0.732 |
P70S6K |
0.669 | -0.100 | -3 | 0.097 |
MINK |
0.669 | -0.057 | 1 | 0.803 |
CDK10 |
0.667 | -0.025 | 1 | 0.687 |
DCAMKL2 |
0.667 | -0.113 | -3 | 0.127 |
HPK1 |
0.667 | -0.043 | 1 | 0.808 |
TNIK |
0.666 | -0.083 | 3 | 0.109 |
TAO2 |
0.665 | -0.132 | 2 | 0.778 |
CHK2 |
0.665 | -0.095 | -3 | 0.089 |
IRAK4 |
0.665 | -0.171 | 1 | 0.766 |
MAP2K6_TYR |
0.664 | 0.218 | -1 | 0.893 |
ERK7 |
0.663 | -0.028 | 2 | 0.472 |
PDHK1_TYR |
0.663 | 0.204 | -1 | 0.910 |
PDHK4_TYR |
0.663 | 0.210 | 2 | 0.845 |
AKT3 |
0.663 | -0.074 | -3 | 0.097 |
HGK |
0.662 | -0.116 | 3 | 0.100 |
PDHK3_TYR |
0.662 | 0.133 | 4 | 0.879 |
KHS2 |
0.661 | -0.048 | 1 | 0.810 |
NEK4 |
0.661 | -0.164 | 1 | 0.782 |
TTK |
0.661 | -0.009 | -2 | 0.836 |
BMPR2_TYR |
0.660 | 0.096 | -1 | 0.899 |
PHKG2 |
0.660 | -0.145 | -3 | 0.133 |
YANK2 |
0.660 | 0.101 | 2 | 0.412 |
CDK6 |
0.660 | -0.039 | 1 | 0.681 |
PKCT |
0.660 | -0.132 | 2 | 0.648 |
MAP3K15 |
0.660 | -0.123 | 1 | 0.770 |
CAMK1A |
0.659 | -0.085 | -3 | 0.089 |
PAK5 |
0.659 | -0.079 | -2 | 0.552 |
MST1 |
0.659 | -0.088 | 1 | 0.794 |
MOK |
0.659 | -0.042 | 1 | 0.759 |
PKCE |
0.659 | -0.094 | 2 | 0.632 |
OSR1 |
0.658 | -0.036 | 2 | 0.735 |
MAP2K4_TYR |
0.658 | 0.103 | -1 | 0.888 |
KHS1 |
0.657 | -0.085 | 1 | 0.795 |
VRK1 |
0.657 | -0.161 | 2 | 0.785 |
RIPK2 |
0.656 | -0.171 | 1 | 0.741 |
MRCKB |
0.656 | -0.081 | -3 | 0.116 |
PAK4 |
0.656 | -0.076 | -2 | 0.561 |
LRRK2 |
0.656 | -0.164 | 2 | 0.781 |
PKCI |
0.656 | -0.128 | 2 | 0.665 |
CDK4 |
0.655 | -0.041 | 1 | 0.660 |
STK33 |
0.654 | -0.103 | 2 | 0.570 |
NEK1 |
0.654 | -0.195 | 1 | 0.780 |
MRCKA |
0.654 | -0.086 | -3 | 0.122 |
SLK |
0.654 | -0.096 | -2 | 0.685 |
ROCK2 |
0.654 | -0.081 | -3 | 0.139 |
MEKK6 |
0.653 | -0.185 | 1 | 0.792 |
PBK |
0.653 | -0.054 | 1 | 0.777 |
MEK2 |
0.652 | -0.185 | 2 | 0.766 |
PKN1 |
0.651 | -0.121 | -3 | 0.100 |
DMPK1 |
0.650 | -0.069 | -3 | 0.139 |
MAP2K7_TYR |
0.650 | 0.040 | 2 | 0.817 |
FYN |
0.649 | 0.058 | -1 | 0.833 |
LOK |
0.648 | -0.150 | -2 | 0.723 |
FGR |
0.647 | 0.017 | 1 | 0.836 |
INSRR |
0.647 | -0.021 | 3 | 0.097 |
TESK1_TYR |
0.647 | -0.079 | 3 | 0.164 |
SYK |
0.647 | 0.139 | -1 | 0.832 |
YSK1 |
0.646 | -0.137 | 2 | 0.729 |
TXK |
0.646 | 0.015 | 1 | 0.831 |
FER |
0.645 | -0.015 | 1 | 0.843 |
BUB1 |
0.645 | -0.086 | -5 | 0.791 |
BLK |
0.645 | -0.006 | -1 | 0.867 |
PKMYT1_TYR |
0.645 | -0.123 | 3 | 0.139 |
YES1 |
0.644 | -0.025 | -1 | 0.847 |
PINK1_TYR |
0.644 | -0.076 | 1 | 0.824 |
CRIK |
0.643 | -0.076 | -3 | 0.104 |
LCK |
0.643 | -0.026 | -1 | 0.856 |
HCK |
0.643 | -0.044 | -1 | 0.850 |
EPHA6 |
0.642 | -0.054 | -1 | 0.892 |
ABL2 |
0.642 | -0.047 | -1 | 0.831 |
BIKE |
0.641 | -0.021 | 1 | 0.749 |
EPHA4 |
0.641 | -0.020 | 2 | 0.772 |
SRMS |
0.641 | -0.027 | 1 | 0.833 |
EPHB4 |
0.641 | -0.069 | -1 | 0.860 |
ASK1 |
0.641 | -0.107 | 1 | 0.762 |
HASPIN |
0.640 | -0.061 | -1 | 0.663 |
KIT |
0.640 | -0.029 | 3 | 0.092 |
STLK3 |
0.639 | -0.051 | 1 | 0.748 |
FLT1 |
0.639 | 0.041 | -1 | 0.874 |
ROCK1 |
0.639 | -0.095 | -3 | 0.123 |
CSF1R |
0.639 | -0.097 | 3 | 0.088 |
RET |
0.639 | -0.097 | 1 | 0.791 |
PTK2 |
0.638 | 0.071 | -1 | 0.834 |
PKG1 |
0.638 | -0.104 | -2 | 0.500 |
EPHB2 |
0.637 | -0.043 | -1 | 0.845 |
LYN |
0.637 | -0.034 | 3 | 0.082 |
NEK3 |
0.636 | -0.215 | 1 | 0.749 |
EPHB1 |
0.636 | -0.077 | 1 | 0.827 |
SRC |
0.636 | 0.002 | -1 | 0.822 |
JAK2 |
0.636 | -0.144 | 1 | 0.791 |
ABL1 |
0.636 | -0.057 | -1 | 0.818 |
MYO3A |
0.636 | -0.122 | 1 | 0.775 |
MET |
0.636 | -0.026 | 3 | 0.090 |
TYK2 |
0.635 | -0.154 | 1 | 0.789 |
ERBB2 |
0.635 | -0.016 | 1 | 0.754 |
EPHB3 |
0.634 | -0.071 | -1 | 0.845 |
FGFR2 |
0.634 | -0.073 | 3 | 0.118 |
ROS1 |
0.634 | -0.181 | 3 | 0.075 |
JAK3 |
0.634 | -0.085 | 1 | 0.772 |
MST1R |
0.634 | -0.175 | 3 | 0.095 |
KDR |
0.633 | -0.077 | 3 | 0.084 |
MYO3B |
0.633 | -0.148 | 2 | 0.743 |
EGFR |
0.633 | 0.039 | 1 | 0.664 |
FGFR3 |
0.633 | -0.031 | 3 | 0.114 |
ERBB4 |
0.633 | 0.051 | 1 | 0.685 |
TYRO3 |
0.633 | -0.170 | 3 | 0.089 |
ITK |
0.632 | -0.090 | -1 | 0.810 |
BMX |
0.631 | -0.040 | -1 | 0.740 |
FGFR4 |
0.631 | 0.019 | -1 | 0.797 |
FLT3 |
0.631 | -0.106 | 3 | 0.084 |
MERTK |
0.630 | -0.072 | 3 | 0.112 |
LIMK2_TYR |
0.629 | -0.187 | -3 | 0.149 |
TAO1 |
0.629 | -0.153 | 1 | 0.727 |
EPHA7 |
0.628 | -0.071 | 2 | 0.764 |
EPHA5 |
0.628 | -0.033 | 2 | 0.766 |
DDR1 |
0.628 | -0.153 | 4 | 0.787 |
EPHA3 |
0.627 | -0.066 | 2 | 0.739 |
LIMK1_TYR |
0.627 | -0.225 | 2 | 0.798 |
TEK |
0.627 | -0.154 | 3 | 0.083 |
NTRK1 |
0.627 | -0.100 | -1 | 0.827 |
EPHA8 |
0.626 | -0.048 | -1 | 0.841 |
INSR |
0.626 | -0.089 | 3 | 0.083 |
TEC |
0.626 | -0.086 | -1 | 0.742 |
FGFR1 |
0.625 | -0.125 | 3 | 0.108 |
TNK2 |
0.625 | -0.155 | 3 | 0.081 |
FRK |
0.625 | -0.075 | -1 | 0.871 |
IGF1R |
0.625 | -0.040 | 3 | 0.082 |
MATK |
0.624 | -0.027 | -1 | 0.757 |
PDGFRB |
0.623 | -0.172 | 3 | 0.087 |
ZAP70 |
0.623 | 0.080 | -1 | 0.738 |
ALK |
0.623 | -0.146 | 3 | 0.076 |
BTK |
0.622 | -0.142 | -1 | 0.766 |
NTRK3 |
0.622 | -0.088 | -1 | 0.782 |
FLT4 |
0.621 | -0.102 | 3 | 0.095 |
LTK |
0.621 | -0.134 | 3 | 0.086 |
AAK1 |
0.620 | -0.011 | 1 | 0.656 |
PTK2B |
0.620 | -0.077 | -1 | 0.770 |
AXL |
0.620 | -0.152 | 3 | 0.101 |
NTRK2 |
0.619 | -0.152 | 3 | 0.094 |
EPHA2 |
0.619 | -0.052 | -1 | 0.817 |
CSK |
0.619 | -0.054 | 2 | 0.757 |
JAK1 |
0.619 | -0.151 | 1 | 0.745 |
WEE1_TYR |
0.617 | -0.081 | -1 | 0.740 |
NEK10_TYR |
0.616 | -0.115 | 1 | 0.694 |
PTK6 |
0.616 | -0.113 | -1 | 0.721 |
EPHA1 |
0.613 | -0.160 | 3 | 0.081 |
TNNI3K_TYR |
0.613 | -0.134 | 1 | 0.793 |
DDR2 |
0.612 | -0.132 | 3 | 0.086 |
TNK1 |
0.611 | -0.206 | 3 | 0.090 |
PDGFRA |
0.611 | -0.236 | 3 | 0.080 |
FES |
0.609 | -0.050 | -1 | 0.707 |
MUSK |
0.591 | -0.148 | 1 | 0.650 |